Tuesday, November 16, 2021
Print Entire 2021 Program:
|
|
SESSION 1 SCHEDULE | |
Tuesday
SESSION 1:
PROGRESS IN TRANSCATHETER VALVE REPLACEMENT AND TREATMENT OF ASCENDING AORTIC DISEASE
Moderators:Hazim J. Safi, MD / Christoph A. Nienaber, MD, PhD
|
|
x | |
6:44 AM - 6:50 AM | Opening Remarks |
Presenter(s):Frank J. Veith, MD | |
View Slides in PDF | |
TRANSCATHETER HEART VALVES | |
6:50 AM - 6:55 AM Power Point Presentation with Synched Audio |
The Future Of TAVR |
Presenter(s):Martin Leon B. Leon, MD | |
View Slides in PDF | |
6:56 AM - 7:01 AM | Update On Current State Of Transcatheter Aortic Valve Replacement (TAVR): A Cardiac Surgeon’s View: What Is The Role Of Surgery In Aortic Valve Disease Treatment |
Presenter(s):Ali B. Khoynezhad, MD, PhD | |
View Slides in PDF | |
THE ASCENDING AORTA | |
7:02 AM - 7:07 AM | Progress In Endovascular Graft Treatment Of Ascending Aortic Lesions |
Presenter(s):Rodney A. White, MD | |
View Slides in PDF | |
7:08 AM - 7:13 AM | Progress In Endovascular Combined Devices For Repairing Lesions Of The Ascending Aorta And The Aortic Valve: The Endo-Bentall Concept |
Presenter(s):Ali B. Khoynezhad, MD, PhD | |
View Slides in PDF | |
7:14 AM - 7:19 AM | Update On Endovascular Treatment Of Ascending Aortic Lesions: What Is Here And What Is On The Horizon |
Presenter(s):Christoph A. Nienaber, MD, PhD | |
7:20 AM - 7:25 AM | Endovascular Treatment Of Type A Aortic Dissections (TAADs): What Is Here And What Is Coming |
Presenter(s):Ali Azizzadeh, MD | |
View Slides in PDF | |
7:25 AM - 7:25 AM | Panel Discussion Will Be Combined With Session 2 at 7:56 A.M. |
END OF SESSION 1 | |
SESSION 2 SCHEDULE | |
Tuesday
SESSION 2:
PROGRESS IN THE TREATMENT OF AORTIC ARCH LESIONS AND AORTIC DISSECTIONS
Moderators:Alan B. Lumsden, MD, FACS / Anthony L. Estrera, MD
|
|
x | |
7:26 AM - 7:31 AM | Hybrid Repair Of Aortic Arch And Thoracic Aortic Aneurysms Using ThoraFlex (Hybrid) And Relay Devices For Frozen Elephant Trunk (FET) And TEVAR: Indications And Results |
Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD | |
View Slides in PDF | |
7:32 AM - 7:37 AM | Current Status Of Complete Hybrid Arch Repair With Elephant Trunk And FET: What Does The Future Hold |
Presenter(s):Anthony L. Estrera, MD | |
View Slides in PDF | |
7:38 AM - 7:43 AM Power Point Presentation with Synched Audio |
Endovascular Arch Repair With Cook 2- Or 3-Branched Device For Lesions Involving The Entire Aortic Arch: Indications, Contraindications And Results |
Presenter(s):Stephan Haulon, MD | |
View Slides in PDF | |
7:44 AM - 7:49 AM Power Point Presentation with Synched Audio |
Update On Relay Branch For Arch Lesion Endovascular Repairs: Advantages, Limitations And Results |
Presenter(s):Vicente Riambau, MD, PhD / Ciro Ferrer, MD, PhD / Martin Czerny, MD | |
View Slides in PDF | |
7:50 AM - 7:55 AM Power Point Presentation with Synched Audio |
Total And Partial Aortic Arch Lesion Repairs With The Gore TAG Single Branch Endograft: An Off-The-Shelf (OTS) Device For Revascularizing Arch Branches: Experience To Date, Advantages And Limitations |
Presenter(s):Michael D. Dake, MD | |
View Slides in PDF | |
7:56 AM - 8:08 AM | Combined Panel Discussion (Sessions 1 and 2) |
END OF SESSION 2 | |
SESSION 3 SCHEDULE | |
Tuesday
SESSION 3:
PROGRESS IN THE ENDOVASCULAR TREATMENT OF AORTIC DISSECTIONS: REPORTING STANDARDS, CLASSIFICATION SYSTEMS, STABILISE, AND MORE
Moderators:James H. Black, III, MD / Joseph V. Lombardi, MD
|
|
x | |
8:08 AM - 8:13 AM | New SVS-STS Aortic Dissection Reporting Standards And Classification System: How Are They Different And Better |
Presenter(s):Joseph V. Lombardi, MD | |
View Slides in PDF | |
8:14 AM - 8:19 AM Power Point Presentation with Synched Audio |
Update On The STABILISE Concept For Treating Acute And Chronic TBADs By Disrupting The Intimal Flap By Overdilating The Distal Bare Stent: How It Works, Precautions And Results |
Presenter(s):Jean-Marc Alsac, MD, PhD | |
View Slides in PDF | |
8:20 AM - 8:25 AM | Dual Lumen Interventions To Promote False Lumen Thrombosis In Chronic Aortic Dissections: The FLIRT Procedure: Indications, Technique And Results |
Presenter(s):Christoph A. Nienaber, MD, PhD | |
8:26 AM - 8:31 AM | DEBATE: Fenestrated And Branched Endovascular Grafts (F/B/EVAR) Are Usually The Best Treatment For Post-Dissection Thoraco-Abdominal Aneurysms (TAAAs) |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
View Slides in PDF | |
8:32 AM - 8:37 AM | DEBATE: There Will Always Be A Need For Open Repair For Post-Dissection TAAAs: In What Circumstances |
Presenter(s):Hazim J. Safi, MD / Anthony L. Estrera, MD | |
View Slides in PDF | |
8:38 AM - 8:43 AM | Distal Stent-Graft Induced New Re-Entry Tears (SINEs) With TEVAR Treatment Of TBADs: Prevention By Avoiding Oversizing And Ballooning And Using Tapered Endografts |
Presenter(s):Ludovic Canaud, MD, PhD | |
View Slides in PDF | |
8:44 AM - 8:49 AM | When Is TEVAR The Best Treatment For Marfan Syndrome And Its Complications |
Presenter(s):James H. Black, III, MD | |
View Slides in PDF | |
8:50 AM - 8:56 AM | Panel Discussion |
END OF SESSION 3 | |
SESSION 4 SCHEDULE | |
Tuesday
SESSION 4:
MORE NEW DEVELOPMENTS IN THE TREATMENT OF TBADs, THORACIC AORTIC DISEASE AND THORACOABDOMINAL ANEURYSMS (TAAAs)
Moderators:Hazim J. Safi, MD / Ali B. Khoynezhad, MD, PhD
|
|
x | |
8:56 AM - 9:01 AM | Long-Term Durability Of Open Repair Of Type I-IV TAAAs Remains Excellent: When Should It Be The First Line Treatment And When Should A Hybrid (Endo + Open) Down-Staging Approach Be Used To Improve Outcomes: How To Do The Latter |
Presenter(s):Mark Conrad, MD, MMSc / Richard P. Cambria, MD | |
View Slides in PDF | |
9:02 AM - 9:07 AM | Lessons Learned From The STABLE I And II Trials: What Are The Advantages And Limitations Of A Distal Bare Stent Combined With A Proximal Covered Stent |
Presenter(s):Joseph V. Lombardi, MD | |
View Slides in PDF | |
9:08 AM - 9:13 AM | Why Is F/B/EVAR The Best Treatment For Post TBAD TAAAs: Challenges And Results |
Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
View Slides in PDF | |
9:14 AM - 9:19 AM | Gore TAMBE Endovascular Graft Device For TAAA Repair: How Does It Work: Results To Date, Advantages And Limitations |
Presenter(s):Mark A. Farber, MD | |
View Slides in PDF | |
9:20 AM - 9:25 AM | How To Predict TAAA Patients Who Should Not Have An Endovascular Repair And How To Minimize Mortality: Age And Mural Thrombus Matter |
Presenter(s):Patrick W. Kelly, MD | |
View Slides in PDF | |
9:26 AM - 9:31 AM | Improved Aortic Remodeling With TEVAR And A Distal Bare Metal Stent In Acute Complicated TBAD |
Presenter(s):Christoph A. Nienaber, MD, PhD | |
9:32 AM - 9:37 AM | Embolization Strategies To Achieve False Lumen Thrombosis With False Lumen TAAAs After TEVAR For TBADs |
Presenter(s):Carlos H. Timaran, MD | |
View Slides in PDF | |
9:38 AM - 9:43 AM | High Failure Rate Of Best Medical Treatment For Intramural Hematoma Mandates Increased Use Of TEVAR: Does This Help Outcomes |
Presenter(s):Jean M. Panneton, MD | |
View Slides in PDF | |
9:44 AM - 9:54 AM | Panel Discussion |
9:54 AM - 10:20 AM | Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 4 | |
SESSION 5 SCHEDULE | |
Tuesday
SESSION 5:
NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY AND TREATMENT, EVAR AND EVAS (ENDOVASCULAR ANEURYSM SEALING)
Moderators:Tilo Koelbel, MD, PhD / Kenneth Ouriel, MD, MBA
|
|
x | |
10:20 AM - 10:25 AM | Current Pros And Cons Of The Nellix EVAS Endograft For AAA Repair: First Update Of The EVAS2 IDE Trial Of The Modified Improved Nellix Endograft |
Presenter(s):Jeffrey P. Carpenter, MD | |
View Slides in PDF | |
10:26 AM - 10:31 AM | Failing EVARs Are An Emerging Epidemic: Etiology And How Best To Avoid And Treat The Problem |
Presenter(s):Murray L. Shames, MD | |
View Slides in PDF | |
10:32 AM - 10:37 AM | Diabetes And AAAs: Facts, Clues And Potential Treatment Opportunities |
Presenter(s):Ronald L. Dalman, MD | |
View Slides in PDF | |
10:38 AM - 10:43 AM | How Does Metformin Work To Slow AAA Growth At The Cellular Level: Could It Be Effective Treatment For Small AAAs: Is It The Reason For Decreased AAA Incidence In Diabetes |
Presenter(s):Kak Khee Yeung, MD, PhD | |
View Slides in PDF | |
Moderator(s): Mark A. Adelman, MD / Michel Makaroun, MD | |
10:44 AM - 10:49 AM | How Should AAA Sac Behavior After EVAR Be Used To Assess Treatment Success And Patient Prognosis |
Presenter(s):Jean-Pierre Becquemin, MD, FRCS | |
View Slides in PDF | |
10:50 AM - 10:55 AM | Impact Of AAA Sac Size On EVAR Outcomes Short And Long-Term: Large Size Is Associated With Failure: What To Do About It |
Presenter(s):Carlos H. Timaran, MD | |
View Slides in PDF | |
10:56 AM - 11:01 AM | Decreased AAA Sac Diameter After EVAR Is Associated With Good Outcomes While Sac Stability Is Not |
Presenter(s):Andres Schanzer, MD | |
View Slides in PDF | |
11:02 AM - 11:12 AM | Panel Discussion |
Moderator(s): Tilo Koelbel, MD, PhD / Michel Makaroun, MD | |
11:13 AM - 11:18 AM Power Point Presentation with Synched Audio |
Should Saccular AAAs Be Fixed At A Smaller Diameter Than Fusiform AAAs: How Should AAA Diameter Be Measured To Include The Normal Aorta Or Not |
Presenter(s):Frans L. Moll, MD, PhD | |
View Slides in PDF | |
11:19 AM - 11:24 AM | In Patients Suitable For EVAR Or Open Repair, Adverse Neck Anatomy (Short, Wide, Angulated) Is Associated With Increased Reintervention And Mortality Rates Equally After Open And Endo Repairs: From The DREAM RCT: How Should This Influence Treatment |
Presenter(s):Jan D. Blankensteijn, MD | |
View Slides in PDF | |
11:25 AM - 11:30 AM | Why AAA Diameter Is Often Not Enough To Make A Decision Regarding Threshold For Repair Or Re-Treatment After EVAR: What Other Parameters Should Enter Into The Decision |
Presenter(s):S. Rao Vallabhaneni, MD, FRCS | |
View Slides in PDF | |
11:31 AM - 11:36 AM | Improved AAA Sac Diameter Surveillance After EVAR Using A Home Smart Phone Ultrasound System: Device Description And Why It Will Improve Outcomes |
Presenter(s):Ian Loftus, MD / Roger M. Greenhalgh, MD | |
View Slides in PDF | |
11:37 AM - 11:42 AM | Key New Developments In Long-Term Evaluation Of EVAR For AAA Treatment |
Presenter(s):Jason T. Lee, MD | |
View Slides in PDF | |
11:43 AM - 11:48 AM | Long-Term EVAR Outcomes Have Improved Over Time Whereas Open Repair Outcomes Have Remained Stable: A VQI Propensity Study Explains Differing Results Of RCTs And Shows Late Survival Advantage Of EVAR |
Presenter(s):Marc L. Schermerhorn, MD | |
View Slides in PDF | |
11:49 AM - 11:59 AM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break - Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 5 | |
SESSION 6 SCHEDULE | |
Tuesday
SESSION 6:
MORE ABOUT AAAs, EVAR AND THE PUBLISHED UK NICE AAA GUIDELINES AND THEIR IMPACT ON AAA TREATMENT IN THE UK AND ELSEWHERE
|
|
x | |
1:00 PM - 1:05 PM | The Scientific Rationale Underlying The AAA NICE Guidelines: A View From A Writing Committee Member |
Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS | |
View Slides in PDF | |
1:06 PM - 1:11 PM | Long-Term Results Of The OVER RCT: Pertinence To NICE AAA Guidelines: How Operator Training And Experience Influence EVAR Outcomes |
Presenter(s):Jon S. Matsumura, MD | |
View Slides in PDF | |
1:12 PM - 1:17 PM | Impact Of NICE Guidelines On AAA Practice In The UK: Decreased Use Of EVAR Is NOT Justified By Recent Data Showing That EVAR Has Better 10-Year Survival Than Open Repair |
Presenter(s):Ian Loftus, MD | |
View Slides in PDF | |
1:18 PM - 1:23 PM | Are The NICE AAA Guidelines The End Of EVAR In The UK: Why The Guidelines Are Wrong And Can They Be Fixed |
Presenter(s):Richard G.J. Gibbs, FRCS / Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS | |
View Slides in PDF | |
1:24 PM - 1:29 PM | What Is Wrong With The NICE AAA Guidelines: Do They Still Limit The Use Of EVAR As In The Draft Guidelines |
Presenter(s):Bijan Modarai, PhD, FRCS | |
View Slides in PDF | |
1:30 PM - 1:35 PM | Update On What Has Happened With The NICE Guidelines In The UK And Elsewhere: Where Do They Stand In November 2021 |
Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC, PhD, FACS | |
View Slides in PDF | |
1:36 PM - 1:41 PM | Impact Of UK NICE AAA Guidelines On Other Countries Served By The European ESVS Guidelines |
Presenter(s):Anders Wanhainen, MD, PhD | |
View Slides in PDF | |
1:42 PM - 1:47 PM | What Has Been The Impact Of The UK NICE AAA Guidelines In Germany And Elsewhere – Despite Their Flaws |
Presenter(s):Dittmar Boeckler, MD | |
View Slides in PDF | |
1:47 PM - 1:52 PM | Panel Discussion |
END OF SESSION 6 | |
SESSION 7 SCHEDULE | |
Tuesday
SESSION 7:
MORE NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC DISSECTIONS AND THORACIC PATHOLOGY; STROKE PREVENTION WITH TEVAR
Moderators:Mark A. Farber, MD / Thomas C. Bower, MD
|
|
x | |
1:52 PM - 1:57 PM | Update On Stroke Reduction Strategies With TEVAR: How To Decrease Particulate And Gas Emboli: What Is The STEP 2 Study Telling Us |
Presenter(s):Tilo Koelbel, MD, PhD / Stephan Haulon, MD | |
View Slides in PDF | |
1:58 PM - 2:03 PM | Advances In Stroke Prevention From TEVAR: How To Decrease Gas And Particulate Emboli: When Should These Methods Be Used |
Presenter(s):Richard G.J. Gibbs, FRCS | |
View Slides in PDF | |
2:04 PM - 2:09 PM | Update On Value Of Embolic Brain Protection Devices For Proximal TEVAR And TAVR Procedures: When Are They Mandatory |
Presenter(s):Jeffrey P. Carpenter, MD | |
View Slides in PDF | |
2:10 PM - 2:15 PM | Material Properties Of The Aortic Arch Can Predict Bird Beaking And Type 1A Endoleaks With TEVAR: Will Conformable Endografts With Proximal Adjustable Angle Control Eliminate The Problem |
Presenter(s):Thomas L. Forbes, MD | |
View Slides in PDF | |
2:16 PM - 2:22 PM | Panel Discussion |
END OF SESSION 7 | |
SESSION 8 SCHEDULE | |
Tuesday
SESSION 8:
MORE NEW DEVELOPMENTS REGARDING TBADs AND TEVAR: NATURAL HISTORY; NEED FOR AND TIMING OF TEVAR FOR ACUTE UNCOMPLICATED TBADs
Moderators:William D. Jordan Jr., MD / Thomas L. Forbes, MD
|
|
x | |
2:22 PM - 2:28 PM | Long-Term Outcomes Of Medically Managed Acute TBADs: How Were Patients Selected For This Treatment |
Presenter(s):Thomas C. Bower, MD | |
View Slides in PDF | |
MEGA DEBATE ON TREATMENT OF ACUTE UNCOMPLICATED TBADs | |
2:29 PM - 2:34 PM Power Point Presentation with Synched Audio |
DEBATE: Many Uncomplicated Acute TBADs Never Need Invasive Interventions And Are Better Treated Medically; How To Select Such Patients |
Presenter(s):Rachel E. Clough, MD, PhD, FRCS | |
View Slides in PDF | |
2:35 PM - 2:40 PM | DEBATE: With Uncomplicated Acute TBADs, The Case For Waiting 2-6 Weeks From Onset And Then Limiting Aortic Coverage With TEVAR |
Presenter(s):Mark A. Farber, MD | |
View Slides in PDF | |
2:41 PM - 2:46 PM | DEBATE: With Uncomplicated TBADs, The Case For Early TEVAR With Extensive Aortic Coverage In Most Patients |
Presenter(s):William D. Jordan Jr., MD / Brad Leshnower, MD | |
View Slides in PDF | |
2:47 PM - 2:52 PM | DEBATE: Early Intervention For Acute TBADs (7-30 Days After Onset) With TEVAR For Acute TBADs Prevents Abdominal Extension Of False Lumen And TAAA Formation |
Presenter(s):Rodney A. White, MD | |
View Slides in PDF | |
2:53 PM - 2:58 PM | Ideal Timing And Patient Selection Of TEVAR In Acute Uncomplicated TBAD Patients: When Is Medical Treatment Indicated |
Presenter(s):Ali Azizzadeh, MD | |
View Slides in PDF | |
2:59 PM - 3:03 PM | [SS] Impact Of Cocaine Abuse On The Course Of Acute TBADs And Their Treatment: What Is The Mechanism |
Presenter(s):Frank R. Arko, MD | |
View Slides in PDF | |
3:03 PM - 3:08 PM | Techniques For And Advantages Of Rerouting A Misplaced TEVAR Which Is Leading To A Growing False Lumen And Malperfusion In Acute TBAD Patients |
Presenter(s):David M. Williams, MD | |
View Slides in PDF | |
3:09 PM - 3:14 PM | Re-Entry Specific Endovascular Therapy (RESET), i.e., TEVAR Plus Dealing With Re-Entry Tears Improves Outcomes: How To Do It |
Presenter(s):Jean M. Panneton, MD | |
View Slides in PDF | |
3:15 PM - 3:21 PM | Panel Discussion |
END OF SESSION 8 | |
SESSION 9 SCHEDULE | |
Tuesday
SESSION 9:
MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 1
Moderators:Michael R. Jaff, DO
|
|
x | |
3:22 PM - 3:25 PM | Introduction To The Symposium |
Presenter(s):Frank J. Veith, MD | |
3:25 PM - 3:29 PM | Welcome And Introduction |
Presenter(s):Michael R. Jaff, DO | |
3:29 PM - 3:36 PM | The Easy And Hard Parts About Running A PERT Program: Lessons Learned |
Presenter(s):Ziv J. Haskal, MD, FACR, FAHA, FSIR | |
View Slides in PDF | |
3:36 PM - 3:46 PM | The Basics Of Pulmonary Embolism: What Is The Role Of The History, Exam, Biomarkers |
Presenter(s):Raghu Kolluri, MD | |
View Slides in PDF | |
3:46 PM - 3:54 PM | Do We Need An Echo To Manage Acute Submassive PE |
Presenter(s):David M. Dudzinski, MD | |
View Slides in PDF | |
3:54 PM - 4:01 PM | Advanced Imaging For PE: What Is The Optimal Strategy For The Diagnosis Of Acute And Chronic PE |
Presenter(s):Brian B. Ghoshhajra, MD, MBA | |
View Slides in PDF | |
4:01 PM - 4:11 PM | Medical Treatment Of PE: When, Why, For How Long, And How Can I Remember |
Presenter(s):Ido Weinberg, MD, MSc | |
View Slides in PDF | |
4:11 PM - 4:19 PM | Testing For Cancer And Other Hypercoagulable States In PE |
Presenter(s):Rachel Rosovsky, MD, MPH | |
View Slides in PDF | |
4:19 PM - 4:26 PM | The First Opportunity – The Emergency Physician Algorithm For Acute PE Management |
Presenter(s):D. Mark Courtney, MD | |
View Slides in PDF | |
4:26 PM - 4:33 PM | Ultrasound-Assisted Pharmacomechanical Thrombectomy: Does This Really Work |
Presenter(s):Kush R. Desai, MD | |
View Slides in PDF | |
4:33 PM - 4:40 PM | Mechanical Thrombectomy: The Indigo System |
Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA | |
View Slides in PDF | |
4:40 PM - 4:50 PM | What Strategy Is Best For Acute PE Intervention |
Presenter(s):Patrick Troy, MD | |
View Slides in PDF | |
4:50 PM - 4:57 PM | Step-By-Step Technical Tips For Pharmacomechanical Intervention For PE |
Presenter(s):Gary M. Ansel, MD | |
View Slides in PDF | |
4:57 PM - 5:04 PM | Percutaneous Mechanical Thrombectomy: The Flowtriever System: Where Does This Fit |
Presenter(s):Mitchell D. Weinberg, MD | |
View Slides in PDF | |
END OF SESSION 9 | |
SESSION 10 SCHEDULE | |
Tuesday
SESSION 10:
MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2
Moderators:Michael R. Jaff, DO
|
|
x | |
5:04 PM - 5:11 PM | Low-Dose Systemic Lytics: Is This An Effective Strategy For Acute PE Treatment |
Presenter(s):Mohsen Sharifi, MD | |
View Slides in PDF | |
5:11 PM - 5:18 PM | Vortex Strategy For Massive PE |
Presenter(s):Christopher J. Kwolek, MD, MBA | |
View Slides in PDF | |
5:18 PM - 5:26 PM | ECMO And Surgical Thromboembolectomy For Massive PE: When, How, And Why |
Presenter(s):Mark G. Davies, MD | |
View Slides in PDF | |
5:26 PM - 5:36 PM | Putting It All Together: What Is The Modern Algorithm For Management Of Massive And Submassive PE |
Presenter(s):Ido Weinberg, MD, MSc | |
View Slides in PDF | |
5:36 PM - 5:43 PM | Vena Cava Filters In PE Treatment: Do We Need To Do This, And If So, When |
Presenter(s):Kush R. Desai, MD | |
View Slides in PDF | |
5:43 PM - 5:50 PM | Balloon Angioplasty For Chronic Thromboembolic Pulmonary Hypertension: Has This Become Mainstream |
Presenter(s):Kenneth Rosenfield, MD | |
View Slides in PDF | |
5:50 PM - 5:58 PM | The Team Approach To PE Management: The National PERT Consortium |
Presenter(s):William B. Keeling, MD | |
View Slides in PDF | |
Moderator(s): Michael R. Jaff, DO | |
5:58 PM - 6:15 PM | Challenging Cases And “PERT” Decisions” Decisions |
Panelist(s): Mark G. Davies, MD / Kush R. Desai, MD / Ziv J. Haskal, MD, FACR, FAHA, FSIR / William B. Keeling, MD / Christopher J. Kwolek, MD, MBA / Kenneth Rosenfield, MD / Mohsen Sharifi, MD / Ido Weinberg, MD, MSc | |
6:15 PM - 6:15 PM | End of Program A |
END OF SESSION 10 | |
SESSION 11 SCHEDULE | |
Tuesday
SESSION 11:
PROGRESS IN VASCULAR ROBOTICS, GUIDANCE SYSTEMS, LAPAROSCOPY AND SIMULATION
Moderators:Willem Wisselink, MD / Sean P. Lyden, MD
|
|
x | |
6:44 AM - 6:49 AM | Opening Remarks |
Presenter(s):Enrico Ascher, MD | |
View Slides in PDF | |
6:50 AM - 6:55 AM | Update On Endovascular Robotics: They Have A Promising Future |
Presenter(s):Joseph J. Ricotta II, MD, MS, DFSVS, FACS | |
View Slides in PDF | |
6:56 AM - 7:01 AM | Robotic Decompression Of The Median Arcuate Ligament |
Presenter(s):Michael J. Singh, MD | |
View Slides in PDF | |
7:02 AM - 7:07 AM | Laparoscopic Assisted Aortofemoral Bypasses For Juxtarenal Aortic Occlusions: Why It Is The Best Treatment Method |
Presenter(s):Joseph S. Giglia, MD | |
View Slides in PDF | |
7:08 AM - 7:13 AM | Laparoscopic Robotic Assisted Aortic Surgery: Is It Worthwhile And Cost Effective In The Endovascular Era: Based On A 7-Year Experience In 87 Patients |
Presenter(s):Pierre-Olivier Thiney | |
View Slides in PDF | |
7:14 AM - 7:19 AM | Present Status And Future Potential Of Radiation Free Guidewire And Catheter Guidance: The Fiber Optic RealShape (FORS) From Philips: What Are Microbots And How Do They Work |
Presenter(s):Barry T. Katzen, MD | |
View Slides in PDF | |
7:20 AM - 7:25 AM | Update On The 3D Radiation Free Intraoperative Positioning System (IOPS) From Centerline For Endovascular Guidance: How Does It Work, Advantages And Limitations |
Presenter(s):Matthew J. Eagleton, MD | |
View Slides in PDF | |
7:26 AM - 7:32 AM | Panel Discussion |
END OF SESSION 11 | |
SESSION 12 SCHEDULE | |
Tuesday
SESSION 12:
NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; DIFFERING VIEWS ON TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND CAROTID SCREENING
|
|
x | |
7:32 AM - 7:37 AM | Variations In Carotid Treatment Within Countries And Between Countries In Europe, The US And Australia Is Great Despite All The RCTs: What Are The Implications |
Presenter(s):Maarit Venermo, MD, PhD | |
View Slides in PDF | |
7:38 AM - 7:43 AM | What Vascular Surgeons And Vascular Specialists Need To Know About What Can Be Learned From MRI And MRA Studies Of The Head And Neck |
Presenter(s):Allan L. Brook, MD | |
View Slides in PDF | |
7:44 AM - 7:49 AM | Update On Isolated Carotid Webs As A Cause Of Cryptogenic Stroke: How To Diagnose And Treat |
Presenter(s):Clayton J. Brinster, MD / W. Charles Sternbergh III, MD | |
View Slides in PDF | |
DIFFERING VIEWS ON TREATMENT OF ACS | |
7:50 AM - 7:55 AM Power Point Presentation with Synched Audio |
DEBATE: ALL Asymptomatic Carotid Stenosis (ACS) Patients Are Best Treated Medically: Invasive Treatment Causes More Harm Than Good |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
View Slides in PDF | |
7:56 AM - 8:01 AM | DEBATE: Not So: About 25% Of ACS Patients Can Benefit From CEA Or CAS And Should Be So Treated |
Presenter(s):Bruce A. Perler, MD, MBA | |
View Slides in PDF | |
8:02 AM - 8:07 AM | DEBATE: Both Views Are Wrong: About 5-10% Of ACS Patients Should Be Treated Invasively And Benefit From Such Treatment: Why Are Too Many ACS Patients Getting CEA Or CAS |
Presenter(s):Kosmas I. Paraskevas, MD | |
View Slides in PDF | |
DIFFERING VIEWS ON CAROTID SCREENING | |
8:08 AM - 8:13 AM | DEBATE: The Case For Widespread Carotid Screening |
Presenter(s):George S. Lavenson, MD | |
View Slides in PDF | |
8:14 AM - 8:19 AM Power Point Presentation with Synched Audio |
DEBATE: The Case Against Carotid Screening: It Leads To Unneeded And Possibly Harmful Treatment |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
View Slides in PDF | |
8:20 AM - 8:25 AM | DEBATE: Lifeline Proprietary Carotid Screening: Who Profits: Is It A Good Thing Or A Hoax And A Scam: What Can It Tell Us About The Prevalence Of ACS |
Presenter(s):James F. Meschia, MD / Thomas G. Brott, MD | |
View Slides in PDF | |
8:26 AM - 8:32 AM | Panel Discussion |
END OF SESSION 12 | |
SESSION 13 SCHEDULE | |
Tuesday
SESSION 13:
MORE ABOUT CAROTID AND VERTEBRAL DISEASE: UPDATE ON INVASIVE TREATMENT FOR ACUTE STROKES
Moderators:Allan L. Brook, MD / Klaus D. Mathias, MD
|
|
x | |
8:32 AM - 8:37 AM | Endovascular Treatment Of Carotid Artery Aneurysms Of Etiologies: Technical Aspects |
Presenter(s):Klaus D. Mathias, MD | |
View Slides in PDF | |
8:38 AM - 8:43 AM | When After Thrombolysis Treatment From A Stroke Should Carotid Endarterectomy (CEA) Be Performed And What Is The Best Timing For Those CEAs: Delay Has Consequences |
Presenter(s):Maarit Venermo, MD, PhD | |
View Slides in PDF | |
8:44 AM - 8:49 AM | Why Vascular Surgeons Should Become Involved In Intracranial Endovascular Treatments For Acute Strokes: How To Learn These Procedures And Benefit Patients |
Presenter(s):Laura Capoccia, MD, PhD | |
View Slides in PDF | |
8:50 AM - 8:55 AM | What Is New With Endovascular Intracranial Techniques For Arterial Clot Removal For Acute Strokes: New Methods; When And How Can The Time Window For Success Be Increased |
Presenter(s):Adnan H. Siddiqui, MD, PhD / L. Nelson Hopkins, MD | |
View Slides in PDF | |
8:56 AM - 9:01 AM | Update And New Developments In Intracranial Endovascular Treatment For Acute Strokes: Should Other Specialists Learn How To Do It And The Ways To Learn |
Presenter(s):Adnan H. Siddiqui, MD, PhD / L. Nelson Hopkins, MD | |
View Slides in PDF | |
9:02 AM - 9:07 AM | Improvements In The Treatment Of Acute Strokes: Why A Dedicated Stroke Center Matters: What And Who Must Be Involved: Yes, It Does Matter In Better Patient Outcomes |
Presenter(s):Hernan A. Bazan, MD, DFSVS, FACS | |
View Slides in PDF | |
9:08 AM - 9:14 AM | Panel Discussion |
9:14 AM - 9:24 AM | Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 13 | |
SESSION 14 SCHEDULE | |
Tuesday
SESSION 14:
PROGRESS IN THE TREATMENT OF AORTIC AND AORTO-ILIAC OCCLUSIVE DISEASE
|
|
x | |
9:24 AM - 9:29 AM | Current Concepts And Techniques For Treating External Iliac Artery Endofibrosis In Committed Athletes: What Works And Doesn’t Work: Is There A Role For Endovascular Treatment |
Presenter(s):Kenneth J. Cherry, MD | |
View Slides in PDF | |
9:30 AM - 9:35 AM Power Point Presentation with Synched Audio |
Iliac Stenosis In Professional Cyclists: How To Diagnose And Treat: ABIs Don’t Help |
Presenter(s):Gabriel Szendro, MD | |
View Slides in PDF | |
9:36 AM - 9:41 AM Power Point Presentation with Synched Audio |
Value Of VBX Balloon Expandable Covered Stents In Treating Complex Aorto-Iliac Occlusive Disease: Advantages And Limitations |
Presenter(s):Ehrin Armstrong, MD | |
COVERED ENDOVASCULAR RECONSTRUCTION OF THE AORTIC BIFURCATION (CERAB) PROCEDURE | |
9:42 AM - 9:47 AM | 5-Year Outcomes Of The CERAB Procedure With Covered Stents For Complex Aorto-Iliac Occlusive Disease: Why It’s Better Than Kissing Stents And Which Covered Stent Works Best |
Presenter(s):Michel M.P. Reijnen, MD, PhD / Peter C.J. Goverde, MD | |
View Slides in PDF | |
9:48 AM - 9:53 AM | CERAB Procedure Versus Kissing Stents For Complex Aorto-Iliac Occlusive Diseases: Advantages And Disadvantages Of Each: CERAB Requires More Time And Radiation |
Presenter(s):Maria A. Ruffino, MD, EBIR | |
View Slides in PDF | |
9:54 AM - 9:59 AM | Covered Endovascular Reconstruction Of The Aortic Bifurcation (CERAB) Technique: Multicentre UK Experience |
Presenter(s):Hany M. Zayed, MD | |
View Slides in PDF | |
10:00 AM - 10:05 AM Power Point Presentation with Synched Audio |
Value Of Shockwave Intravascular Lithotripsy For Calcified Aorto-Iliac Occlusive Disease Treatment |
Presenter(s):Andrew Holden, MBChB | |
View Slides in PDF | |
10:06 AM - 10:12 AM | Panel Discussion |
10:12 AM - 10:17 AM | Treatment Of Isolated Aortic Stenosis Without Iliac Disease: When Stents; When Stent-Grafts; When Open Bypass |
Presenter(s):Sigrid Nikol, MD | |
View Slides in PDF | |
10:18 AM - 10:23 AM | DEBATE: How To Treat Chronic Flush Juxtarenal Aortic Occlusions Endovascularly With Safety: Endo Is The Way To Go |
Presenter(s):David J. Minion, MD | |
View Slides in PDF | |
10:24 AM - 10:29 AM | DEBATE: Not So: Open Surgery Is the Best Way To Treat Flush Juxtarenal Aortic Occlusions Safely: Technical Tips On How To Do It |
Presenter(s):Thomas C. Bower, MD | |
View Slides in PDF | |
10:30 AM - 10:35 AM | DEBATE: Both Wrong: Hybrid Repairs Are Best For Complex Aorto-Iliac Occlusive Disease: Technical Tips On How To Do It |
Presenter(s):Yamume Tshomba, MD | |
View Slides in PDF | |
10:36 AM - 10:42 AM | Panel Discussion |
END OF SESSION 14 | |
SESSION 15 SCHEDULE | |
Tuesday
SESSION 15:
HOT NEW SHORT SUMMARY TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE
Moderators:Neal S. Cayne, MD / Palma M. Shaw, MD, FACS, RPVI, DFSVS
|
|
x | |
10:42 AM - 10:47 AM | Key Steps For Success With Radial Artery Access For Remote Visceral, Renal Or Lower Extremity Lesion Treatment |
Presenter(s):Marcelo Guimaraes, MD, MBA, FSIR | |
View Slides in PDF | |
10:48 AM - 10:53 AM | DEBATE: CO2 As A Contrast Agent Is Valuable For Lower Extremity Angiography And Treatments If Used Appropriately |
Presenter(s):Palma M. Shaw, MD, FACS, RPVI, DFSVS | |
View Slides in PDF | |
10:54 AM - 10:59 AM | DEBATE: Not So: CO2 As A Lower Extremity Contrast Agent Is Unnecessary And Has Downsides |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Slides in PDF | |
11:00 AM - 11:05 AM | Value Of Tack Optimized Balloon Angioplasty In Lower Extremity Interventions: When Should They Be Used And When Not (Tacks From Intact Vascular) |
Presenter(s):Lawrence A. Garcia, MD | |
View Slides in PDF | |
11:06 AM - 11:11 AM | Heel Ulceration And Ischemic Gangrene Involving The Achilles Tendon Should Not Be An Indication For A BTK Amputation: How To Save Such A Limb |
Presenter(s):Mark G. Davies, MD | |
View Slides in PDF | |
11:12 AM - 11:17 AM | Popliteal Artery-To-Distal Bypass For Limb Salvage; Status In 2021: Technical Tips And Value: When Is It Better Than Endovascular Treatments Francesco Spinelli, MD |
Presenter(s):Francesco Spinelli, MD | |
View Slides in PDF | |
11:18 AM - 11:24 AM | Panel Discussion |
END OF SESSION 15 | |
SESSION 16 SCHEDULE | |
Tuesday
SESSION 16:
MORE HOT NEW SHORT SUMMARY TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND CHRONIC LIMB THREATENING ISCHEMIA (CLTI) (4 3/4-MINUTE TALKS)
Moderators:Enrico Ascher, MD / Peter A. Schneider, MD
|
|
x | |
11:24 AM - 11:29 AM | Value Of External Duplex Ultrasound And Other Technical Factors In Optimizing BTK DCB Angioplasty |
Presenter(s):Francesco Liistro, MD | |
View Slides in PDF | |
11:29 AM - 11:34 AM Power Point Presentation with Synched Audio |
How To Size Lower Extremity Target Arteries For Endo Treatments Accurately Using Intravascular Ultrasound (IVUS): Why It Is Important |
Presenter(s):Jos C. van den Berg, MD, PhD | |
View Slides in PDF | |
11:34 AM - 11:39 AM | Patterns Of Calcification In BTK Arteries: How They Influence Endovascular Treatments |
Presenter(s):Jihad A. Mustapha, MD | |
View Slides in PDF | |
11:39 AM - 11:44 AM | How To Do Bypass Surgery To Heavily Non-Compressible Calcified Target Arteries |
Presenter(s):Enrico Ascher, MD / Frank J. Veith, MD | |
View Slides in PDF | |
11:44 AM - 11:49 AM | Challenge Of Getting Endovascular Revascularization To Achieve Healing Of Ischemic Wounds: Value Of A Wound Center In A Limb Salvage Program |
Presenter(s):Robert B. McLafferty, MD, MBA | |
View Slides in PDF | |
11:49 AM - 11:54 AM Power Point Presentation with Synched Audio |
Lower Extremity Interventions (PTA, Stents, Atherectomy) Under IVUS Guidance: Its Costs, Value And Limitations |
Presenter(s):Ignacio Escotto, MD | |
View Slides in PDF | |
11:54 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 AM | Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 16 | |
SESSION 17 SCHEDULE | |
Tuesday
SESSION 17:
NEW CONCEPTS, MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE (AI)
|
|
x | |
1:00 PM - 1:05 PM | What Is The Bright Future Of AI And Robotic Technology In Vascular Surgery |
Presenter(s):Willem Wisselink, MD | |
View Slides in PDF | |
1:06 PM - 1:11 PM | Unconventional Renal Allograft Landing Sites (Venous Anastomoses) In The Presence Of Near Total Caval Thrombosis |
Presenter(s):Robert A. Montgomery, MD, D.Phil | |
View Slides in PDF | |
1:12 PM - 1:17 PM | How Vascular Treatment Will Intersect With Other New Technologies: Wearable Trackers, AI, And Tissue Engineering |
Presenter(s):David H. Deaton, MD, FACS | |
View Slides in PDF | |
1:18 PM - 1:23 PM | How 3D And 4D Machine Learning Is Changing Vascular Surgery |
Presenter(s):Matthew T. Menard, MD | |
View Slides in PDF | |
1:24 PM - 1:29 PM | How Can AI Be Used To Predict Endoleaks And AAA Growth: Will It Have Clinical Value |
Presenter(s):Kak Khee Yeung, MD, PhD | |
View Slides in PDF | |
1:30 PM - 1:35 PM | Siemens I-Flow: A New Intelligent Technology To Improve The Endo Treatment Of Lower Extremity Occlusive Disease |
Presenter(s):Ravi K. Veeraswamy, MD | |
View Slides in PDF | |
1:36 PM - 1:41 PM | Totally Radiation Free Deployment Of A Complex AAA Endograft Using An Intraoperative Positioning System (IOPS From Centerline) And Positional Markers On Graft Components As Well As Catheters And Wires To Enable Accurate 3D Guidance: It Is Analogous To Precise GPS Targeting |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
View Slides in PDF | |
1:42 PM - 1:54 PM | Panel Discussion |
END OF SESSION 17 | |
SESSION 18 SCHEDULE | |
Tuesday
SESSION 18:
VASCULAR SURGERY’S NUMBERS, IDENTITY, RECOGNITION, INDEPENDENT SPECIALTY STATUS; HOW TO INCREASE OUR NUMBERS TO MEET FUTURE NEEDS FOR OUR SERVICES
Moderators:Bruce A. Perler, MD, MBA / Ronald L. Dalman, MD
|
|
x | |
1:54 PM - 1:59 PM | Updated Workforce Model Predicts A Shortage Of Vascular Surgeons For The Next 20 Years: What Should Vascular Surgery And The American Board of Surgery (ABS) Do About It |
Presenter(s):Bhagwan Satiani, MD, MBA / K. Craig Kent, MD | |
View Slides in PDF | |
2:00 PM - 2:05 PM | What Makes Vascular Surgery Different, Why Are There Insufficient Numbers Of Vascular Surgeons: How Can We Expand Our Numbers |
Presenter(s):Evan C. Lipsitz, MD, MBA | |
View Slides in PDF | |
2:06 PM - 2:11 PM | The Clouded Identity Of Vascular Surgery Amongst Other Doctors And The Public: Why Is It So And What Can Be Done About It |
Presenter(s):James C. Stanley, MD / Frank J. Veith, MD | |
View Slides in PDF | |
2:12 PM - 2:17 PM | Why US News & World Report Cannot And Does Not Rank Vascular Surgery Programs: Vascular Surgery Needs To Be An Independent ABMS Approved Specialty: Why Isn’t It |
Presenter(s):James H. Black, III, MD | |
View Slides in PDF | |
2:18 PM - 2:23 PM | The American Board Of Vascular Surgery Or ABVS: Its Time Is Now |
Presenter(s):Alan M. Dietzek, MD, RPVI, FACS | |
View Slides in PDF | |
2:24 PM - 2:29 PM | The SVS Executive Committee: What Is Its Function And How Has It Not Promoted Vascular Surgery And Thereby Failed To Serve Its Membership’s Interests |
Presenter(s):Benjamin W. Starnes, MD | |
View Slides in PDF | |
2:30 PM - 2:35 PM | What Will Happen If Vascular Surgery Does Not Become A Separate Specialty: How Have Our Vascular Societies Failed Vascular Surgeons |
Presenter(s):David H. Deaton, MD, FACS | |
View Slides in PDF | |
2:36 PM - 2:41 PM | Why Vascular Surgery Must Be An Independent Specialty: It Needs Independent Departments So As To Not Be Exploited By Other Department Chairs |
Presenter(s):Patrick J. Geraghty, MD | |
View Slides in PDF | |
2:42 PM - 2:47 PM | The Key To More Vascular Surgeons Is Better Exposure To Medical Students: We Are A Hidden Specialty Because Of Our Subordinate Specialty Status Which Also Limits Our Training Programs |
Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd | |
View Slides in PDF | |
2:48 PM - 2:53 PM | Vascular Surgery Training Program’s Update For 0+5 And 5+2 Programs: Do We Need More Applicants Or More Programs Or Both: How Can We Get There |
Presenter(s):Murray L. Shames, MD | |
View Slides in PDF | |
2:54 PM - 2:59 PM | Is Getting A Vascular Surgery Training Position Becoming Less Competitive For 0+5 Residencies; For 5+2 Fellowships |
Presenter(s):Peter L. Faries, MD, FACS | |
View Slides in PDF | |
3:00 PM - 3:05 PM | Leadership Roles Vascular Surgeons And Vascular Specialists Should Seek: Why They Are Important And How To Get There Without Abandoning Your Original Specialty |
Presenter(s):Christopher J. Kwolek, MD, MBA | |
View Slides in PDF | |
3:06 PM - 3:18 PM | Panel Discussion And Break Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 18 | |
SESSION 19 SCHEDULE | |
Tuesday
SESSION 19:
PROGRESS IN THE TREATMENT OF VISCERAL AND RENAL ARTERY DISEASE
Moderators:James C. Stanley, MD / Alan M. Dietzek, MD, RPVI, FACS
|
|
x | |
3:18 PM - 3:23 PM | DEBATE: All Visceral And Renal Artery Aneurysms Can Be Treated Endovascularly |
Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA | |
View Slides in PDF | |
3:24 PM - 3:29 PM | DEBATE: Open Treatment Of Visceral And Renal Artery Aneurysms Is Sometimes Best: When Is This |
Presenter(s):Timur P. Sarac, MD | |
View Slides in PDF | |
3:30 PM - 3:35 PM | Technical Tips For Percutaneous Endovascular Treatment Of Visceral And Renal Artery Aneurysms |
Presenter(s):Jacob Cynamon, MD, FACR, FSIR | |
View Slides in PDF | |
3:36 PM - 3:41 PM | Update On New SVS Practice Guidelines For Treating Visceral Artery Aneurysms; When Endo; When Open |
Presenter(s):Rabih A. Chaer, MD | |
View Slides in PDF | |
3:42 PM - 3:47 PM | Current Optimal Treatment Of Pancreatico-Duodenal Aneurysms With And Without Celiac Axis Occlusion: When Endo; When Open: Why They Are Both Challenging |
Presenter(s):Benjamin M. Jackson, MD / Ronald M. Fairman, MD | |
View Slides in PDF | |
3:48 PM - 3:53 PM | At What Size Do Renal Artery Aneurysms Need To Be Treated Invasively: A New Vascular Consortium Study Shows They Are Only Dangerous When >3 cm In Diameter |
Presenter(s):Peter F. Lawrence, MD | |
View Slides in PDF | |
3:54 PM - 3:59 PM | Optimal Current Treatment Of Renal Artery Aneurysms: When Endo; When Open; Technical Tips |
Presenter(s):Fred A. Weaver, MD, MMM | |
View Slides in PDF | |
4:00 PM - 4:06 PM | Panel Discussion |
END OF SESSION 19 | |
SESSION 20 SCHEDULE | |
Tuesday
SESSION 20:
UPDATE ON OPEN VASCULAR SURGICAL AND HYBRID PROCEDURES; PROGRESS IN THE TREATMENT OF AORTIC COARCTATIONS
Moderators:Enrico Ascher, MD / Jerry Goldstone, MD, FACS, FRCSEd
|
|
x | |
OPEN AND HYBRID VASCULAR SURGERY | |
4:06 PM - 4:11 PM | Minimal Incision For Retroperitoneal Aorto-Bifemoral Bypass: Technical Tips And Limitations |
Presenter(s):Robert M. Proczka, MD, PhD | |
View Slides in PDF | |
4:12 PM - 4:17 PM | Duplex Surveillance Should Be Used After All Aorto-Bifemoral Bypasses: It Improves Outcomes |
Presenter(s):Keith D. Calligaro, MD | |
View Slides in PDF | |
4:18 PM - 4:23 PM | Thoraco-Bifemoral Bypass: A Good Option After All Endo And Open Standard Approaches Have Failed: Technical Tips |
Presenter(s):Manju Kalra, MBBS | |
View Slides in PDF | |
4:24 PM - 4:29 PM | Long-Term Survival Results After Type II TAAA Endovascular Repair: When Is The Procedure Contraindicated |
Presenter(s):Matthew J. Eagleton, MD | |
View Slides in PDF | |
4:30 PM - 4:35 PM | Technical Tips For Aortic And Inferior Vena Cava Resections During Cancer Operations |
Presenter(s):Benjamin M. Jackson, MD | |
View Slides in PDF | |
UPDATE ON COARCTATION TREATMENT | |
4:36 PM - 4:41 PM | Endovascular Techniques Are The Best Treatment For Aortic Coarctations: When Bare Stents; When Covered Stents; Precautions |
Presenter(s):Zvonimir Krajcer, MD, FACC | |
View Slides in PDF | |
4:42 PM - 4:47 PM Power Point Presentation with Synched Audio |
Value Of BeGraft (From Bentley), A Balloon Expandable Covered Stent In Treating Aortic Coarctations: Can It Treat All Cases |
Presenter(s):Elchanan Bruckheimer, MBBS | |
View Slides in PDF | |
4:48 PM - 4:53 PM | Long-Term Outcomes Of Stent-Graft Treatment Of Aortic Coarctations |
Presenter(s):Frank R. Arko, MD | |
View Slides in PDF | |
4:54 PM - 5:00 PM | Panel Discussion |
END OF SESSION 20 | |
SESSION 21 SCHEDULE | |
Tuesday
SESSION 21:
ETHANOL ENDOVASCULAR CURATIVE TREATMENT OF VASCULAR MALFORMATIONS – PART 1
|
|
x | |
5:00 PM - 5:02 PM | Welcome And Introduction |
Presenter(s):Krassi Ivancev, MD, PhD | |
5:03 PM - 5:08 PM | International Society for the Study of Vascular Anomalies (ISSVA) Classification System: How It Is Applied In My Practice |
Presenter(s):Wayne F. Yakes, MD | |
View Slides in PDF | |
5:09 PM - 5:17 PM | The Yakes AVM Classification System: A Guide For Curative AVM Treatment As Documented In 100 Consecutive AVM Patients |
Presenter(s):Krassi Ivancev, MD, PhD | |
View Slides in PDF | |
5:18 PM - 5:26 PM | A Step-By-Step Practicum For Ethanol Endovascular Treatment Of AVMs Applying The Yakes Classification System |
Presenter(s):Robert L. Vogelzang, MD | |
View Slides in PDF | |
5:27 PM - 5:34 PM | A Step-By-Step Practicum For Ethanol Endovascular Treatment Of Venous Malformations |
Presenter(s):Krassi Ivancev, MD, PhD | |
View Slides in PDF | |
5:35 PM - 5:40 PM | Panel Discussion |
END OF SESSION 21 | |
SESSION 22 SCHEDULE | |
Tuesday
SESSION 22:
ETHANOL ENDOVASCULAR CURATIVE TREATMENT OF VASCULAR MALFORMATIONS – PART 2
|
|
x | |
5:41 PM - 5:48 PM | Curative Ethanol Endovascular Treatment of Complex Head & Neck AVMs |
Presenter(s):Wayne F. Yakes, MD | |
View Slides in PDF | |
5:49 PM - 5:55 PM | New Agents And Drugs For Vascular Malformation Management: Do They Offer Any Hope |
Presenter(s):Robert L. Vogelzang, MD | |
View Slides in PDF | |
5:56 PM - 6:03 PM | Endovascular Ethanol Treatment Of Complex Low-Flow Venous And Lymphatic Malformations |
Presenter(s):Wayne F. Yakes, MD | |
View Slides in PDF | |
6:04 PM - 6:10 PM | Problems! I’ve Got ‘Em---Managing The Tough Vascular Malformation Case |
Presenter(s):Robert L. Vogelzang, MD | |
View Slides in PDF | |
6:10 PM - 6:10 PM | End of Program B |
END OF SESSION 22 | |
Wednesday, November 17, 2021
Print Entire 2021 Program:
|
|
SESSION 23 SCHEDULE | |
Wednesday
SESSION 23:
GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI
Moderators:Enrico Ascher, MD / Gary M. Ansel, MD
|
|
x | |
6:40 AM - 6:45 AM | Do Diabetic Patients With CLTI And Substantial Foot Necrosis Have Time For An Endovascular First Strategy: Why Primary Open Bypass Treatment Is Better |
Presenter(s):Katariina M. Noronen, MD, PhD | |
View Slides in PDF | |
6:46 AM - 6:51 AM | Key New Developments In Endovascular Treatments For CLTI |
Presenter(s):Sahil A. Parikh, MD | |
View Slides in PDF | |
OPTIMAL TECHNIQUES FOR VESSEL PREP FOR ENDOVASCULAR TREATMENTS | |
6:52 AM - 6:57 AM | Technical Tips For Vessel Prep Before DCBs And DESs: It Is Different And Not Simple |
Presenter(s):Erwin Blessing, MD | |
View Slides in PDF | |
6:58 AM - 7:03 AM | Thirteen Technical Tips For Safe Radial Access For Renal/Visceral And Lower Extremity Interventions: How Far Distally In The Leg Can Lesions Be Treated |
Presenter(s):Craig M. Walker, MD | |
View Slides in PDF | |
7:04 AM - 7:09 AM | What Are The Downsides To Trans-Radial Or Pedal Access |
Presenter(s):Gary M. Ansel, MD | |
View Slides in PDF | |
TECHNICAL TIPS ON GUIDEWIRE CHOICE AND USAGE | |
7:10 AM - 7:15 AM | Tips For Treating Difficult BTK/BTA Lesions: How To Get A Guidewire Across A Long Calcified Occlusion And Getting A Resistant Balloon To Go Over The Wire |
Presenter(s):Marco G. Manzi, MD | |
View Slides in PDF | |
7:16 AM - 7:22 AM | Panel Discussion |
END OF SESSION 23 | |
SESSION 24 SCHEDULE | |
Wednesday
SESSION 24:
NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE)
Moderators:Craig M. Walker, MD / James F. McKinsey, MD
|
|
x | |
PROGRESS IN ATHERECTOMY | |
7:22 AM - 7:27 AM | New Developments In Laser Atherectomy: What Makes It Different: When Is It Beneficial With Certainty |
Presenter(s):George L. Adams, MD, FACS | |
View Slides in PDF | |
7:28 AM - 7:33 AM | Value Of Phoenix Atherectomy And Stellarex DCB For Infrapopliteal Lesions: Why IVUS Guidance Is Beneficial: 1-Year Results In CLTI Patients |
Presenter(s):Michael K.W. Lichtenberg, MD / Thomas Zeller, MD | |
View Slides in PDF | |
7:34 AM - 7:39 AM | Optical Coherence Tomography (OCT) Guided Atherectomy (Pantheris) For In Stent Restenosis (ISR): Why It Is More Effective Treatment: From The INSIGHT Trial |
Presenter(s):Todd R. Vogel, MD, MPH | |
View Slides in PDF | |
7:40 AM - 7:45 AM | Current Role Of Atherectomy In Treating Lower Extremity CLTI: A Vascular Surgeon’s View |
Presenter(s):James F. McKinsey, MD | |
View Slides in PDF | |
UPDATE ON THE SUPERA STENT | |
7:46 AM - 7:51 AM Power Point Presentation with Synched Audio |
Update On The Advantages Of The Supera Vasculomimetic (VMI) Stent For Treating Long Complex Fempop Occlusive Lesions: Is There Value To DCB Vessel Prep First |
Presenter(s):Peter C.J. Goverde, MD | |
7:52 AM - 7:57 AM | Value And Technical Tips To Make The Supera Stent Work In Curved And Angulated Non-SFA Lesion Locations |
Presenter(s):Rajiv Parakh, MBBS, MS, FRCS | |
View Slides in PDF | |
DRUG ELUTING STENTS FOR BTK LESIONS | |
7:58 AM - 8:03 AM | 10-Year Experience With Everolimus DESs To Treat Long Infrapopliteal Lesions Causing CLTI: Indications, Results, Value And Limitations |
Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA | |
View Slides in PDF | |
8:04 AM - 8:09 AM | What Is The Future For Bioresorbable DESs To Treat BTK Lesions: Good Long-Term Results Including The DISAPPEAR Trial Justify A New Trial: The LIFE-BTK Trial With The Esprit Stent From Abbott |
Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) / Sahil A. Parikh, MD / Brian G. DeRubertis, MD / Steven Kum, MD | |
View Slides in PDF | |
8:10 AM - 8:15 AM | A 3-French Compatible Microstent (From Micro Medical) For Antegrade Or Retrograde Insertion To Treat Tibial Artery Lesions: The STAND Trial |
Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI | |
View Slides in PDF | |
8:16 AM - 8:22 AM | Panel Discussion |
END OF SESSION 24 | |
SESSION 25 SCHEDULE | |
Wednesday
SESSION 25:
LOWER EXTREMITY TOPICS RELATED TO THE DRUG COATED DEVICES CAUSING INCREASED MORTALITY CONTROVERSY: DO PACLITAXEL COATED DEVICES CAUSE INCREASED MORTALITY (5 AND 4 ¾-MINUTE SHORT SUMMARY [SS] TALKS)
Moderators:Kenneth Ouriel, MD, MBA / Sahil A. Parikh, MD
|
|
x | |
8:22 AM - 8:27 AM | Older And More Recent Meta-Analyses Reveal An Increased Mortality Signal In Patients Receiving Paclitaxel Coated Devices Compared To Uncoated Devices: A More Recent Study Reveals Increased Amputation Rates With Paclitaxel Coated Devices: What About Mortality |
Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR | |
View Slides in PDF | |
8:28 AM - 8:33 AM | Large Population Based German Multicenter Study Of Paclitaxel Coated BTK DCBs And DESs Indicates Decreased Mortality And Amputation Rates Compared To Uncoated Devices: Initial Thoughts About Katsanos’ Recent Amputation Data |
Presenter(s):Christian A. Behrendt, MD | |
View Slides in PDF | |
8:34 AM - 8:39 AM | Real World Big Data Patient-Level Evidence Confirms No Harm From Paclitaxel Coated Devices For Treating Fempop Disease: Update On Medicare Data From Over 150,000 Patients |
Presenter(s):Eric A. Secemsky, MD, MSc / Robert Yeh, MD | |
View Slides in PDF | |
8:40 AM - 8:45 AM | Mortality Rates After Paclitaxel Coated Device Use In Patients With Both Critical Limb Ischemia (CLI) And Claudication: Two Systematic Reviews And Meta-Analyses Of Randomized Controlled Trials Show NO Increased Mortality With Paclitaxel Coated Devices Up To 5 Years |
Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) / Andrew Holden, MBChB / Krystal Dinh, MD / Peter A. Schneider, MD | |
View Slides in PDF | |
RELEVANT COMMENTS AS SHORT SUMMARY [SS] TOPICS (4 ¾-MINUTE TALKS) | |
8:46 AM - 8:51 AM | [SS] The Paclitaxel Increased Mortality Effect Reported By Dr. Katsanos et al. Seems Not To Be Confirmed By Added Data: Initial Thought About Katsanos’ Recent Meta-Analysis Showing Increased Amputation Rates With Paclitaxel Coated Devices |
Presenter(s):Peter A. Schneider, MD | |
View Slides in PDF | |
8:51 AM - 8:56 AM | [SS] New Data On The Paclitaxel Mortality Controversy: Should You Continue Using These Devices |
Presenter(s):Gary M. Ansel, MD | |
View Slides in PDF | |
8:56 AM - 9:01 AM | [SS] VQI Data Do Not Support The Paclitaxel Increased Mortality Signal |
Presenter(s):Daniel J. Bertges, MD / Jack L. Cronenwett, MD | |
View Slides in PDF | |
9:01 AM - 9:08 AM | Panel Discussion |
END OF SESSION 25 | |
SESSION 26 SCHEDULE | |
Wednesday
SESSION 26:
NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs (5-MINUTE TALKS)
Moderators:Joseph L. Mills, MD / John R. Laird, MD
|
|
x | |
NEW INFORMATION ON DCBs AND DESs FOR FEMPOP LESIONS: UPDATES ON RCTs | |
9:08 AM - 9:13 AM Power Point Presentation with Synched Audio |
Cost Effectiveness Of Drug Eluting Technologies For Femoropopliteal Lesions: They Are Worth The Increased Device Costs |
Presenter(s):Stefan Mueller-Huelsbeck, MD | |
View Slides in PDF | |
9:14 AM - 9:19 AM | Stellarex (Philips) DCBs With Low Dose Paclitaxel Is Safe And Effective In Fempop Lesions: Final 5-Year Data From The ILLUMENATE RCTs |
Presenter(s):Sean P. Lyden, MD | |
View Slides in PDF | |
9:20 AM - 9:25 AM | Pooled Data From The In.Pact RCT DCB Trials For SFA-Pop Lesions Show Safety And Efficacy For 5 Years Compared To POBA: Continued Use Is Justified |
Presenter(s):Peter A. Schneider, MD / John R. Laird, MD | |
View Slides in PDF | |
9:26 AM - 9:31 AM | New Findings From The DRASTICO Study Comparing DESs To DCBs For Fempop Lesions: 4-Year Results With TASC A/B Lesions Versus TASC C/D Lesions |
Presenter(s):Francesco Liistro, MD | |
View Slides in PDF | |
9:32 AM - 9:37 AM Power Point Presentation with Synched Audio |
Update On The Randomized Head To Head Comparison Of In.Pact (Medtronic) And Ranger (Boston Scientific) DCBs For Complex SFA Lesions: 2-Year Results Of The COMPARE RCT: Similar Results With Different Paclitaxel Dosages |
Presenter(s):Dierk Scheinert, MD / Sabine Steiner, MD | |
View Slides in PDF | |
9:38 AM - 9:43 AM | Update On The Global RANGER II RCT Comparing Ranger DCBs With POBA |
Presenter(s):Marianne Brodmann, MD | |
View Slides in PDF | |
9:44 AM - 9:49 AM | Panel Discussion |
9:49 AM - 10:02 AM | Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) Session 26 will continue after the Break. |
NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs (5-MINUTE TALKS) | |
Moderator(s): Joseph L. Mills, MD / John R. Laird, MD | |
10:02 AM - 10:07 AM Power Point Presentation with Synched Audio |
New Information On The Safety And Effectiveness Of The Cook Zilver PTX DES Based On Global Trials Including A RCT: When Is It The Best Treatment |
Presenter(s):Michael D. Dake, MD | |
View Slides in PDF | |
10:08 AM - 10:13 AM | Update On Clinical Trials Of The Boston Scientific Eluvia DES |
Presenter(s):William A. Gray, MD / Stefan Mueller-Huelsbeck, MD / Thomas Zeller, MD | |
View Slides in PDF | |
NEW INFORMATION ON BTK DCBs AND DESs | |
10:14 AM - 10:19 AM | The Sirolimus DCB BTK Era Begins – Current Experience With The Selution DCB And Design Of The SELUTION SLR .014 BTK IDE Trial: Early Results From Singapore And Europe |
Presenter(s):Patrick J. Geraghty, MD | |
View Slides in PDF | |
10:20 AM - 10:25 AM | 1-Year Results From The AcoArt II BTK DCB RCT Show Safety (No Increased Mortality) And Improved Patency Versus POBA |
Presenter(s):Francesco Liistro, MD / Wei Guo, MD | |
View Slides in PDF | |
10:26 AM - 10:31 AM | Why BTK DCB Trials Do Not Show Uniformly Better Results: Technical Factors Matter |
Presenter(s):Francesco Liistro, MD / Wei Guo, MD | |
View Slides in PDF | |
10:32 AM - 10:37 AM | Update On The SAVAL Trial With A Self-Expanding DES (From Boston Scientific) For BTK Occlusive Lesions |
Presenter(s):Jihad A. Mustapha, MD / Miguel F. Montero-Baker , MD | |
View Slides in PDF | |
10:38 AM - 10:43 AM | Panel Discussion |
END OF SESSION 26 | |
SESSION 27 SCHEDULE | |
Wednesday
SESSION 27:
PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: HOW TO SAVE THE “NO OPTION FOR TREATMENT” LIMB OR THE “DESERT FOOT” WITH NO PATENT TARGET ARTERIES
Moderators:Daniel G. Clair, MD / Marco G. Manzi, MD
|
|
x | |
10:43 AM - 10:48 AM | Contemporary Survival After Below-Knee Amputation (BKA), Above-Knee Amputation (AKA), Bilateral Amputations For Trauma; For Vascular Disease: It Is Worthwhile Saving Limbs Especially In Vascular Patients |
Presenter(s):Philip P. Goodney, MD, MS | |
View Slides in PDF | |
VALUE OF PROSTHETIC (PTFE) TIBIAL BYPASSES | |
10:49 AM - 10:54 AM | Value Of Spliced Vein Grafts Versus PTFE Grafts For Bypasses: When A Single Autologous Vein Is Inadequate |
Presenter(s):Joseph L. Mills, MD | |
View Slides in PDF | |
10:55 AM - 11:00 AM | PTFE Tibial And Peroneal Artery Bypasses Can Save No Option Limbs Which Would Otherwise Require Amputation: They Can Have Long-Term Patency And Limb Salvage And Are Worthwhile |
Presenter(s):Gregg S. Landis, MD / Richard F. Neville, MD / Hasan H. Dosluoglu, MD / Neal S. Cayne, MD / Mark A. Adelman, MD / Frank J. Veith, MD | |
View Slides in PDF | |
11:01 AM - 11:06 AM | For Patients Facing Amputation With No Endo Options Or Useable Vein, PTFE Tibial Bypasses Are A Worthwhile Option |
Presenter(s):R. Clement Darling III, MD | |
View Slides in PDF | |
11:07 AM - 11:12 AM | Current Outcomes With PTFE Bypasses To Infrapopliteal (Tibial) Targets: Is There Variability Between Surgeons And Institutions |
Presenter(s):Matthew T. Menard, MD | |
View Slides in PDF | |
11:13 AM - 11:18 AM | Panel Discussion |
UPDATE ON FOOT VEIN ARTERIALIZATION FOR CLTI | |
11:18 AM - 11:23 AM | What Is The Real Prevalence Of No Option Anatomy Among The CLTI Population: What Is The Role For Foot Vein Arterialization: Impact Of The PROMISE I Trial With The LimFlow System |
Presenter(s):Peter A. Schneider, MD | |
View Slides in PDF | |
11:24 AM - 11:29 AM Power Point Presentation with Synched Audio |
Role And Value Of Vein Arterialization: Best Way To Do It And Long-Term Results: From The Pioneer |
Presenter(s):Pramook Mutirangura, FRCS (Edinburgh) | |
View Slides in PDF | |
11:30 AM - 11:35 AM Power Point Presentation with Synched Audio |
Pathophysiology Of Venous Arterialization And Neo Angiogenesis For No Option CLTI: How To Predict When It Will Work And When It Won’t |
Presenter(s):Roberto Ferraresi, MD | |
View Slides in PDF | |
11:36 AM - 11:41 AM | 2-Year Registry Results With Deep Vein Arterialization With The LimFlow Device For CLTI With Gangrene Shows Reasonable Limb Salvage And Wound Healing |
Presenter(s):Daniela Branzan, MD / Andrej Schmidt, MD | |
View Slides in PDF | |
11:42 AM - 11:47 AM | How To Perform The LimFlow Procedure: Equipment Required And Technical Tips |
Presenter(s):Miguel F. Montero-Baker , MD | |
View Slides in PDF | |
11:48 AM - 11:53 AM | Deep Vein Arterialization And Valve Lysis By Surgical Means For No Option Desert Feet With Gangrene: How To Do It And Results |
Presenter(s):Richard F. Neville, MD | |
View Slides in PDF | |
11:54 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 27 | |
SESSION 28 SCHEDULE | |
Wednesday
SESSION 28:
NEW DEVELOPMENTS IN STENTS; PROSTHETIC GRAFTS; ENDOVASCULAR BYPASSES; STENT GRAFTS AND TREATMENT OF IN STENT RESTENOSIS (ISR)
Moderators:Mark A. Adelman, MD / Anahita Dua, MD, MS, MBA
|
|
x | |
1:00 PM - 1:04 PM | 3-Year Results From The BioMimics 3D Swirling Flow Stent In The MIMICS-2 Study: Who Needs Paclitaxel |
Presenter(s):Michael K.W. Lichtenberg, MD / Peter Gaines, MD / Timothy M. Sullivan, MD | |
View Slides in PDF | |
ARTERIAL PTFE BYPASSES | |
1:06 PM - 1:11 PM Power Point Presentation with Synched Audio |
RCT Comparing Heparin Bonded PTFE (Propaten) Grafts With Plain PTFE Grafts For BTK CLTI Bypasses: Is Heparin Bonding Helpful |
Presenter(s):Yann Gouëffic, MD, PhD | |
View Slides in PDF | |
1:12 PM - 1:17 PM | Hybrid Fluoroscopically Guided Improved Method For Restoring Patency To Occluded PTFE Bypasses: It’s Less Invasive And More Effective |
Presenter(s):Neal S. Cayne, MD / Frank J. Veith, MD | |
View Slides in PDF | |
PERCUTANEOUS BYPASSES | |
1:18 PM - 1:23 PM | Percutaneous (PQ) Tranvenous Fempop PTFE Bypasses With The Torus 2 Device: How It Works And Status Of The DETOUR And TORUS Trials In The US And Europe |
Presenter(s):Sean P. Lyden, MD / Daniel G. Clair, MD / Ehrin Armstrong, MD / Peter A. Schneider, MD | |
View Slides in PDF | |
1:24 PM - 1:29 PM | 3-Year Results Of The Detour PQ Fempop Arterial Bypass Routed Through TheFemoral Vein: Will It Make Open Bypass Obsolete |
Presenter(s):Dainis K. Krievins, MD | |
View Slides in PDF | |
1:30 PM - 1:35 PM | A Novel Technique For PQ Fempop Bypass Routing The PTFE Bypass Through The Soft Tissue Of The Thigh: How To Do It And Early Results |
Presenter(s):Pierre G. Sarradon, MD / Jean-Pierre Becquemin, MD, FRCS | |
View Slides in PDF | |
NEW INFORMATION ON STENT-GRAFTS | |
1:36 PM - 1:41 PM | 2-Year Results Of The SUPER B RCT Shows That Viabahn Stent-Grafts Have Patency Rates As Good As Open Fempop PTFE Bypasses But Require More Reinterventions: How To Make Viabahns Work Best |
Presenter(s):Michel M.P. Reijnen, MD, PhD | |
View Slides in PDF | |
TREATMENT OF IN STENT RESTENOSIS (ISR) | |
1:42 PM - 1:47 PM | Laser Atherectomy May Facilitate Endovascular Treatment Of ISR But Does Not Provide Long-Term Benefit: How Should ISR Be Treated |
Presenter(s):Russell H. Samson, MD, DFSVS, RVT, FACS | |
View Slides in PDF | |
1:48 PM - 1:53 PM | The Excimer Laser For Treating ISR: It Has A Role In Grossing And Debulking Difficult Lesions: Technical Tips |
Presenter(s):Craig M. Walker, MD | |
View Slides in PDF | |
1:54 PM - 2:00 PM | Panel Discussion |
END OF SESSION 28 | |
SESSION 29 SCHEDULE | |
Wednesday
SESSION 29:
LOWER EXTREMITY TRIALS; GUIDELINES; FOOT PERFUSION EVALUATION METHODS AND VALUE OF ANGIOSOMES
Moderators:Mark K. Eskandari, MD / Gregg S. Landis, MD
|
|
x | |
2:00 PM - 2:05 PM | Update On The BEST-CLI RCT Comparing Endovascular And Open Treatment Of Lower Extremity Ischemia: Current Status, Challenges And What Will Be Its Value |
Presenter(s):Matthew T. Menard, MD / Alik Farber, MD, MBA / Kenneth Rosenfield, MD | |
View Slides in PDF | |
METHODS FOR EVALUATING FOOT PERFUSION | |
2:06 PM - 2:11 PM Power Point Presentation with Synched Audio |
Measuring Foot Perfusion After Endo Treatments For CLTI With Perfusion Angiography And Smart Software: Why It Is Important And How To Do It |
Presenter(s):Jim Reekers, MD, PhD | |
View Slides in PDF | |
2:12 PM - 2:17 PM | Indocyanine Green Fluorescence (IGC-FL) Is A Good Way To Measure Foot Perfusion After Treatment: How It Explains Why The Angiosome Concept Is Important After Endo Treatments But Not After Bypasses |
Presenter(s):Maarit Venermo, MD, PhD | |
View Slides in PDF | |
2:18 PM - 2:23 PM | How And Why To Measure Foot Perfusion During Endo Treatments: Hyperspectral Imaging, O2 Sensors, Etc: When Is The Angiosome Concept Helpful; When Not |
Presenter(s):Marianne Brodmann, MD | |
View Slides in PDF | |
2:24 PM - 2:29 PM | What Are The Best Ways To Evaluate CLTI Treatment Outcomes: Physiology, Wound Healing, Anatomy (Angiography Or Ultrasound), MACE Or MALE: Why It Matters |
Presenter(s):Ido Weinberg, MD, MSc | |
View Slides in PDF | |
2:30 PM - 2:35 PM | Pedal Arch Patency Is Key To Predicting Limb Salvage With Endovascular Treatment For CLTI With Tissue Necrosis: How Is It Best Evaluated |
Presenter(s):Hasan H. Dosluoglu, MD / Linda Harris, MD | |
View Slides in PDF | |
2:36 PM - 2:41 PM | Foot Perfusion Measurements Show Why Open Bypasses Are Better Than Endovascular Treatments For CLTI |
Presenter(s):Werner Lang, MD | |
View Slides in PDF | |
2:42 PM - 2:48 PM | Panel Discussion |
2:48 PM - 3:08 PM | Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 29 | |
SESSION 30 SCHEDULE | |
Wednesday
SESSION 30:
NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION AND ACUTE LIMB ISCHEMIA
Moderators:Matthew T. Menard, MD / Caitlin W. Hicks, MD, MS
|
|
x | |
INTERMITTENT CLAUDICATION (IC) | |
3:08 PM - 3:13 PM | Overuse Of Vascular Interventions For IC Is A Measure Of Poor Care: How Is This Determined |
Presenter(s):Caitlin W. Hicks, MD, MS / James H. Black, III, MD | |
View Slides in PDF | |
ACUTE LIMB ISCHEMIA (ALI) (See Also Session 59) | |
3:14 PM - 3:19 PM | Update On Thrombosuction Devices For Treating ALI: Which Device In Which Circumstance: Advantages And Limitations |
Presenter(s):Eric L.G. Verhoeven, MD, PhD / Athanasios Katsargyris, MD | |
View Slides in PDF | |
3:20 PM - 3:25 PM | Computer Aided Mechanical Aspiration Thrombectomy (CMAT) Is Obviating The Need For Thrombolytics In ALI: Which Device Is Best When And Why |
Presenter(s):Patrick E. Muck, MD, FACS | |
View Slides in PDF | |
3:26 PM - 3:31 PM | Aspiration Thrombectomy Devices And Techniques For ALI: Are Thrombolytics And Fogarty Balloon Catheters Obsolete |
Presenter(s):Maria A. Ruffino, MD, EBIR | |
View Slides in PDF | |
3:32 PM - 3:37 PM | Penumbra Indigo Clot Aspiration System To Treat ALI: Why Is It A Game Changer: Technical Tips For Usage |
Presenter(s):James F. Benenati, MD | |
View Slides in PDF | |
3:38 PM - 3:43 PM | Value And Technical Tips For Using The Indigo Clot Removal System Before Treating ISR And Other Lesions With Balloon And Stents |
Presenter(s):Frank R. Arko, MD | |
View Slides in PDF | |
3:44 PM - 3:49 PM | How To Treat ALI Under Duplex Ultrasound Guidance: Advantages And Limitations |
Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM / Enrico Ascher, MD | |
View Slides in PDF | |
3:50 PM - 3:56 AM | Panel Discussion |
END OF SESSION 30 | |
SESSION 31 SCHEDULE | |
Wednesday
SESSION 31:
ADVANCES IN MEDICAL TREATMENTS, NEW ANTIATHEROGENIC DRUGS, VALUE OF RIVAROXABAN AND PREVENTING MIs IN VASCULAR SURGERY PATIENTS
Moderators:Ido Weinberg, MD, MSc / Bhama Ramkhelawon, PhD
|
|
x | |
3:56 PM - 4:01 PM | What Adequate And Ideal Lipid Levels Should We Strive For In PAD Patients: How To Get There |
Presenter(s):Marianne Brodmann, MD | |
View Slides in PDF | |
4:02 PM - 4:07 PM | Risks And Consequences Of Perioperative Myocardial Infarctions (MIs) In Open Vascular Surgery Patients: What Can Be Done To Decrease MI Incidence And Their Morbidity And Mortality When They Occur |
Presenter(s):Peter Henke, MD | |
View Slides in PDF | |
4:08 PM - 4:13 PM Power Point Presentation with Synched Audio |
Update On LDL-C Lowering During A Lifetime: How Low To Strive For; How Young To Start If High; How Old To Continue Statins |
Presenter(s):J. David Spence, MD | |
View Slides in PDF | |
4:14 PM - 4:19 PM | DEBATE: LDL-C Lowering And Statins For Prophylaxis Of Vascular Events Are Dangerous And Not Helpful |
Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC, PhD, FACS | |
View Slides in PDF | |
4:20 PM - 4:25 PM | DEBATE: Not So: LDL-C Lowering With Statins And Other Drugs Stabilizes And Shrinks Plaques And Decreases Morbid Vascular Events: Stopping Statins Increases Patients’ Risk Of MI And Death |
Presenter(s):Ron Waksman, MD | |
View Slides in PDF | |
4:26 PM - 4:31 PM | Low Dose Rivaroxaban And Aspirin Improve Survival And Decrease Major Adverse Limb Events (MALE) After Endo And Open Treatments For PAD/CLTI: From The VOYAGER RCT |
Presenter(s):Sebastian E. Debus, MD, PhD / Marianne Brodmann, MD | |
View Slides in PDF | |
4:32 PM - 4:37 PM | How Does The Morbidity And Pathology Of Adverse Events With Arteriosclerosis Depend On Thrombosis: This Explains The Benefits Of Rivaroxaban And Aspirin Seen In The VOYAGER And COMPASS Trials |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Slides in PDF | |
4:38 PM - 4:43 PM | New Adjunctive Drugs (Plus Statins) To Lower LDL-Cholesterol (LDL-C) In Vascular Patients: Inclisiran, Bempedoic Acid And Ezetimbe: How Do They Work And When And How To Use Them: Level Of LDL-C To Strive For |
Presenter(s):Richard Bulbulia, MA, MD, FRCS | |
View Slides in PDF | |
4:44 PM - 4:50 PM | Panel Discussion |
END OF SESSION 31 | |
SESSION 32 SCHEDULE | |
Wednesday
SESSION 32:
CATHETER BASED TREATMENTS OF RESISTANT HYPERTENSION; MANAGEMENT OF CARDIAC PROBLEMS, SMOKING AND TRANSFUSION IN VASCULAR SURGERY PATIENTS; MORTALITY RISK IN STROKE PATIENTS; VASCULAR AND CARDIAC COMPLICATIONS OF COVID-19
Moderators:Christopher K. Zarins, MD / Michael R. Jaff, DO
|
|
x | |
UPDATE ON RENAL DENERVATION FOR HYPERTENSION | |
4:50 PM - 4:55 PM | Current Status Of Renal Denervation For Drug Resistant Hypertension: Why The Simplicity Spyral Radiofrequency Denervation System Is Different: Status Of The SPYRAL HTN-OFF MED RCT (Versus Sham) |
Presenter(s):Sahil A. Parikh, MD | |
View Slides in PDF | |
4:56 PM - 5:01 PM | Preop Cardiac Evaluation With CT-Based Fractional Flow Reserve (FFRCT) And Selective Coronary Revascularization Saves Lives In Patients Undergoing Procedures For CLTI And Carotid Disease |
Presenter(s):Christopher K. Zarins, MD / Dainis K. Krievins, MD | |
View Slides in PDF | |
5:02 PM - 5:07 PM Power Point Presentation with Synched Audio |
How And Why Do Thoracic Stent-Grafts For TEVAR Negatively Affect The Heart |
Presenter(s):Frans L. Moll, MD, PhD | |
View Slides in PDF | |
5:08 PM - 5:13 PM | Permissive Transfusion Strategies Increase Mortality And Serious Adverse Events After Major Vascular And General Surgery Operative Interventions |
Presenter(s):Panos Kougias, MD, MSc | |
View Slides in PDF | |
5:14 PM - 5:19 PM | Vascular Complications Of COVID-19 Infections: What Is Known And Unknown: How To Diagnose And Treat |
Presenter(s):Michael E. Barfield, MD | |
View Slides in PDF | |
5:20 PM - 5:25 PM Power Point Presentation with Synched Audio |
Cardiac Complications Of COVID-19 Infections: What Is Their Genesis: Diagnosis And Treatment |
Presenter(s):Roxana Mehran, MD | |
View Slides in PDF | |
5:26 PM - 5:31 PM | Panel Discussion |
5:31 PM - 5:31 PM | End of Program C |
END OF SESSION 32 | |
SESSION 33 SCHEDULE | |
Wednesday
SESSION 33:
PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM
Moderators:Timur P. Sarac, MD / Michel Makaroun, MD
|
|
x | |
TO TREAT OR NOT TO TREAT TYPE 2 ENDOLEAKS | |
7:00 AM - 7:05 AM | Most Type 2 Endoleaks Are Benign: The Case Can Be Made That By Treating Type 2 Endoleaks The Harm And Cost Of Such Treatment Outweighs The Benefits: When If Ever Should They Be Treated; AAA Sac Behavior Predicts Late Survival After EVAR |
Presenter(s):Michel M.P. Reijnen, MD, PhD | |
View Slides in PDF | |
TREATING TYPE 1 ENDOLEAKS | |
7:06 AM - 7:11 AM | Type 1A Endoleaks After EVAR Are Predictable And Preventable: How To Do So |
Presenter(s):Michael J. Singh, MD | |
View Slides in PDF | |
7:12 AM - 7:17 AM | When And How To Use Embolization Coils To Treat Type 1A Endoleaks Successfully: When Won’t Coils Work: How To Diagnose Type 1A Endoleaks Accurately |
Presenter(s):Sigrid Nikol, MD | |
View Slides in PDF | |
7:18 AM - 7:23 AM Power Point Presentation with Synched Audio |
How To Minimize Gutter Type 1A Endoleaks With Chimney EVAR (Ch/EVAR): How To Treat Them When They Occur: When Not To Treat Them |
Presenter(s):Konstantinos P. Donas, MD | |
View Slides in PDF | |
7:24 AM - 7:29 AM Power Point Presentation with Synched Audio |
Shape Memory Technology For AAA Sac Filling: How Does It Work And Why It May Be A Better Form Of EVAR |
Presenter(s):Andrew Holden, MBChB | |
View Slides in PDF | |
ROLE OF INFLAMMATION | |
7:30 AM - 7:35 AM | The Role Of Inflammation In Causing Late Endoleaks: How To Evaluate It And How Should It Influence Treatment |
Presenter(s):Furuzan Numan, MD | |
View Slides in PDF | |
7:36 AM - 7:42 AM | Panel Discussion |
END OF SESSION 33 | |
SESSION 34 SCHEDULE | |
Wednesday
SESSION 34:
PREVENTION OF TYPE 2 ENDOLEAKS AFTER EVAR
Moderators:Ross Milner, MD / Adam Beck, MD
|
|
x | |
7:42 AM - 7:47 AM Power Point Presentation with Synched Audio |
A RCT Shows The Advantages Of Inferior Mesenteric Artery (IMA) And Lumbar Embolization: Confirmed By A Japanese RCT: When And How To Do It |
Presenter(s):Dominique Fabre, MD, PhD / Stephan Haulon, MD | |
View Slides in PDF | |
7:48 AM - 7:53 AM | With A Large IMA (> 3mm), When Should It Be Embolized; When Should It Be Revascularized And Why |
Presenter(s):Piotr M. Kasprzak, MD | |
View Slides in PDF | |
TREATMENT OF TYPE 2 ENDOLEAKS AFTER EVAR | |
7:54 AM - 7:59 AM | How Duplex Ultrasound Velocities In Type 2 Endoleaks Determine Behavior And Help In Treatment: Technical Tips |
Presenter(s):Ross Milner, MD | |
View Slides in PDF | |
8:00 AM - 8:05 AM | Glue Embolization Is Effective Treatment For Most Threatening Type 2 Endoleaks: When And How Best To Do It |
Presenter(s):Neal S. Cayne, MD | |
View Slides in PDF | |
8:06 AM - 8:11 AM | Transcaval Access To AAA Sacs For Treatment Of Type 2 Endoleaks After EVAR: When And How To Do It |
Presenter(s):Adam Beck, MD | |
View Slides in PDF | |
8:12 AM - 8:17 AM | How To Best Leverage 3D Fusion Software (GE) To Get Into The Nidus And Treat Type 2 Endoleaks: Best Embolic Agent And Value Of Transcaval Access |
Presenter(s):Mark W. Mewissen, MD, RVT | |
View Slides in PDF | |
8:18 AM - 8:23 AM | Transgraft Approach To Treat Type 2 Endoleaks: Indications, Equipment, Advantages And Precautions |
Presenter(s):James F. McKinsey, MD | |
View Slides in PDF | |
8:24 AM - 8:29 AM | Laser Assisted Transgraft Onyx Embolization Of Type 2 Endoleaks: Indications, Equipment And Technique |
Presenter(s):Zvonimir Krajcer, MD, FACC | |
View Slides in PDF | |
8:30 AM - 8:35 AM | With Type 2 Endoleaks And Sac Expansion Open Sacotomy And Branch Ligation Is The Best Treatment: Why And What Precautions Are Needed To Be Sure There Is Not Occult Type 1 Leak |
Presenter(s):Zachary M. Arthurs, MD | |
View Slides in PDF | |
8:36 AM - 8:48 AM | Panel Discussion |
END OF SESSION 34 | |
SESSION 35 SCHEDULE | |
Wednesday
SESSION 35:
MORE TOPICS RELATED TO THE THORACIC AORTA, AORTIC DISSECTIONS, INTRAMURAL HEMATOMAS (IMHs) AND THEIR TREATMENT
Moderators:Ramon Berguer, MD, PhD / Paulo E. Ocke Reis, MD, PhD
|
|
x | |
8:48 AM - 8:53 AM | False Lumen Area >50% Of Total Aortic Cross-Section Area At The Tracheal Bifurcation At Time Of TEVAR For TBAD Is A Predictor Of Early Death: How To Decrease This Mortality |
Presenter(s):Johnny Steuer, MD, PhD | |
View Slides in PDF | |
8:54 AM - 8:59 AM | Results From A Global Multicenter Registry On Candy Plug In Chronic TBAD |
Presenter(s):Tilo Koelbel, MD, PhD | |
View Slides in PDF | |
9:00 AM - 9:05 AM | Staged Hybrid Single Lumen Reconstruction Is The Best Treatment For Complex Chronic TBAD With Visceral Segment Involvement Of The Aorta: How To Do It, Advantages And Results |
Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC, PhD, FACS | |
View Slides in PDF | |
9:06 AM - 9:11 AM | Reinterventions After TEVAR For TBADs: How To Decrease Them At The Index Procedure And How Planning Helps |
Presenter(s):Bijan Modarai, PhD, FRCS | |
View Slides in PDF | |
9:12 AM - 9:17 AM | Adjunctive Peripheral And Visceral Interventions During TEVAR For Complicated TBADs: Indications, Technical Tips And Results |
Presenter(s):Mark K. Eskandari, MD | |
View Slides in PDF | |
9:18 AM - 9:23 AM | Update On Intramural Hematoma (IMH): Etiology, Natural History And Indications For TEVAR |
Presenter(s):Frank J. Criado, MD | |
View Slides in PDF | |
9:24 AM - 9:30 AM | Panel Discussion |
9:30 AM - 9:42 AM | Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 35 | |
SESSION 36 SCHEDULE | |
Wednesday
SESSION 36:
MORE ADVANCES RELATED TO LESIONS INVOLVING THE ASCENDING AORTA AND THE AORTIC ARCH; AORTIC DISSECTIONS AND THEIR TREATMENT
Moderators:Rodney A. White, MD / Alan B. Lumsden, MD, FACS
|
|
x | |
9:42 AM - 9:47 AM | Value Of Transcranial Doppler (TCD) For TEVAR And Endo Procedures Involving The Ascending Aorta And Aortic Arch |
Presenter(s):Alan B. Lumsden, MD, FACS | |
View Slides in PDF | |
9:48 AM - 9:53 AM | Antegrade Stent-Graft Delivery For Treating Acute Type A Dissections: When Is It Advantageous And How To Do It |
Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD | |
View Slides in PDF | |
9:54 AM - 9:59 AM | The Pulley Effect: Endovascular Instrumentation At The Aortic Bifurcation Generates Unexpected Forces That May Tear The Aorta |
Presenter(s):Martin Malina, MD, PhD | |
View Slides in PDF | |
10:00 AM - 10:05 AM | For Precise TEVAR In The Aortic Arch Rapid Pacing And Caval Occlusion Are NOT Needed: Valsalva And PEEP By Anesthesiologist Do Just As Well And Are Simple: Technical Tips |
Presenter(s):Nikolaos Tsilimparis, MD, PhD | |
View Slides in PDF | |
10:06 AM - 10:11 AM | Arch Lesion Repair With Single, Double Or 3-Branched Devices: When Is Each Best And Why |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
View Slides in PDF | |
10:12 AM - 10:17 AM | Laser Fenestration Option For TEVAR Involving The Great Arch Branches: When Is It Better Than Branched Endografts: Technique And Results |
Presenter(s):Timothy A. Resch, MD, PhD | |
View Slides in PDF | |
10:18 AM - 10:26 AM | Panel Discussion |
END OF SESSION 36 | |
SESSION 37 SCHEDULE | |
Wednesday
SESSION 37:
OPEN AND ENDO TREATMENT OF COMPLEX AAAs (JUXTA, PARA- AND SUPRA-RENAL) AND TAAAs; NEW DEVICES FOR THEIR TREATMENT
Moderators:Giovanni B. Torsello, MD / Gustavo S. Oderich, MD, FACS
|
|
x | |
COMPLEX AAAs AND TAAAs | |
10:27 AM - 10:32 AM | Open Repair Is The Best Way To Treat Short Neck, No Neck And Pararenal AAAs: Why Is This So |
Presenter(s):Laurent Chiche, MD, FEBVS | |
View Slides in PDF | |
10:33 AM - 10:38 AM | Comparative Morbidity And Mortality Outcomes Of Open, Hybrid And F/B/EVAR For Type II And III TAAAs Justify Greater Use Of F/B/EVAR For These Complex Lesions |
Presenter(s):Gilbert R. Upchurch, MD / Salvatore T. Scali, MD / Dean Arnaoutakis, MD | |
View Slides in PDF | |
10:39 AM - 10:44 AM | New Techniques To Improve The Open Repair Of TAAAs |
Presenter(s):Laurent Chiche, MD, FEBVS | |
View Slides in PDF | |
TOPICS RELATED TO INTERESTING NEW DEVICES | |
10:45 AM - 10:50 AM | A New Hybrid Device (Thoracoflo From Terumo Aortic) For TAAA Repair: How It Works, Early Clinical Experience And Advantages |
Presenter(s):Sebastian E. Debus, MD, PhD | |
View Slides in PDF | |
10:51 AM - 10:56 AM | How To Prevent Patch Aneurysms After Open TAAA Repair With Long Antegrade Grafts: How To Treat Them When They Occur |
Presenter(s):Thomas C. Bower, MD / Manju Kalra, MBBS | |
View Slides in PDF | |
10:57 AM - 11:02 AM | Role Of Device Engineering On Sac Regression Seen With The TREO Endograft |
Presenter(s):Michael C. Stoner, MD | |
View Slides in PDF | |
11:03 AM - 11:08 AM | Update On The Colt Manifold Device For TAAAs, Complex AAAs, Failed EVARs And Failed EVAS Procedures: How Does It Work And Results |
Presenter(s):Piotr Szopinski, MD, PhD | |
View Slides in PDF | |
11:09 AM - 11:17 AM | Panel Discussion |
END OF SESSION 37 | |
SESSION 38 SCHEDULE | |
Wednesday
SESSION 38:
PROGRESS IN TREATING ILIAC ANEURYSMS; ILIAC BRANCHED DEVICES (IBDs); UPDATE ON MULTILAYER FLOW MODULATING (MLFM) AND OTHER BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS
Moderators:Thomas S. Maldonado, MD / Rodney A. White, MD
|
|
x | |
TREATMENT OF ILIAC ANEURYSMS AND IBDs | |
11:18 AM - 11:23 AM Power Point Presentation with Synched Audio |
DEBATE: How Best To Treat Iliac Aneurysms In 2021: There Is Not Much Of A Need For Open Surgery |
Presenter(s):Stefan Mueller-Huelsbeck, MD | |
View Slides in PDF | |
11:24 AM - 11:29 AM | DEBATE: There Is A Role For Open Surgery In The Treatment Of Iliac Aneurysms: What Is It And Technical Tips |
Presenter(s):Heron E. Rodriguez, MD | |
View Slides in PDF | |
11:30 AM - 11:35 AM | Long-Term Experience With Cook IBD For The Treatment Of Common Iliac Aneurysms: Advantages And Limitations |
Presenter(s):Giovanni B. Torsello, MD | |
View Slides in PDF | |
11:36 AM - 11:41 AM | Update On The Gore IBE Excluder For Treating Iliac Aneurysms And Preserving Hypogastric Artery Flow: Advantages And Limitations: From The European ICEBERG Registry |
Presenter(s):Michel M.P. Reijnen, MD, PhD | |
View Slides in PDF | |
11:42 AM - 11:47 AM | Advantages And Limitations Of The Jotec-Cryolite Iliac Branch Device For Treating Common And Internal Iliac Artery Aneurysms |
Presenter(s):Lee Bouwman, MD, PhD, MSc | |
View Slides in PDF | |
11:48 AM - 11:53 AM | MLFM Bare Stent (From Cardiatis) Is A Promising Treatment For Acute Aortic Dissections: What Is The Evidence In Support |
Presenter(s):Rodney A. White, MD | |
View Slides in PDF | |
11:54 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 38 | |
SESSION 39 SCHEDULE | |
Wednesday
SESSION 39:
MORE NEW DEVELOPMENTS IN AAA TREATMENT AND STANDARD EVAR: A NEW DEVICE TO SLOW AAA GROWTH; AAA NECK DILATATION AFTER EVAR; VALUE OF LOW PROFILE AAA ENDOGRAFTS; LINK TO CANCER; IMPROVED ULTRASOUND SURVEILLANCE AND ALL AAAs ARE NOT TIME BOMBS WAITING TO EXPLODE
Moderators:Thomas S. Maldonado, MD / Fiona Rohlffs, MD
|
|
x | |
1:00 PM - 1:05 PM | A Novel New Technology (Nectero) To Slow AAA Growth; How Does It Work And Early Clinical Results |
Presenter(s):Venkatesh G. Ramaiah, MD | |
View Slides in PDF | |
AAA NECK BEHAVIOR AFTER EVAR | |
1:06 PM - 1:11 PM | Impact Of Oversizing And Level Of Fixation (Infra Versus Supra-Renal) On Aortic Neck Behavior: How Do These Variables Affect EVAR Outcomes: From A 10-Year Study |
Presenter(s):Carlos F. Bechara, MD | |
View Slides in PDF | |
1:12 PM - 1:17 PM | Aortic Neck Dilatation Is Different After F/EVAR And EVAR: What Is The Reason And Why Is It Important For Outcomes |
Presenter(s):Thomas S. Maldonado, MD | |
View Slides in PDF | |
1:18 PM - 1:23 PM | Major Aortic Neck Dilatation Occurs Equally After EVAR And Open Repair: From The DREAM RCT: This ONLY Occurs After EVAR With Self-Expanding Endografts |
Presenter(s):Jan D. Blankensteijn, MD | |
View Slides in PDF | |
1:24 PM - 1:29 PM | Do AAA Necks Dilate After F/EVAR For Juxtarenal AAAs: What Are The Good Or Bad Consequences For Procedural Outcomes |
Presenter(s):Benjamin W. Starnes, MD | |
View Slides in PDF | |
1:30 PM - 1:35 PM | DEBATE: Low Profile Devices For EVAR Are Failing: Their Future Is Questionable |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
View Slides in PDF | |
1:36 PM - 1:41 PM | DEBATE: Not So: Ovation Stent-Graft (From Endologix) Have Good 5-Year Results With No Neck Dilatation Or Migration Even With Challenging Neck Anatomy: Based On A Multicenter International Study Of A Low Profile Endograft |
Presenter(s):Mahmoud B. Malas, MD, MHS | |
View Slides in PDF | |
1:42 PM - 1:47 PM | Current Status Of The Link Between EVAR And Cancer: Is It Real And What Is Its Etiology |
Presenter(s):Janet T. Powell, MD, PhD | |
View Slides in PDF | |
1:48 PM - 1:53 PM | Presenting AAAs As Ticking Time Bombs Or Unexploded Grenades Is Wrong-Headed, Inaccurate And Harmful |
Presenter(s):Frank J. Criado, MD | |
View Slides in PDF | |
1:54 PM - 2:00 PM | Panel Discussion |
END OF SESSION 39 | |
SESSION 40 SCHEDULE | |
Wednesday
SESSION 40:
MORE NEW DEVELOPMENTS IN AAAs: HOW DO THEIR NECK AND SAC SIZE AND THROMBUS LOAD EFFECT PROGNOSIS AFTER EVAR AND EVAS; OTHER RELATED AAA TOPICS
Moderators:Ali F. AbuRahma, MD / Janet T. Powell, MD, PhD
|
|
x | |
AAA NECK AND SAC THROMBUS LOAD | |
2:00 PM - 2:05 PM | DEBATE: Large Amount Of AAA Sac Thrombus Promotes Morbidity With And Without Rupture: What Is The Mechanism And How To Quantitate Thrombus Load |
Presenter(s):David H. Deaton, MD, FACS | |
View Slides in PDF | |
2:06 PM - 2:11 PM | DEBATE: Large Flow Lumenal Space In AAA Sac With Minimal Mural Thrombus Is Associated With Adverse Events After EVAR: It Is More Important Than AAA Sac Size: Thrombus May Be Protective |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
View Slides in PDF | |
2:12 PM - 2:17 PM | Graft Infolding: A Unique EVAR Complication: How To Prevent It And How To Treat It |
Presenter(s):Ashraf Mansour, MD | |
View Slides in PDF | |
2:18 PM - 2:23 PM | Large AAA Necks (> 29 mm) Increase Migration And Leak Risks After EVAR With Self-Expanding Endografts Due To Neck Dilatation: Not So With Anatomically Adaptive (Polymer) Sealing Endografts (Ovation) Which Are Not Followed With Neck Dilatation |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
View Slides in PDF | |
2:24 PM - 2:29 PM | Does Doxycycline Stabilize AAA Neck Diameter: From The NTACT Trial |
Presenter(s):Jon S. Matsumura, MD | |
View Slides in PDF | |
2:30 PM - 2:35 PM | EVAS With Sac Filling Technology (Nellix) Has Lower Late Mortality Than EVAR With Other Endografts – Especially With Large AAAs: What Is The Mechanism Thought To Be |
Presenter(s):Marc L. Schermerhorn, MD | |
View Slides in PDF | |
2:36 PM - 2:42 PM | Panel Discussion |
2:42 PM - 2:56 PM | Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 40 | |
SESSION 41 SCHEDULE | |
Wednesday
SESSION 41:
HOT AORTIC TOPICS (4 ¾ AND 5--MINUTE FAST PACED TALKS)
Moderators:Timothy A.M. Chuter, DM / Luis A. Sanchez, MD
|
|
x | |
2:56 PM - 3:01 PM | A Large Proportion Of EVARs Are Performed On Small AAAs: What Are The Implications And What Should Be Done About It |
Presenter(s):Salvatore T. Scali, MD | |
View Slides in PDF | |
3:01 PM - 3:06 PM | Late Delayed Renal Artery Revascularization After Inadvertent Occlusion During Complex EVAR Is Worthwhile: Collaterals Keep The Kidney Viable Although No Urine Is Produced |
Presenter(s):Nikolaos Tsilimparis, MD, PhD | |
View Slides in PDF | |
3:06 PM - 3:11 PM | How Can A Long-Term Aortic Risk (LEAR) Model Predict Mortality And Complication Risks And Guide Surveillance: Can The Model Be Made Device Specific |
Presenter(s):Ian Loftus, MD / Pete Holt, MD, PhD | |
View Slides in PDF | |
3:12 PM - 3:17 PM | Visceral Debranching With A Simple Aortic Endograft Is The Best Way To Treat AAAs In Good Risk Patients: How To Do It Safely |
Presenter(s):Guillermo A. Escobar, MD | |
View Slides in PDF | |
3:18 PM - 3:23 PM | Update On Maintaining Euglycemia To Decrease Spinal Cord Ischemia With Complex AAA And TAAA Repairs |
Presenter(s):Jade S. Hiramoto, MD | |
View Slides in PDF | |
3:24 PM - 3:29 PM | Incidence And Etiology Of Cerebrovascular Injuries With Acute TBADs With And Without Treatment |
Presenter(s):Loay S. Kabbani, MD, MHSA | |
View Slides in PDF | |
3:30 PM - 3:35 PM | EVAR, F/EVAR And B/EVAR Results In Females: Are There Still Differences |
Presenter(s):Eric L.G. Verhoeven, MD, PhD / Athanasios Katsargyris, MD | |
View Slides in PDF | |
3:36 PM - 3:41 PM | Update On Performing EVAR With Only IVUS Guidance To Decrease Radiation: Technical Tips And 3-Year Results |
Presenter(s):Jörg Tessarek, MD | |
View Slides in PDF | |
3:42 PM - 3:47 PM | Risk Factors And Late Clinical Consequences Of AAA Neck Dilatation >6 Years After EVAR With Self-Expanding Endografts: Does The Neck Keep Dilating After The Spring Is Gone: What Are The Differences Between Excluder And Endurant Endografts |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
View Slides in PDF | |
3:48 PM - 3:58 PM | Panel Discussion |
END OF SESSION 41 | |
SESSION 42 SCHEDULE | |
Wednesday
SESSION 42:
MORE SHORT HOT NEW TOPICS RELATED TO AORTIC DISEASE AND ITS TREATMENT AND MISCELLANEOUS TOPICS
Moderators:Luis A. Sanchez, MD / Michael L. Marin, MD
|
|
x | |
3:58 PM - 4:03 PM | Impact Of Iliac Aneurysms On The Treatment Of Complex AAAs |
Presenter(s):Matthew J. Eagleton, MD | |
View Slides in PDF | |
4:04 PM - 4:09 PM | How To Treat AAAs With Large (>34 mm Diameter) Necks: When EVAR; When F/EVAR; When Open |
Presenter(s):Rabih A. Chaer, MD | |
View Slides in PDF | |
4:10 PM - 4:15 PM | A New Gene Family In AAA Smooth Muscle Is Related To Aneurysm Diameter And Rupture: Could It Be A Screening Tool |
Presenter(s):Kak Khee Yeung, MD, PhD | |
View Slides in PDF | |
4:16 PM - 4:21 PM | How Should Intramural Hematomas (IMHs) In The Ascending Aorta And Arch Be Treated |
Presenter(s):Jennifer L. Perri, MD, MBA / Timothy A.M. Chuter, DM | |
View Slides in PDF | |
4:22 PM - 4:27 PM | How To Safely Stent The Large Fenestration Of A ZFEN Endograft When It Is Crossed By Struts: Indications For Doing So And Late Results |
Presenter(s):Luis A. Sanchez, MD | |
View Slides in PDF | |
4:28 PM - 4:33 PM | The Sandwich-Periscope Technique For Left Subclavian Revascularization With Zone 2 TEVAR: It May Be The Best Way And How To Do It |
Presenter(s):Sukgu Han, MD | |
View Slides in PDF | |
4:34 PM - 4:39 PM | Comparison Of Endo And Open (Carotid-Subclavian Bypass) Treatments For Subclavian Artery Stenosis And Occlusions: Safety, Durability And Costs |
Presenter(s):Ali F. AbuRahma, MD | |
View Slides in PDF | |
4:40 PM - 4:46 PM | Panel Discussion |
MISCELLANEOUS TOPICS | |
4:46 PM - 4:51 PM | Propensity Score Matching Studies: How Do They Work And What Are Their Strengths And Weaknesses |
Presenter(s):Charles C. Miller, PhD | |
View Slides in PDF | |
4:52 PM - 4:57 PM | The Ever Changing Reimbursement For Lower Extremity Endovascular Therapies In Hospitals And OBLs: Why It’s Happening And Where Is It Going |
Presenter(s):Sean P. Roddy, MD / Robert M. Zwolak, MD, PhD | |
View Slides in PDF | |
4:58 PM - 5:03 PM | How Can Vascular Surgeons Identify High Risk, High Cost Patients And Help Health Care Systems Control Costs: How To Prevent Inappropriate Treatments In These Patients |
Presenter(s):Lee Kirksey, MD | |
View Slides in PDF | |
5:04 PM - 5:09 PM | What Obstacles And Blows Are Vascular Surgeons And Other Vascular Specialists Facing In 2021: Will Planned Increased Reimbursement For Office And Hospital Visits Cause Decreases In Procedural Reimbursements |
Presenter(s):Sean P. Roddy, MD | |
View Slides in PDF | |
5:10 PM - 5:15 PM | What Vascular Injury Killed Martin Luther King, Jr. And Why He Might Have Survived Today |
Presenter(s):Cynthia K. Shortell, MD | |
View Slides in PDF | |
5:16 PM - 5:21 PM | Historical Perspective Over The Last 25 Years On FDA Approvals Of EVAR Devices Submitted By Investigators And Industry: Lessons Learned To Guide Future Applications |
Presenter(s):Kenneth Ouriel, MD, MBA / Dorothy B. Abel, BSBME | |
View Slides in PDF | |
5:22 PM - 5:27 PM | Are The Quality, Safety And Effectiveness Of Generic Drugs Equating Those Of The Patented Original Drugs: How Is The FDA Assuring Equivalence; Should The FDA Do More |
Presenter(s):Valerie M. Merkle, PhD | |
View Slides in PDF | |
5:28 PM - 5:34 PM | Panel Discussion |
5:34 PM - 5:39 PM | A Balanced View Of Atherectomy In Outpatient Facilities And OBLs In 2020: Is The Procedure Overused And Why |
Presenter(s):Krishna Jain, MD | |
View Slides in PDF | |
5:40 PM - 5:45 PM | Inherent Conflicts Of Interest In OBLs: Why They Occur And Are Bad For Patients: How To Counteract Them |
Presenter(s):O. William Brown, MD, JD | |
View Slides in PDF | |
5:46 PM - 5:51 PM | Why And How Do Outpatient Angio Suites And OBLs Fail |
Presenter(s):Sam S. Ahn, MD, FACS, MBA | |
View Slides in PDF | |
5:52 PM - 5:57 PM | SVS VQI – From Quality Improvement To Disruptive Technology |
Presenter(s):Jens Eldrup-Jorgensen, MD / Jack L. Cronenwett, MD | |
View Slides in PDF | |
5:58 PM - 6:03 PM Power Point Presentation with Synched Audio |
Improved Outcomes Of Type A Aortic Dissections With Use Of Bare Stents (Cardiatis And Ascyrus): They Decrease Malperfusion, Promote Aortic Remodeling And Prevent Strokes: How Do They Work |
Presenter(s):Ralf R. Kolvenbach, MD | |
View Slides in PDF | |
6:04 PM - 6:10 PM | Panel Discussion |
6:10 PM - 6:10 PM | End of Program D |
END OF SESSION 42 | |
Thursday, November 18, 2021
Print Entire 2021 Program:
|
|
SESSION 43 SCHEDULE | |
Thursday
SESSION 43:
EXCITING NEW OR REDISCOVERED TECHNIQUES, DEVICES OR CONCEPTS
Moderators:Richard F. Neville, MD / Frank J. Veith, MD
|
|
x | |
7:00 AM - 7:05 AM | Combating Bias In Medical And Vascular Studies And Therapeutic Decision Making: Why It Is Such A Big Deal And What To Do About It |
Presenter(s):Matthew T. Menard, MD | |
View Slides in PDF | |
7:06 AM - 7:11 AM | Update On Remote Monitoring Of Vascular Grafts: Where Is It At And Where Is It Going |
Presenter(s):Richard F. Neville, MD | |
View Slides in PDF | |
7:12 AM - 7:17 AM | Value Of Digital Health In Vascular Disease Management: Virtual And Otherwise |
Presenter(s):Tony S. Das, MD | |
View Slides in PDF | |
7:18 AM - 7:23 AM | Vascular Surgical Risks Of Shoulder Reconstructive Surgery: What Are They And How Should They Be Managed |
Presenter(s):Jacques Busquet, MD | |
View Slides in PDF | |
7:24 AM - 7:29 AM | Measuring Aortic Diameters Is Inaccurate And Subjective: Even With Newer Imaging Technology, One Can Make The Diameter What You Want: What Are The Implications |
Presenter(s):Janet T. Powell, MD, PhD | |
View Slides in PDF | |
7:30 AM - 7:35 AM | The Temporary Perfuse Dual Chamber Stent-Graft For Clamp Free Aortic Surgery, Drug Delivery And Other Uses: How Does It Work |
Presenter(s):Bryan W. Tillman, MD, PhD | |
View Slides in PDF | |
7:36 AM - 7:41 AM | Non-Compliant Endografts For TEVAR Have A Detrimental Effect On Systolic Blood Pressure And Cardiac Function; Compliant Endografts Are The Remedy |
Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC, PhD, FACS / Juan C. Parodi, MD | |
View Slides in PDF | |
7:42 AM - 7:47 AM | Update On Isolated Limb Perfusion To Enable Amputated Limb Reimplantation |
Presenter(s):Zachary M. Arthurs, MD | |
View Slides in PDF | |
7:48 AM - 7:59 AM | Panel Discussion |
END OF SESSION 43 | |
SESSION 44 SCHEDULE | |
Thursday
SESSION 44:
PROGRESS IN FENESTRATED AND BRANCHED EVAR (F/B/EVAR) AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
Moderators:James F. McKinsey, MD / Timothy A.M. Chuter, DM
|
|
x | |
8:00 AM - 8:05 AM | Lower Extremity Ischemic Complications After F/B/EVAR: Etiology And How To Avoid Them |
Presenter(s):Thomas S. Maldonado, MD | |
View Slides in PDF | |
8:06 AM - 8:11 AM | F/B/EVAR Treatment Of FAILED EVAR: A Safer Better Way To Treat: How Has The Aortic Research Consortium Helped To Promote Solutions To This And Other Problems |
Presenter(s):Andres Schanzer, MD | |
View Slides in PDF | |
8:12 AM - 8:17 AM Power Point Presentation with Synched Audio |
When Is Ch/EVAR Indicated And Equally Effective To F/EVAR For Juxta And Pararenal AAAs In Terms Of Outcomes And Cost: Why Are Opinions On Ch/EVAR So Divergent |
Presenter(s):Konstantinos P. Donas, MD | |
View Slides in PDF | |
8:18 AM - 8:23 AM | Fenestrated EVAR: Techniques And Outcomes With Physician Modification And Their Impact On A New IDE Pivotal Study |
Presenter(s):Benjamin W. Starnes, MD | |
View Slides in PDF | |
8:24 AM - 8:29 AM | Mortality From Aneurysm Rupture While Waiting For A Customized F/B/EVAR Endograft: Strategy To Prevent: Are There Reasons For Open Repairs In A High Volume F/B/EVAR Center |
Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
View Slides in PDF | |
8:30 AM - 8:35 AM | Why Balloon Expandable Bridging Stent-Grafts Are Best For F/B/EVAR: Which One Is Best And Why: A US Perspective |
Presenter(s):Mark A. Farber, MD | |
View Slides in PDF | |
8:36 AM - 8:41 AM Power Point Presentation with Synched Audio |
What Is The Best Bridging Covered Stent (Stent-Graft) For F/B/EVAR Based On An In Vitro Fatigue Testing Model And Other Considerations |
Presenter(s):Martin J. Austermann, MD | |
View Slides in PDF | |
8:42 AM - 8:47 AM | How To Safely And Effectively Treat TAAAs With Off-The-Shelf (OTS) Devices Including Chimney And Sandwich Stent-Grafts: The Docking Station Approach: How To Do It And Midterm Results |
Presenter(s):Manish Mehta, MD, MPH | |
View Slides in PDF | |
8:48 AM - 9:03 AM | Panel Discussion |
9:04 AM - 9:38 AM | Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 44 | |
SESSION 45 SCHEDULE | |
Thursday
SESSION 45:
MORE PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
Moderators:Mark A. Farber, MD / Frank J. Veith, MD
|
|
x | |
9:38 AM - 9:43 AM | Percutaneous Femoral And Axillary Access For Complex Endovascular AAA Repair: How To Do It Safely And To Safely Downsize Femoral Sheaths To Restore Lower Extremity Flow |
Presenter(s):Darren B. Schneider, MD | |
View Slides in PDF | |
9:44 AM - 9:49 AM | Present Status Of Parallel Grafts For Complex AAAs And TAAAs: How To Do These Repairs Safely And Effectively: Results To Date |
Presenter(s):Armando C. Lobato, MD, PhD | |
View Slides in PDF | |
9:50 AM - 9:55 AM | Value And Advantages Of Preloaded Wires And Catheters For F/B/EVAR: How Do They Work; Are There Pitfalls |
Presenter(s):Mark A. Farber, MD | |
View Slides in PDF | |
9:56 AM - 10:01 AM | DEBATE: The Case Against Ch/EVAR And Parallel Grafts For Complex AAA And TAAA Repairs: F/B/EVAR Is Much Better |
Presenter(s):Adam Beck, MD | |
View Slides in PDF | |
10:02 AM - 10:07 AM | DEBATE: Nonsense! Ch/EVAR And Parallel Grafts If Done Right Are As Safe And Effective As F/B/EVAR And In Some Cases Better And Cheaper |
Presenter(s):Edward Y. Woo, MD | |
View Slides in PDF | |
10:08 AM - 10:13 AM | F/EVAR Is Sometimes Justified In Patients >80: How About >90 |
Presenter(s):Clark J. Zeebregts, MD, PhD | |
View Slides in PDF | |
10:14 AM - 10:19 AM | DEBATE: Increasing The Number Of Fenestrations In F/EVAR Beyond 2 Improves Outcomes Without Increasing Downsides |
Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
View Slides in PDF | |
10:20 AM - 10:25 AM | DEBATE: Not So! 2 Branch F/EVAR Is Sometimes Better And Has Fewer Complications And Downsides In Some Cases: Which Ones |
Presenter(s):Timothy A. Resch, MD, PhD | |
View Slides in PDF | |
10:26 AM - 10:31 AM | Advantages Of Steerable (Variable Curve) Sheaths For Complex AAA And TAAA Repairs And TBADs: Which One Is Best And Why: Pitfalls And How To Prevent Them |
Presenter(s):W. Anthony Lee, MD | |
View Slides in PDF | |
10:32 AM - 10:42 AM | Panel Discussion |
END OF SESSION 45 | |
SESSION 46 SCHEDULE | |
Thursday
SESSION 46:
A TRIBUTE TO OUR MILITARY AND MILITARY PHYSICIANS: SOME MILITARY HISTORY; TREATMENT OF MILITARY AND CIVILIAN VASCULAR INJURIES AND CONTROL OF HEMORRHAGE; INNOVATIVE TECHNOLOGIES SUPPORTED BY THE DEFENSE DEPARTMENT
Moderators:Joseph J. DuBose, MD / Todd E. Rasmussen, MD, FACS
|
|
x | |
10:42 AM - 10:54 AM | The Vietnam Battle Of Ia Drang (November 14-16, 1965): Why Was It Fought And Why Was It Significant (12-Minute Talk) |
Presenter(s):Wayne F. Yakes, MD | |
View Slides in PDF | |
10:55 AM - 11:01 AM | Department of Defense Effort To Support Vascular Surgery Research And US National Preparedness For Mass Casualties |
Presenter(s):Todd E. Rasmussen, MD, FACS | |
View Slides in PDF | |
11:02 AM - 11:08 AM | Update On Endovascular Resuscitation And Control Of Bleeding: What Is New And Different: What Is The EVTM Society |
Presenter(s):Tal M. Hoerer, MD, PhD | |
View Slides in PDF | |
11:09 AM - 11:15 AM | Update On Civilian REBOA (Resuscitative Endovascular Balloon Occlusion Of The Aorta) For Treatment Of Hemorrhage And Trauma: What Is New And Different: When And Where Should It Be Used And By Whom |
Presenter(s):Joseph J. DuBose, MD | |
View Slides in PDF | |
11:16 AM - 11:22 AM | Is REBOA A Panacea For Battlefield Hemorrhage Or Not Yet Ready For Prime Time Use |
Presenter(s):Brandon Propper, MD / Zachary M. Arthurs, MD / Todd E. Rasmussen, MD, FACS | |
View Slides in PDF | |
11:23 AM - 11:29 AM | Current Advances In The Treatment Of Blast And High Velocity Gun Shot Injuries |
Presenter(s):Paul W. White, MD | |
View Slides in PDF | |
11:30 AM - 11:36 AM | Update On The Retrievable Rescue Stent Graft To Control Massive Aortic Or Caval Bleeding: How Does It Work And Present Status |
Presenter(s):Bryan W. Tillman, MD, PhD | |
View Slides in PDF | |
11:37 AM - 11:43 AM | Major Amputation Prosthetics Can Be Fixed Into Bone: How Does Osteointegration Work And How Is Infection Avoided |
Presenter(s):Zachary M. Arthurs, MD / Todd E. Rasmussen, MD, FACS | |
View Slides in PDF | |
11:44 AM - 11:50 AM | Update On Tissue Engineered Biological Arterial Grafts (Humacyte): How Well Are They Working In Patients And In What Vascular Bed |
Presenter(s):Jeffrey H. Lawson, MD, PhD | |
View Slides in PDF | |
11:51 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 46 | |
SESSION 47 SCHEDULE | |
Thursday
SESSION 47:
PROGRESS IN THE TREATMENT OF RUPTURED INFRARENAL AAAs, COMPLEX AAAs, TAAAs AND RELATED TOPICS
|
|
x | |
1:00 PM - 1:05 PM | Value, Limitations And Technical Tips For Using The Nellix Endograft For Ruptured AAAs |
Presenter(s):Tal M. Hoerer, MD, PhD | |
View Slides in PDF | |
1:06 PM - 1:11 PM | The Incidence Of Ruptured AAAs Is Decreasing And So Is Their Mortality: Why Are These 2 Facts So |
Presenter(s):Ross Milner, MD | |
View Slides in PDF | |
1:12 PM - 1:17 PM | Statins Decrease The Growth Rate And Rupture Risk Of AAAs As Well As The Perioperative Mortality: Who Should Receive Them, When And At What Dose |
Presenter(s):Thomas L. Forbes, MD | |
View Slides in PDF | |
1:18 PM - 1:23 PM | Impact Of Weekends On Treatment Method (Endo Versus Open Repair) And Outcomes (Early And Late) Of Treatment For Ruptured AAAs |
Presenter(s):Sebastian E. Debus, MD, PhD | |
View Slides in PDF | |
1:24 PM - 1:29 PM | Long-Term Results Of The AJAX RCT Comparing EVAR With Open Repair For Ruptured AAAs: EVAR Wins In The End – Especially In Patients >80 |
Presenter(s):Willem Wisselink, MD | |
View Slides in PDF | |
1:30 PM - 1:35 PM | Variation In Use Of EVAR Versus Open Repair For Ruptured AAAs Depends On Training And Bias Rather Than Data Logic Or Facts: EVAR Is Clearly The Best Treatment If It Can Be Done |
Presenter(s):Martin Malina, MD, PhD | |
View Slides in PDF | |
1:36 PM - 1:41 PM | Emergency Treatment As Aortic Rupture From Chronic TBAD Using The Candy Plug Technique: Technical Tips And Results |
Presenter(s):Daniela Branzan, MD | |
View Slides in PDF | |
1:42 PM - 1:47 PM | EVAR Is A Better Treatment For Ruptured AAAs Than Open Repair In Most Patients: The Mortality Benefit Of EVAR Is Increasing More Recently: Based On A Meta-Analysis |
Presenter(s):George A. Antoniou, MD, PhD, MSc, FEBVS | |
View Slides in PDF | |
1:48 PM - 1:53 PM | DEBATE: With Ruptured Complex AAAs And TAAAs, Off-The-Shelf F/B/EVAR Is The Best Treatment |
Presenter(s):Mark A. Farber, MD | |
View Slides in PDF | |
1:54 PM - 1:59 PM Power Point Presentation with Synched Audio |
DEBATE: Not So: With Ruptured Complex AAAs And TAAAs Parallel Grafts Are Simpler, More Effective And Less Costly |
Presenter(s):Konstantinos P. Donas, MD | |
View Slides in PDF | |
2:00 PM - 2:06 PM | Panel Discussion |
END OF SESSION 47 | |
SESSION 48 SCHEDULE | |
Thursday
SESSION 48:
MORE NEW DEVELOPMENTS IN RUPTURED AAAs AND TAAAs; WHAT IS AND SHOULD BE HAPPENING WITH AAA SCREENING
Moderators:Keith D. Calligaro, MD / Manish Mehta, MD, MPH
|
|
x | |
NEW DEVELOPMENTS IN AAA SCREENING | |
2:06 PM - 2:11 PM | Why The Current US PSTF Guidelines For AAA Screening Are Insufficient: Many At Risk Patients Are Not Screened |
Presenter(s):Malachi Sheahan, MD | |
View Slides in PDF | |
2:12 PM - 2:17 PM | Update On Current Screening For AAAs In The US: Most Ruptured AAAs Occur In Patients Not Being Screened: How Should US PSTF Recommendations Be Changed |
Presenter(s):Marc L. Schermerhorn, MD | |
View Slides in PDF | |
2:18 PM - 2:23 PM | Flaws In AAA Screening In Finland Result In AAA Ruptures In Patients Too Young For Screening And Whose AAAs Are Too Small To Reach Threshold For Repair |
Presenter(s):Maarit Venermo, MD, PhD | |
View Slides in PDF | |
2:24 PM - 2:29 PM | Why AAA Screening Should Be Expanded To More Females, Younger Men And Older Men |
Presenter(s):Thomas F.X. O'Donnell, MD | |
View Slides in PDF | |
MORE ABOUT AAA RUPTURES AND THEIR TREATMENT | |
2:30 PM - 2:35 PM | AAA Rupture After EVAR Behaves Differently From De Novo Rupture: How Should Treatment Be Modified In Patients With Post EVAR Ruptures |
Presenter(s):Piotr Szopinski, MD, PhD | |
View Slides in PDF | |
2:36 PM - 2:41 PM | Update On Treating All (100%) Ruptured AAAs With EVAR: The Orebro And Zurich Experience Shows It Is The Best Treatment And Lowers The Turndown Rate |
Presenter(s):Mario L. Lachat, MD / David T. McGreevy, MD / Thomas Larzon, MD, PhD | |
View Slides in PDF | |
2:42 PM - 2:47 PM | Update On Status Of Retrograde And Prograde In Site Fenestration For Arch Aneurysms And TAAAs: How To Do Them |
Presenter(s):Jean M. Panneton, MD | |
View Slides in PDF | |
2:48 PM - 2:53 PM | Open Repair For AAAs Should Not Be Used In Patients >80 Unless Their AAA Is >6 cm And They Are At Risk Of Rupture Or Ruptured: These Restrictions Do Not Apply To EVAR |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
View Slides in PDF | |
2:54 PM - 2:59 PM | When Should Ruptured AAA Patients Be Transferred: Should They Ever Be Denied Invasive Treatment |
Presenter(s):Matthew W. Mell, MD, MS | |
View Slides in PDF | |
3:00 PM - 3:10 PM | Panel Discussion |
3:10 PM - 3:30 PM | Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 48 | |
SESSION 49 SCHEDULE | |
Thursday
SESSION 49:
EXCITING NEW OR UPDATED CONCEPTS, TECHNIQUES AND TREATMENTS
Moderators:Timur P. Sarac, MD / Reese A. Wain, MD
|
|
x | |
3:30 PM - 3:35 PM | The No Intervention Option For Treatment Is More Commonly Elected For Women Than Men With CLTI, AAAs, Ruptured AAAs And Thoracic Aneurysms: It Is Wrong Headed And Unfair |
Presenter(s):Janet T. Powell, MD, PhD | |
View Slides in PDF | |
3:36 PM - 3:41 PM Power Point Presentation with Synched Audio |
Transradial Approaches For Complex Lower Extremity Interventions: CTSOs, Iliac, Fempop And BTK Lesions Can Be Treated: How To Make Them Work And Precautions: Advantages Of The Terumo R2P System |
Presenter(s):David O'Connor, MD | |
View Slides in PDF | |
3:41 PM - 3:42 PM | Transcatheter Bariatric Embolotherapy: Early And Long-Term Results From A Randomized Study |
Presenter(s):Nicholas Kipshidze, MD, PhD, DSc | |
View Slides in PDF | |
3:48 PM - 3:53 PM Power Point Presentation with Synched Audio |
The Spur Stent System (Reflow Medical): A Temporary Stent With Pins To Penetrate The Arterial Wall And Facilitate DCB Drug Delivery: How Does It Work And Results To Date |
Presenter(s):Marianne Brodmann, MD / Andrew Holden, MBChB / Thomas Zeller, MD | |
View Slides in PDF | |
3:54 PM - 3:59 PM Power Point Presentation with Synched Audio |
The Serranator Balloon Catheter (From Cagent Vascular) For Vessel Prep In BTK Arteries: It Makes Microserrations And Prevents Dissections With PTA: Current Status: The PRELUDE BTK Trial |
Presenter(s):Andrew Holden, MBChB | |
View Slides in PDF | |
4:00 PM - 4:05 PM | What Is The OR Black Box System For Measuring Endovascular Operator Performance: How Does It Work And Should It Be In Every Hybrid Angio Suite |
Presenter(s):Isabelle Van Herzeele, MD, PhD | |
View Slides in PDF | |
4:06 PM - 4:11 PM | Update On A Clampless Sutureless Technique For Performing Aorto-Iliac Anastomosis Using Endograft Connectors: The VORTEC Technique – Useful When Arterial Control And Suturing Is Impossible |
Presenter(s):Mario L. Lachat, MD | |
View Slides in PDF | |
4:12 PM - 4:17 PM | Technical Tips For Safe Endovascular Treatment Of Hepatic Artery Stenosis After Liver Transplantation |
Presenter(s):W. Charles Sternbergh III, MD | |
View Slides in PDF | |
4:18 PM - 4:23 PM | Current Status Of Left Gastric Embolization To Treat Obesity: Where Is It And What Will Its Role Be |
Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI | |
View Slides in PDF | |
4:24 PM - 4:29 PM | The Many Possible Uses Of Femoral Veins For Arterial Procedures: How To Harvest Them Safely |
Presenter(s):Timur P. Sarac, MD | |
View Slides in PDF | |
4:30 PM - 4:38 PM | Panel Discussion |
END OF SESSION 49 | |
SESSION 50 SCHEDULE | |
Thursday
SESSION 50:
PROGRESS IN RADIATION SAFETY AND MORE NEW CONCEPTS, DEVICES AND TECHNIQUES
|
|
x | |
PROGRESS IN RADIATION SAFETY | |
4:38 PM - 4:43 PM | Endovascular Team Radiation Safety Performance: How To Monitor It: It Is More Than Dose Measurement |
Presenter(s):Isabelle Van Herzeele, MD, PhD | |
View Slides in PDF | |
4:44 PM - 4:49 PM | What Is New In Radiation Safety: ESVS Radiation Safety Guidelines And Why Chromosomal Aberrations In High Volume Endovascular Operators Matters |
Presenter(s):Bijan Modarai, PhD, FRCS | |
View Slides in PDF | |
4:50 PM - 4:55 PM | Simple Radiation Protection Techniques For All Interventionalists To Use |
Presenter(s):Ripal T. Gandhi, MD, FSVM, FSIR | |
View Slides in PDF | |
NEW CONCEPTS, ETC. | |
4:56 PM - 5:01 PM | Endovascular Emergency Treatment Of Carotid Blowout From Head And Neck Cancer Or Carotid Patch Infections: Planning, Preparation And Technical Tips Are Essential |
Presenter(s):Michael B. Silva, Jr., MD | |
View Slides in PDF | |
5:02 PM - 5:07 PM | Value Of Repetitive Digital Photo Documentation Of The Ischemic Foot: It Improves Decisions And Outcomes |
Presenter(s):Martin Malina, MD, PhD | |
View Slides in PDF | |
5:08 PM - 5:13 PM | COVID-19 Virus Has Been Identified In Periaortic Fat: What Is Its Significance |
Presenter(s):Kak Khee Yeung, MD, PhD | |
View Slides in PDF | |
5:14 PM - 5:25 PM | Panel Discussion |
5:25 PM - 5:25 PM | End of Program E |
END OF SESSION 50 | |
SESSION 51 SCHEDULE | |
Thursday
SESSION 51:
NEW OR IMPROVED DEVICES FOR INFRARENAL AAA REPAIR WITH STANDARD EVAR (5-MINUTE TALKS)
|
|
x | |
7:00 AM - 7:05 AM | Treo Endograft (Terumo Aortic) For Standard Infrarenal EVAR: Approval In US And Japan |
Presenter(s):Matthew J. Eagleton, MD | |
View Slides in PDF | |
7:06 AM - 7:11 AM Power Point Presentation with Synched Audio |
Real World Outcomes With The TREO Endograft (Terumo Aortic): Preliminary Results From The TIGER Registry |
Presenter(s):Vicente Riambau, MD, PhD | |
View Slides in PDF | |
7:12 AM - 7:17 AM | Status In The US Of The Gore Conformable Excluder With Variable Neck Angulation Control For AAAs With Imperfect Necks |
Presenter(s):Robert Y. Rhee, MD | |
View Slides in PDF | |
7:18 AM - 7:23 AM | Status Of The Gore Conformable Excluder For EVAR In Europe: Results From The EXCEL And BSET Registries |
Presenter(s):Marc R.H.M. van Sambeek, MD, PhD / Colin D. Bicknell, MD, FRCS | |
View Slides in PDF | |
7:24 AM - 7:29 AM | When Does The Gore Conformable Excluder For EVAR Really Make A Difference: How Does It Work |
Presenter(s):Richard G.J. Gibbs, FRCS / Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS | |
View Slides in PDF | |
7:30 AM - 7:35 AM | Altura Endograft With Kissing Proximal Stents For Standard EVAR: Advantages And Limitations: From An Experience With 150 Patients And Up To 5-Year Follow-Up |
Presenter(s):Dainis K. Krievins, MD | |
View Slides in PDF | |
7:36 AM - 7:41 AM | Advantages And Limitations Of The Cook ZENITH Alpha Endograft For EVAR: Based On European Multicenter Experience |
Presenter(s):Philippe W.M. Cuypers, MD, PhD / Marc R.H.M. van Sambeek, MD, PhD | |
View Slides in PDF | |
7:42 AM - 7:47 AM | How And Why Do The Endurant Endograft Results For EVAR In France Differ From The Global Results: What Are The Implications |
Presenter(s):Jean-Pierre Becquemin, MD, FRCS | |
View Slides in PDF | |
7:48 AM - 7:53 AM | AAA Repairs With The Endurant Endograft Outside The IFU Can Provide Acceptable Results In Some Patients: When Is This So And When Not |
Presenter(s):Marc R.H.M. van Sambeek, MD, PhD | |
View Slides in PDF | |
7:54 AM - 7:59 AM | Update On The LEOPARD RCT Results Show That AFX Endografts Compare Favorably To Standard Proximally Fixed Endografts For AAA Repair |
Presenter(s):Christopher J. Kwolek, MD, MBA | |
View Slides in PDF | |
8:00 AM - 8:12 AM | Panel Discussion |
END OF SESSION 51 | |
SESSION 52 SCHEDULE | |
Thursday
SESSION 52:
NEW OR UPDATED DEVICES FOR STANDARD EVAR, EVAS (ENDOVASCULAR ANEURYSM SEALING) AND F/EVAR
Moderators:Jerry Goldstone, MD, FACS, FRCSEd / Ramon Berguer, MD, PhD
|
|
x | |
8:12 AM - 8:17 AM | Alto Endograft (From Endologix) For Standard EVAR: This Latest Modification Of The Ovation Endograft Has More Proximal Polymer Sealing Rings: Results From The ELEVATE Trial And 3-4-Year Results From The New Zealand Experience Show Advantages |
Presenter(s):Sean P. Lyden, MD / Andrew Holden, MBChB | |
View Slides in PDF | |
8:18 AM - 8:23 AM | Combination Of Ovation Endograft And Bare Metal Renal Stent For Difficult AAA Neck Unsuitable For F/EVAR |
Presenter(s):Gianmarco de Donato, MD | |
View Slides in PDF | |
8:24 AM - 8:29 AM | Experience With The Nellix Endograft In 120 Patients With Up To 10 Years Follow-Up: What Is The Devices’ Future |
Presenter(s):Dainis K. Krievins, MD | |
View Slides in PDF | |
8:30 AM - 8:35 AM | Update On Multicenter Results With F/EVAR Using The Fenestrated Anaconda Endograft: From The Global FACT Registry: Advantages And Limitations |
Presenter(s):Clark J. Zeebregts, MD, PhD / Michel M.P. Reijnen, MD, PhD | |
View Slides in PDF | |
8:36 AM - 8:41 AM Power Point Presentation with Synched Audio |
Update On The Incraft Endograft For Standard Infrarenal EVAR: Is Its Low Profile An Advantage |
Presenter(s):Matteo Orrico, MD | |
View Slides in PDF | |
8:42 AM - 8:47 AM | Long-Term Outcomes Of The Cook pBranch OTS Device For F/EVAR: Advantages And Limitations |
Presenter(s):Timothy A. Resch, MD, PhD | |
View Slides in PDF | |
8:48 AM - 8:58 AM | Panel Discussion |
8:58 AM - 9:24 AM | Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 52 | |
SESSION 53 SCHEDULE | |
Thursday
SESSION 53:
NEW OR IMPROVED DEVICES FOR THE ASCENDING AORTA, THE AORTIC ARCH OR NEAR THE ARCH
Moderators:Michel C. Henry, MD / Rodney A. White, MD
|
|
x | |
9:24 AM - 9:29 AM | Nexus OTS Endograft From Endospan For Treating Zone 1 Lesions Of The Aortic Arch: How Does It Work And 2-Year Clinical Results: Status In The US |
Presenter(s):Ross Milner, MD / Daniel G. Clair, MD / Andrew Holden, MBChB | |
View Slides in PDF | |
9:30 AM - 9:35 AM Power Point Presentation with Synched Audio |
Outcomes Of The Custom Relay Ascending Aorta Endograft (Terumo Aortic): The European Experience |
Presenter(s):Vicente Riambau, MD, PhD / Afshin Assadian, MD / Mo S. Hamady, MD, FRCR, EBIR, FSIR | |
View Slides in PDF | |
9:36 AM - 9:41 AM | Status In The US Of The RelayBranch Investigational Device For Repair Of Aortic Arch Lesions: How Many Branches Can And Should Be Revascularized: Advantages And Limitations |
Presenter(s):Luis A. Sanchez, MD / Eric E. Roselli, MD | |
View Slides in PDF | |
9:42 AM - 9:47 AM Power Point Presentation with Synched Audio |
Long-Term Safety And Durable Effectiveness Of Relay (Terumo Aortic) Scalloped Endograft For TEVAR Treatment Of Lesions In Or Near The Aortic Arch |
Presenter(s):Mo S. Hamady, MD, FRCR, EBIR, FSIR / Jean-Marc Alsac, MD, PhD | |
View Slides in PDF | |
9:48 AM - 9:53 AM | Status In The US Of The Gore Conformable CTAG Endograft With Variable Angulation Control In The Aortic Arch: How Does It Work And Advantages |
Presenter(s):Jean Bismuth, MD | |
View Slides in PDF | |
9:54 AM - 9:59 AM | When And How To Use The Gore Conformable CTAG Endograft Optimally: Are There Downsides |
Presenter(s):Sukgu Han, MD | |
View Slides in PDF | |
10:00 AM - 10:05 AM | Indications, Value And Limitations Of Single Branched TEVAR Devices For Revascularizing The Left Subclavian Artery: Are They Worth The Effort And Cost |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
View Slides in PDF | |
10:06 AM - 10:15 AM | Panel Discussion |
END OF SESSION 53 | |
SESSION 54 SCHEDULE | |
Thursday
SESSION 54:
NEW OR IMPROVED DEVICES FOR THORACIC AORTIC LESION REPAIRS (TEVAR) AND FOR THORACOABDOMINAL ANEURYSM (TAAA) REPAIRS (ALL TALKS ARE 4 ¾-MINUTES)
Moderators:Giovanni B. Torsello, MD / James F. McKinsey, MD
|
|
x | |
DEVICES FOR TEVAR | |
10:15 AM - 10:20 AM | Low Profile Devices For TEVAR: Advantages And Disadvantages Based On Long-Term Results |
Presenter(s):Giovanni B. Torsello, MD | |
View Slides in PDF | |
10:20 AM - 10:25 AM Power Point Presentation with Synched Audio |
6-Year Experience With The Cook ZENITH Alpha Thoracic Endograft For TEVAR In 400 Patients: How To Achieve Long-Term Durably Good Results |
Presenter(s):Germano Melissano, MD | |
View Slides in PDF | |
10:25 AM - 10:30 AM | Long-Term Outcomes Of TEVAR For Repair Of Traumatic Aortic Injuries From The RESCUE U.S. IDE Clinical Trial |
Presenter(s):Ali Azizzadeh, MD | |
View Slides in PDF | |
10:30 AM - 10:35 AM | Endoanchors To Improve Outcomes With TEVAR: They Can Help Distally As Well As Proximally |
Presenter(s):Ross Milner, MD | |
View Slides in PDF | |
10:35 AM - 10:40 AM | Tips And Tricks Of Endoanchors Application After TEVAR (TESAR) |
Presenter(s):Giovanni Tinelli, MD, PhD / Yamume Tshomba, MD | |
View Slides in PDF | |
10:40 AM - 10:46 AM | Panel Discussion |
10:46 AM - 10:51 AM | The Relay Pro (Terumo Aortic) Endograft For TEVAR And Its Advantages In Treating TBADs: Why Is It Better Than The Older Relay Plus Device |
Presenter(s):Edward Y. Woo, MD / Steven D. Abramowitz, MD | |
View Slides in PDF | |
10:51 AM - 10:56 AM | Patient Specific Custom Designed Relay Pro Endografts (Terumo Aortic): How Do They Work And What Are Their Advantages In Various Circumstances |
Presenter(s):David M. Williams, MD | |
View Slides in PDF | |
10:56 AM - 11:01 AM Power Point Presentation with Synched Audio |
Relay Endografts (Terumo Aortic) For TEVAR: Why Do They Provide Better Wall Apposition For Sealing |
Presenter(s):Fadi Taher, MD / Afshin Assadian, MD | |
View Slides in PDF | |
11:01 AM - 11:06 AM Power Point Presentation with Synched Audio |
European Experience With The Gore CTAG Conformable Endograft For TEVAR With Variable Angulation Control Proximally: When And How Does It Improve Results |
Presenter(s):Vicente Riambau, MD, PhD | |
View Slides in PDF | |
11:06 AM - 11:11 AM | New Polymer Filled Low Profile Endograft Device With O-Ring Sealing: How Does It Work And Why Is It Better |
Presenter(s):Piotr Szopinski, MD, PhD | |
View Slides in PDF | |
11:11 AM - 11:17 AM | Panel Discussion |
NEW OR IMPROVED ENDO DEVICES FOR TAAA REPAIRS | |
11:17 AM - 11:22 AM | To Treat Complex TAAAs A Combination Of A Relay (Terumo) TEVAR And A Fenestrated Anaconda Is Best: How Are The SMA And Celiac Axis Revascularized |
Presenter(s):Mo S. Hamady, MD, FRCR, EBIR, FSIR | |
11:22 AM - 11:27 AM | Status Of The Cook t-Branch OTS Endograft For TAAA Repairs: Advantages And Limitations Based On A Meta-Analysis |
Presenter(s):Nikolaos Tsilimparis, MD, PhD | |
View Slides in PDF | |
11:27 AM - 11:32 AM Power Point Presentation with Synched Audio |
Comparison Of 3 OTS Endografts For Urgent TAAA Repairs: TAMBE (Gore) Versus E-nside (Jotec) Versus t-Branch (Cook): Advantages And Disadvantages Of Each |
Presenter(s):Luca Bertoglio, MD / Germano Melissano, MD / Roberto Chiesa, MD | |
View Slides in PDF | |
11:32 AM - 11:37 AM | Valiant Manifold OTS Endograft (Medtronic) Device For Repairing TAAAs: How Does It Work And Early Clinical Experience In The US |
Presenter(s):Murray L. Shames, MD | |
View Slides in PDF | |
11:37 AM - 11:42 AM | Unitary Manifold Endograft System For Complex Type 4 TAAAs And Failed EVARs: How Does It Work And 2-Year Results |
Presenter(s):Patrick W. Kelly, MD | |
View Slides in PDF | |
11:42 AM - 11:47 AM Power Point Presentation with Synched Audio |
Novel OTS Life Tech Endograft For TAAA Repair: How Does It Work And What Makes It Different |
Presenter(s):Ralf R. Kolvenbach, MD | |
View Slides in PDF | |
11:48 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 54 | |
SESSION 55 SCHEDULE | |
Thursday
SESSION 55:
NEW OR UPDATED INFORMATION ON BALLOON EXPANDABLE COVERED STENTS, LOWER EXTREMITY PROSTHETIC GRAFTS, BIORESORBABLE GRAFTS, PERIGRAFT SEROMA AND VALUE OF A PROSTHETIC PERIGRAFT SIROLIMUS PATCH [SEE ALSO SESSION 28] ALL TALKS ARE 5 MINUTES)
Moderators:Ali F. AbuRahma, MD / Patrick J. Lamparello, MD
|
|
x | |
STENT-GRAFTS | |
1:00 PM - 1:05 PM | Why Are VBX Balloon Expandable Stent-Grafts (From Gore) Different And Better Than Other Covered Stents In Various Vascular Beds |
Presenter(s):James F. McKinsey, MD | |
View Slides in PDF | |
1:06 PM - 1:11 PM | Safety Of MRI Early After Deployment Of Various Covered Stents |
Presenter(s):Maria A. Ruffino, MD, EBIR | |
View Slides in PDF | |
PROSTHETIC GRAFTS | |
1:12 PM - 1:17 PM | Final 3-Year Results Of The ZILVERPASS RCT Comparing Prosthetic PTFE Bypasses With Zilver PTX (Cook) Stents To Treat Long Fempop Lesions: Should Open Prosthetic Bypass Be Abandoned |
Presenter(s):Michel J. Bosiers, MD / Marc Bosiers, MD | |
View Slides in PDF | |
1:18 PM - 1:23 PM | The 3DH Spiral Flow Prosthetic Graft: Does It Prevent Neointimal Hyperplasia In Leg Bypasses Or A-V Access |
Presenter(s):Hosam F. El Sayed, MD | |
View Slides in PDF | |
1:24 PM - 1:29 PM | Heparin Coated (Propaten) PTFE Grafts (Gore) Versus Autologous Vein Grafts For Bypasses To Targets Above And Below The Knee: Are The Heparin Coated Grafts Worth The Cost |
Presenter(s):David J. Dexter, MD | |
View Slides in PDF | |
1:30 PM - 1:35 PM Power Point Presentation with Synched Audio |
Bioabsorbable Arterial Grafts (Xeltis Grafts): How Do They Work And What Is Their Potential |
Presenter(s):Frans L. Moll, MD, PhD | |
View Slides in PDF | |
1:36 PM - 1:41 PM | Perigraft Seromas After PTFE Lower Extremity And Aortic Arterial Grafts: Frequency, Etiology And What To Do About Them |
Presenter(s):Jae S. Cho, MD | |
View Slides in PDF | |
1:42 PM - 1:47 PM | Update On External Sirolimus Patch Wrap-Around For PTFE Graft Anastomoses: Do They Decrease Neointimal Hyperplasia |
Presenter(s):Sriram S. Iyer, MD, FACC | |
View Slides in PDF | |
1:48 PM - 1:54 PM | Panel Discussion |
END OF SESSION 55 | |
SESSION 56 SCHEDULE | |
Thursday
SESSION 56:
NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, TACKS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
Moderators:Kenneth Ouriel, MD, MBA / Enrico Ascher, MD
|
|
x | |
ATHERECTOMY RELATED TOPICS | |
1:54 PM - 1:59 PM | Complications Of Atherectomy: How To Prevent Some, How To Treat The Others |
Presenter(s):Theodosios Bisdas, MD | |
2:00 PM - 2:05 PM | Value And Limitations Of 355 nm Auryon B-LaserTM (From AngioDynamics): It Enables Safe Crossing Of Difficult Lesions Not Crossed With A Guidewire: How Does It Work And Clinical Results |
Presenter(s):Luis R. Leon, MD, RVT, FACS | |
View Slides in PDF | |
2:06 PM - 2:11 PM | Orbital And Laser Atherectomy: Indications, Advantages And Precautions With Above Knee BTK De Novo Lesions And ISR |
Presenter(s):Craig M. Walker, MD | |
View Slides in PDF | |
2:12 PM - 2:17 PM | Value Of Atherectomy And DCBs: Interim Results Of The REALITY Trial |
Presenter(s):Brian G. DeRubertis, MD | |
View Slides in PDF | |
ANCILLARY TECHNIQUES | |
2:18 PM - 2:23 PM | Value of Wingman Catheter (Reflow Medical) For Crossing Difficult Lesions: How Does It Work And Results |
Presenter(s):John R. Laird, MD | |
View Slides in PDF | |
2:24 PM - 2:29 PM | Value of New Dedicated Special Tools And Devices To Facilitate Trans-Radial Access For Lower Extremity Lesion Treatments: How Far Distally Can It Be Effective |
Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) | |
View Slides in PDF | |
NEW INFORMATION ON STENTS | |
2:30 PM - 2:35 PM | Advantages Of Supera (Vasculomimetic – VMI) Stent For Complex Fempop Occlusive Lesions: Technical Tips: They Work Even In The Subintimal Position |
Presenter(s):Erwin Blessing, MD | |
View Slides in PDF | |
2:36 PM - 2:41 PM | Value Of The Supera VMI Stent For Common Femoral Artery (CFA) Occlusive Lesions: Better Than Endarterectomy: 2-Year Results And Status Of The SUPERSURG RCT (Versus Open Surgery) |
Presenter(s):Brian G. DeRubertis, MD | |
View Slides in PDF | |
2:42 PM - 2:52 PM | Panel Discussion |
2:52 PM - 3:12 PM | Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 56 | |
SESSION 57 SCHEDULE | |
Thursday
SESSION 57:
NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ANGIOPLASTY BALLOONS
Moderators:John R. Laird, MD / Kenneth Ouriel, MD, MBA
|
|
x | |
3:12 PM - 3:17 PM Power Point Presentation with Synched Audio |
Chocolate Touch DCBs (From Medtronic): How Do They Work, Advantages And Updated Clinical Results |
Presenter(s):Andrew Holden, MBChB | |
View Slides in PDF | |
3:18 PM - 3:23 PM Power Point Presentation with Synched Audio |
Unfavorable Balloon (Candy) Wrap Can Cause Dissections With Angioplasty: What Is The Mechanism: How Can It Be Recognized And Dissection Avoided: The Chocolate DCB Is One Way |
Presenter(s):Jos C. van den Berg, MD, PhD | |
View Slides in PDF | |
3:24 PM - 3:29 PM Power Point Presentation with Synched Audio |
Update On The TANGO Trial Using The Bullfrog Balloon Device (Mercator Medical Systems) To Inject Sirolimus Drug Into Lesion Wall Before Angioplasty: How Does It Work And Results |
Presenter(s):Ehrin Armstrong, MD | |
View Slides in PDF | |
3:30 PM - 3:35 PM Power Point Presentation with Synched Audio |
The Importance Of Dissection In Angioplasty Treatment Of BTK Lesions: How To Prevent And Treat Such Dissections: The Value Of Tacks (From Intact Vascular): How Do They Work |
Presenter(s):Andrew Holden, MBChB | |
View Slides in PDF | |
3:36 PM - 3:41 PM | 24-Month Results Of TOBA II BTK Trial Of The Tack Device To Decrease Dissections With Balloon Angioplasty Of BTK Lesions Show Safety And 94.7% Target Limb Salvage |
Presenter(s):Patrick J. Geraghty, MD | |
View Slides in PDF | |
3:42 PM - 3:49 PM | Panel Discussion |
END OF SESSION 57 | |
SESSION 58 SCHEDULE | |
Thursday
SESSION 58:
NEW OR IMPROVED DEVICES AND TECHNIQUES TO PREVENT OR TREAT ENDOLEAKS OR DEVICE MIGRATION: ENDOANCHORS, ETC.
Moderators:William D. Jordan Jr., MD / Jean M. Panneton, MD
|
|
x | |
3:49 PM - 3:54 PM | Prophylactic Endoanchors (Medtronic) With TEVAR For Complex Anatomy Improves Outcomes: Technical Tips For Their Use In TEVAR |
Presenter(s):Jean M. Panneton, MD | |
View Slides in PDF | |
3:55 PM - 4:00 PM | New Developments From The ANCHOR Registry With Over 5 Years Of Follow-Up Show The Value Of Endoanchors When Used Prophylactically For Certain Indications Prevent Endoleaks And Migration: What Are Those Indications |
Presenter(s):William D. Jordan Jr., MD | |
View Slides in PDF | |
4:01 PM - 4:06 PM Power Point Presentation with Synched Audio |
New Developments From The ANCHOR Registry With >5 Years Follow-Up Show That Endoanchors Can Be Used To Treat Endoleaks And Migration Effectively In Hostile Neck Anatomy: The Proof |
Presenter(s):Jean-Paul de Vries, MD, PhD | |
View Slides in PDF | |
4:07 PM - 4:12 PM | Vesteck – The Next Generation Of Endoanchor Technology: How Does It Work And Where Does It Stand |
Presenter(s):David H. Deaton, MD, FACS | |
View Slides in PDF | |
4:13 PM - 4:18 PM | Balloon Optimized Molding For Better Deployment And Sealing Of Ovation Alto Low Profile Endografts For EVAR: How To Do It And How It Helps Prevent Endoleaks and Migration |
Presenter(s):David J. Minion, MD | |
View Slides in PDF | |
4:19 PM - 4:25 PM | Panel Discussion |
END OF SESSION 58 | |
SESSION 59 SCHEDULE | |
Thursday
SESSION 59:
NEW OR IMPROVED ENDOVASCULAR DEVICES FOR CLOT REMOVAL OR EMBOLIZATION (SEE ALSO SESSION 30)
Moderators:James F. Benenati, MD / Neal S. Cayne, MD
|
|
x | |
CLOT REMOVING DEVICES | |
4:25 PM - 4:30 PM | Percutaneous Embolectomy Or Thrombectomy With The Indigo System (From Penumbra): What Makes It Different, Technical Tips, Results And Limitations |
Presenter(s):David J. Dexter, MD | |
View Slides in PDF | |
4:31 PM - 4:36 PM | Newer Pharmaco-Mechanical Endovascular Clot Removal Systems: When And Why Is Each Device Best To Use |
Presenter(s):Guillermo A. Escobar, MD | |
View Slides in PDF | |
4:37 PM - 4:42 PM Power Point Presentation with Synched Audio |
Catheter Based Vacuum Assisted Thrombectomy For Acute Limb Ischemia: How Does It Work: Advantages And Limitations: From A Multicenter Study: Key Findings From The INDIAN Trial |
Presenter(s):Gianmarco de Donato, MD / Carlo Setacci, MD | |
View Slides in PDF | |
4:43 PM - 4:48 PM | Technical Tips For Effective Coil Embolization: Importance Of Dense Packing; Coils With Fibers Versus Plain Metal Coils; Value And Indications For Different Coils |
Presenter(s):James F. Benenati, MD / Constantino Pena, MD | |
View Slides in PDF | |
4:49 PM - 4:54 PM | Why Ruby Coils, The Penumbra Occlusion Device (POD) And Packing Coils Have Different Uses And Why They Are Valuable And Cost Effective For Different Lesions: Technical Tips For Optimizing |
Presenter(s):Sean P. Lyden, MD | |
View Slides in PDF | |
4:55 PM - 5:00 PM Power Point Presentation with Synched Audio |
Caterpillar™ Embolic Plug (From Bard): How Does It Work: Advantages And Clinical Results |
Presenter(s):Andrew Holden, MBChB | |
View Slides in PDF | |
5:01 PM - 5:06 PM | How To Treat Type 1A Endoleaks With Ruby Coils: When Will They Work; When Will They Not: Technical Tips |
Presenter(s):Mazin Foteh, MD | |
View Slides in PDF | |
5:07 PM - 5:12 PM | How To Insert Large Vessel Embolization Devices (PODs) Through Low Profile Access |
Presenter(s):Frank R. Arko, MD | |
View Slides in PDF | |
5:13 PM - 5:18 PM | Floating Clot At The Carotid Bifurcation Is A Prime Indication For Flow Reversal Technology During Treatment Of Carotid Stenosis: How Can Flow Reversal Best Be Achieved In This Setting |
Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC, PhD, FACS / Juan C. Parodi, MD | |
View Slides in PDF | |
5:19 PM - 5:30 PM | Panel Discussion |
5:30 PM - 5:30 PM | End of Program F |
END OF SESSION 59 | |
SESSION 60 SCHEDULE | |
Thursday
SESSION 60:
VENOUS CLINICAL EXAMINATION AND HEMODYNAMICS
|
|
x | |
8:00 AM - 8:04 AM | Introduction To Veins At VEITH |
Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
8:05 AM - 8:10 AM | AVF CEAP Revision 2020 |
Presenter(s):Marc A. Passman, MD | |
View Slides in PDF | |
8:11 AM - 8:16 AM | CEAP, VCSS, HASTI: Their Significance And How To Utilize |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FAVLS | |
View Slides in PDF | |
8:17 AM - 8:22 AM | Physiology Of Venous Return |
Presenter(s):Brajesh K. Lal, MD | |
View Slides in PDF | |
8:23 AM - 8:28 AM | Status Of The Evidence For C2 Intervention |
Presenter(s):Peter Gloviczki, MD | |
View Slides in PDF | |
8:29 AM - 8:34 AM | An Algorithm To Predict Disease Severity In C2 Patients |
Presenter(s):Mikel Sadek, MD | |
View Slides in PDF | |
8:35 AM - 8:40 AM | Evidence Summary On The Pathophysiology Of Varicose Veins |
Presenter(s):Thomas W. Wakefield, MD | |
View Slides in PDF | |
8:41 AM - 8:46 AM | CVD: A Clinical Approach Algorithm |
Presenter(s):Seshadri Raju, MD | |
View Slides in PDF | |
8:47 AM - 8:53 AM | Non-Venous Causes Of The Swollen Extremity |
Presenter(s):Andrea T. Obi, MD | |
View Slides in PDF | |
8:53 AM - 8:58 AM | Quality Of Life Tools Reflect Disease Severity, But They Can Be Improved |
Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS | |
View Slides in PDF | |
8:59 AM - 9:04 AM | Panel Discussion |
END OF SESSION 60 | |
SESSION 61 SCHEDULE | |
x | |
9:05 AM - 9:10 AM | 1470mm Laser And Wound Care Trial |
Presenter(s):Lorena Grillo, MD | |
View Slides in PDF | |
9:11 AM - 9:16 AM | Are They Venous Ulcers |
Presenter(s):Raghu Kolluri, MD | |
View Slides in PDF | |
9:17 AM - 9:22 AM | Ambulatory Venous Pressure, Air Plethysmography, And The Role Of Calf Venous Pump In Chronic Venous Disease |
Presenter(s):Seshadri Raju, MD | |
View Slides in PDF | |
9:23 AM - 9:28 AM | Does Deep Venous Reflux Matter With Superficial Ablation |
Presenter(s):Peter Henke, MD | |
View Slides in PDF | |
9:29 AM - 9:34 AM | Non Contact Imaging For Superficial Disease: How Does It Help |
Presenter(s):Steve Elias, MD | |
View Slides in PDF | |
9:35 AM - 9:40 AM | Understanding Venous Physiology Helps Guide Therapy |
Presenter(s):Fedor Lurie, MD, PhD | |
View Slides in PDF | |
9:41 AM - 9:46 AM | Panel Discussion |
END OF SESSION 61 | |
SESSION 62 SCHEDULE | |
Thursday
SESSION 62:
SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
Moderators:Glenn Jacobowitz, MD / Alun H. Davies, MA, DM, DSc, FRCS
|
|
x | |
9:47 AM - 9:52 AM | Results Of Randomized Controlled Trial MOCCA Versus Cyanoacrylate |
Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS | |
View Slides in PDF | |
9:53 AM - 9:58 AM | “Choosing Wisely” Items For Chemical Or Thermal Ablation In The Treatment Of The Incompetent Saphenous Veins And Recurrence |
Presenter(s):Claudine M. Hamel-Desnos, MD | |
View Slides in PDF | |
9:59 AM - 10:04 AM | What Drugs Do I Recommend For Symptomatic Venous Disease |
Presenter(s):Jorge H. Ulloa, MD, FACS | |
View Slides in PDF | |
10:05 AM - 10:10 AM | Ablative Procedures And Cost Effectiveness |
Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS | |
View Slides in PDF | |
10:11 AM - 10:16 AM | SVT Treatment During Pregnancy: Treatment Choices |
Presenter(s):Ellen D. Dillavou, MD | |
View Slides in PDF | |
10:17 AM - 10:22 AM | Vein Histopathology: 5.5 Years After Cyanoacrylate Closure |
Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
View Slides in PDF | |
10:23 AM - 10:28 AM | Saphenous Ablation On Anticoagulation: Is It Safe, Effective And Durable |
Presenter(s):Glenn Jacobowitz, MD | |
View Slides in PDF | |
10:29 AM - 10:34 AM | Panel Discussion |
10:35 AM - 10:50 AM | Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 62 | |
SESSION 63 SCHEDULE | |
Thursday
SESSION 63:
THERMAL AND NON-THERMAL ABLATION – PART 1
|
|
x | |
10:50 AM - 10:55 AM | Decision Making In Saphenous Ablation: What To Use When |
Presenter(s):Ellen D. Dillavou, MD | |
View Slides in PDF | |
10:56 AM - 11:01 AM | HIFU: Is It Ready For Prime Time |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
View Slides in PDF | |
11:02 AM - 11:07 AM | Tips, Tricks And Limitations: HIFU |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
View Slides in PDF | |
11:08 AM - 11:13 AM | Tips, Tricks And Limitations: Perforator Ablation |
Presenter(s):Steve Elias, MD | |
View Slides in PDF | |
11:14 AM - 11:19 AM | Tips, Tricks And Limitations: Varithena |
Presenter(s):Edward G. Mackay, MD | |
View Slides in PDF | |
11:20 AM - 11:25 AM | Tips, Tricks, And Limitations: Laser Truncal Ablation |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FAVLS | |
View Slides in PDF | |
11:26 AM - 11:31 AM | Panel Discussion |
END OF SESSION 63 | |
SESSION 64 SCHEDULE | |
Thursday
SESSION 64:
THERMAL AND NON-THERMAL ABLATION – PART 2
|
|
x | |
11:32 AM - 11:37 AM | Tips, Tricks, And Limitations: Liquid Sclerotherapy |
Presenter(s):Victor M. Canata, MD, PhD | |
View Slides in PDF | |
11:38 AM - 11:43 AM | Tips, Tricks And Limitations: Clarivein |
Presenter(s):Steve Elias, MD | |
View Slides in PDF | |
11:44 AM - 11:49 AM | Tips, Tricks And Limitations: VenaSeal |
Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS | |
View Slides in PDF | |
11:50 AM - 11:55 AM | Tips, Tricks And Limitations: Radiofrequency Ablation |
Presenter(s):Alan M. Dietzek, MD, RPVI, FACS | |
View Slides in PDF | |
11:56 AM - 12:01 PM | Tips, Tricks And Limitations: Brazilian Phlebectomy |
Presenter(s):Gutenberg A. Gurgel, MD, MSc | |
View Slides in PDF | |
12:02 PM - 12:07 PM | Tips, Tricks And Limitations: Phlebogrif |
Presenter(s):Lorena Grillo, MD | |
View Slides in PDF | |
12:08 PM - 12:13 PM | Safety And Efficacy Of Endovenous Ablations InOctogenarians, Nonagenarians, And Centenarians |
Presenter(s):Anil P. Hingorani, MD / Enrico Ascher, MD | |
View Slides in PDF | |
12:14 PM - 12:20 PM | Panel Discussion |
12:20 PM - 1:15 PM | Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 64 | |
SESSION 65 SCHEDULE | |
Thursday
SESSION 65:
SPIDER VEINS, TRUNCAL VEINS, TRIBUTARY VEINS, EXOTIC VEIN TREATMENT
Moderators:Kathleen D. Gibson, MD / Edward G. Mackay, MD
|
|
x | |
1:15 PM - 1:20 PM | Foam Therapies (PCF Versus PEM): When To Use And Does It Make A Difference |
Presenter(s):Edward G. Mackay, MD | |
View Slides in PDF | |
1:21 PM - 1:26 PM | Patient Preferences For Thermal Ablation Versus Non-Thermal, Non-Tumescent Varicose Vein Treatments: A Choice-Based Conjoint (CBS) Analysis |
Presenter(s):Peter J. Pappas, MD | |
View Slides in PDF | |
1:27 PM - 1:32 PM | Randomized Controlled Study Of EVLA And Foam In the SSV-Fovelass Study: 3-Year Results |
Presenter(s):Claudine M. Hamel-Desnos, MD | |
View Slides in PDF | |
1:33 PM - 1:38 PM | CLACS In Paraguay Results Of The Aesthetic Phlebology Trial |
Presenter(s):Victor M. Canata, MD, PhD | |
View Slides in PDF | |
1:39 PM - 1:44 PM | Superficial Ablation Outcomes (5 Years) In 13,000 Patients |
Presenter(s):Peter J. Pappas, MD | |
View Slides in PDF | |
1:45 PM - 1:50 PM | Labial Varices: Choices And How I Do It |
Presenter(s):Ellen D. Dillavou, MD | |
View Slides in PDF | |
1:51 PM - 1:56 PM | Which Saphenous Vein Recanalization Should Be Treated |
Presenter(s):Kathleen D. Gibson, MD | |
View Slides in PDF | |
1:57 PM - 2:02 PM | Is Combination Therapy Laser And Sclerotherapy More Efficacious For Telangiectatic Treatment |
Presenter(s):Gutenberg A. Gurgel, MD, MSc | |
View Slides in PDF | |
2:03 PM - 2:08 PM | Concomitant Versus Staged Tributary Treatment |
Presenter(s):Kathleen D. Gibson, MD | |
View Slides in PDF | |
2:09 PM - 2:14 PM | Panel Discussion |
END OF SESSION 65 | |
SESSION 66 SCHEDULE | |
Thursday
SESSION 66:
VENOUS SOCIETAL AND GOVERNANCE
Moderators:Kathleen J. Ozsvath, MD / Harold J. Welch, MD
|
|
x | |
2:21 PM - 2:26 PM | The Future Of Venous Reimbursement In A Non-Fee For Service Environment |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
View Slides in PDF | |
2:27 PM - 2:32 PM | Can We Use The Data From VQI VVR To Advocate For Coverage Of Venous Procedures |
Presenter(s):Nicholas H. Osborne, MD, MS | |
View Slides in PDF | |
2:33 PM - 3:38 PM | Results Of Appropriateness Criteria (AVF) I |
Presenter(s):Kathleen J. Ozsvath, MD | |
View Slides in PDF | |
2:39 PM - 2:44 PM | Results Of Appropriateness Criteria (AVF) II |
Presenter(s):Kathleen J. Ozsvath, MD | |
View Slides in PDF | |
2:45 PM - 2:50 PM | Ground Zero On 9/11: What Did We Learn |
Presenter(s):Mark A. Adelman, MD | |
View Slides in PDF | |
2:51 PM - 2:56 PM | Focused Practice Designation – Venous Disease Treatment |
Presenter(s):Brajesh K. Lal, MD | |
View Slides in PDF | |
2:57 PM - 3:02 PM | From The AVF And SVS: EHIT Recommendations |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FAVLS | |
View Slides in PDF | |
3:03 PM - 3:12 PM | Panel Discussion |
END OF SESSION 66 | |
SESSION 67 SCHEDULE | |
Thursday
SESSION 67:
MORE SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
|
|
x | |
3:13 PM - 3:18 PM | Risk Factors For EHIT And Recanalization: An Analysis Of 10,000 Patients |
Presenter(s):Anil P. Hingorani, MD | |
View Slides in PDF | |
3:19 PM - 3:24 PM | Ablation Outcomes In Obese Patients |
Presenter(s):Peter J. Pappas, MD | |
View Slides in PDF | |
3:25 PM - 3:30 PM | Venolymphatic Edema And Its Treatment Options Raghu Kolluri, MD |
Presenter(s):Raghu Kolluri, MD | |
View Slides in PDF | |
3:31 PM - 3:36 PM | Radiofrequency Ablation Increases The Incidence Of Endothermal Heat Induced Thrombosis |
Presenter(s):Anil P. Hingorani, MD | |
View Slides in PDF | |
3:37 PM - 3:42 PM | Varithena® VLU Registry: The Effects Of Polidocanol Endovenous Microfoam On Wound Healing And Recurrence |
Presenter(s):Raghu Kolluri, MD | |
View Slides in PDF | |
3:43 PM - 3:48 PM | Saphenous Incompetence With Post-Thrombotic Deep Veins |
Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
View Slides in PDF | |
3:49 PM - 3:54 PM | European College Of Phlebology Guideline for Truncal Ablation |
Presenter(s):Kursat A. Bozkurt, MD | |
View Slides in PDF | |
3:55 PM - 4:00 PM | Varicose Veins Among Klippel Trenaunay Syndrome: What You Should Know About |
Presenter(s):Byung-Boong Lee, MD | |
View Slides in PDF | |
4:01 PM - 4:10 PM | Panel Discussion |
4:10 PM - 4:25 PM | Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 67 | |
SESSION 68 SCHEDULE | |
Thursday
SESSION 68:
VENOUS CLINICAL TRIALS; LYMPHATIC AND VEIN TREATMENT STRATEGIES
Moderators:Peter Gloviczki, MD / Mark H. Meissner, MD
|
|
x | |
4:25 PM - 4:30 PM | What Articles Are JVS-VL Looking For and How Can You Write A Paper That Will Be Accepted And Published |
Presenter(s):Peter Gloviczki, MD | |
View Slides in PDF | |
4:31 PM - 4:36 PM | Unilateral, Bilateral, Staged Endovenous Ablation – VQI Data |
Presenter(s):Nicholas H. Osborne, MD, MS | |
View Slides in PDF | |
4:37 PM - 4:42 PM | Is Saphenous Vein Stripping A Cost-Effective Treatment |
Presenter(s):Lourdes Reina, MD | |
View Slides in PDF | |
4:43 PM - 4:48 PM | The Recalcitrant Ulcer: Our 52-Week Analysis |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
View Slides in PDF | |
4:49 PM - 4:54 PM | Correlation Amongst Transabdominal/Transvaginal Duplex Versus Venography For Pelvic Venous Insufficiency And Leg Varicosities |
Presenter(s):Lourdes Reina, MD | |
View Slides in PDF | |
4:55 PM - 5:00 PM | Treating Low And Moderate Severity Venous Disease Is Beneficial – Data From The VQI VVR |
Presenter(s):Nicholas H. Osborne, MD, MS | |
View Slides in PDF | |
5:01 PM - 5:06 PM | What Venous Trials Do We Need |
Presenter(s):Mark H. Meissner, MD | |
View Slides in PDF | |
5:07 PM - 5:12 PM | Panel Discussion |
END OF SESSION 68 | |
SESSION 69 SCHEDULE | |
Thursday
SESSION 69:
LIPEDEMA, LYMPHEDEMA, PHLEBOLYMPHEDEMA
Moderators:Thomas F. O'Donnell, Jr., MD / Steven M. Dean, DO
|
|
x | |
5:13 PM - 5:18 PM | Diagnosis Of Lipedema And Treatment |
Presenter(s):Steven M. Dean, DO | |
View Slides in PDF | |
5:19 PM - 5:24 PM | Overview Of Lymphatic Anatomy, Physiology And Imaging Techniques |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
View Slides in PDF | |
5:25 PM - 5:30 PM | Phlebolymphedema: Hallmark Of Combined Insufficiency Of Venous-Lymphatic System |
Presenter(s):Byung-Boong Lee, MD | |
View Slides in PDF | |
5:31 PM - 5:36 PM | Clinical Characteristics Of Lower Extremity Lymphedema |
Presenter(s):Steven M. Dean, DO | |
View Slides in PDF | |
5:37 PM - 5:42 PM | Advanced Pneumatic Compression: Continued Improvement In Quality Of Life |
Presenter(s):Thomas S. Maldonado, MD | |
View Slides in PDF | |
5:43 PM - 5:50 PM | Panel Discussion |
5:50 PM - 5:50 PM | End of Program G |
END OF SESSION 69 | |
SESSION 70 SCHEDULE | |
Thursday
SESSION 70:
STROKE 2021 INCLUDING COVID
Moderators:Allan L. Brook, MD / Joshua A. Hirsch, MD
|
|
x | |
7:45 AM - 7:50 AM | Introduction |
Presenter(s):Allan L. Brook, MD | |
7:51 AM - 8:01 AM | Lessons Learned On Patient Selection For Acute Stroke Treatment |
Presenter(s):Michael D. Hill, MD | |
View Slides in PDF | |
8:02 AM - 8:12 AM | Innovative And Novel Stroke Therapies That Are In The Pipeline |
Presenter(s):Michael D. Hill, MD | |
View Slides in PDF | |
8:13 AM - 8:23 AM | COVID-19 Overview Of What Happened |
Presenter(s):Seon-Kyu Lee, MD, PhD | |
View Slides in PDF | |
8:24 AM - 8:34 AM | Long -Term Effects Of Stroke: COVID-19 Is Here To Stay |
Presenter(s):Reade A. De Leacy, MBBS | |
View Slides in PDF | |
8:35 AM - 8:45 AM | How CSC/Organized Medicine Helped Prepare Us For The COVID Onslaught |
Presenter(s):Ansaar T. Rai, MD | |
View Slides in PDF | |
8:45 AM - 8:50 AM | Collateral Physiologic Flow: Our Friends And Our Foes |
Presenter(s):Allan L. Brook, MD | |
View Slides in PDF | |
8:50 AM - 9:00 AM | Panel Discussion |
9:00 AM - 9:10 AM | Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 70 | |
SESSION 71 SCHEDULE | |
Thursday
SESSION 71:
CAROTIDS AND REVASCULARIZATION
Moderators:Evan C. Lipsitz, MD, MBA / Joshua A. Hirsch, MD
|
|
x | |
9:11 AM - 9:21 AM Power Point Presentation with Synched Audio |
Carotid Revascularization: Observations Of Change Over The Course Of A Career |
Presenter(s):Adnan H. Siddiqui, MD, PhD / L. Nelson Hopkins, MD | |
9:22 AM - 9:33 AM | Medical Management Of Carotid Disease |
Presenter(s):Michael D. Hill, MD | |
View Slides in PDF | |
9:33 AM - 9:43 AM | TCAR: Technical Pearls: Why It’s The Latest Trending Vascular Procedure |
Presenter(s):Mahmoud B. Malas, MD, MHS | |
View Slides in PDF | |
9:44 AM - 9:54 AM | TCAR: Why Not Just Do An Endarterectomy |
Presenter(s):Marc L. Schermerhorn, MD | |
View Slides in PDF | |
9:55 AM - 10:05 AM | Pooled Analysis With Greater Power From The CREST And ACT I Trials With Asymptomatic Patients Clarifies The CREST Conclusion: Sex Makes No Difference Between CEA And CAS While Oldest Age Group Demonstrates Worse Results With CAS |
Presenter(s):Jon S. Matsumura, MD / Bret M. Hanlon, PhD | |
View Slides in PDF | |
10:06 AM - 10:30 AM | Panel Discussion |
10:30 AM - 10:40 AM | Break - Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 71 | |
SESSION 72 SCHEDULE | |
x | |
10:40 AM - 10:50 AM | Hemicraniectomy: Why It Is Not A Lost Art, And Benefits |
Presenter(s):Adam S. Arthur, MD | |
View Slides in PDF | |
10:51 AM - 11:01 AM | Devices Are The Next Generation Of Aneurysm Treatment Or Is It Prevention |
Presenter(s):Ajay K. Wakhloo, MD, PhD, FAHA | |
View Slides in PDF | |
11:02 AM - 12:00 PM | Intrasaccular Devices: Overview And Indications |
Presenter(s):David J. Altschul, MD | |
View Slides in PDF | |
11:13 AM - 11:23 PM | Unruptured Aneurysms: Why Do We Treat These |
Presenter(s):James Milburn, MD | |
View Slides in PDF | |
11:24 AM - 11:34 AM | Intracranial Hemorrhage: Open Or Closed Treatment-Decision Tree |
Presenter(s):Brian L. Hoh, MD | |
View Slides in PDF | |
11:35 AM - 11:45 AM | Sub-Dural Hemorrhage Endovascular Therapy: Trials And Tribulations |
Presenter(s):Adam S. Arthur, MD | |
View Slides in PDF | |
11:46 AM - 11:56 AM | Cerebrovascular Vascular Malformation Classification And Management Decisions |
Presenter(s):Wayne F. Yakes, MD | |
View Slides in PDF | |
11:57 AM - 12:10 PM | Panel Discussion |
12:10 PM - 12:10 PM | End of Program H |
12:11 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 72 | |
Friday, November 19, 2021
Print Entire 2021 Program:
|
|
SESSION 73 SCHEDULE | |
Friday
SESSION 73:
PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) ASSOCIATED WITH THE TREATMENT OF THORACIC, THORACOABDOMINAL AND COMPLEX ABDOMINAL ANEURYSMS
Moderators:Richard P. Cambria, MD / Christian D. Etz, MD, PhD
|
|
x | |
7:00 AM - 7:05 AM | A Multidisciplinary Approach To Prevent SCI During Endovascular TAAA Repairs |
Presenter(s):Patrick W. Kelly, MD | |
View Slides in PDF | |
7:06 AM - 7:11 AM | Strategies To Minimize Paraplegia After TAAA Repairs: How A Biomarker Can Help |
Presenter(s):Bijan Modarai, PhD, FRCS | |
View Slides in PDF | |
7:12 AM - 7:17 AM Power Point Presentation with Synched Audio |
Cerebrospinal Fluid (CSF) Drainage (To Decrease SCI) Is Not A Benign Procedure: Why: When Not And When To Use It |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
View Slides in PDF | |
7:18 AM - 7:23 AM | SCI Is More Severe And Resolves Less When Routine CSF Drainage Is Used With TAAA Repairs: When Should It Be Used Selectively And With What Precautions |
Presenter(s):Adam Beck, MD | |
View Slides in PDF | |
7:24 AM - 7:29 AM | Near Infrared Spectrometry (NIRS) Monitoring Is Helpful In Decreasing SCI With TAAA Repairs: How To Do It: Why Is There Controversy |
Presenter(s):Carlos H. Timaran, MD | |
View Slides in PDF | |
7:30 AM - 7:35 AM | Current Strategies To Minimize SCI With TAAA Repairs, Endo And Open: Status Of Intercostal Embolization As Preconditioning To Prevent Ischemia (MIS2ACE): Status Of PAPA-ARTIS RCT |
Presenter(s):Christian D. Etz, MD, PhD | |
View Slides in PDF | |
7:36 AM - 7:41 AM | Clinical Experience With Intercostal Coil Embolization (MIS2ACE) To Prevent SCI With Endovascular TAAA Repair |
Presenter(s):Daniela Branzan, MD / Christian D. Etz, MD, PhD / Andrej Schmidt, MD | |
View Slides in PDF | |
7:42 AM - 7:50 AM | Panel Discussion |
END OF SESSION 73 | |
SESSION 74 SCHEDULE | |
Friday
SESSION 74:
NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS WITH MESH COVERED STENTS AND TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION (TCAR)
Moderators:Frank J. Veith, MD / Klaus D. Mathias, MD
|
|
x | |
MESH COVERED STENTS | |
7:50 AM - 7:55 AM Power Point Presentation with Synched Audio |
Long-Term Results Of Micromesh Stents Show Their Value In Carotid Artery Stenting (CAS): Are There Limitations: Do The Differences In The 3 Micromesh Stents Matter |
Presenter(s):Max Amor, MD | |
7:56 AM - 8:01 AM | Advantages And Limitations Of Mesh Covered Stents In CAS: Are They Really Better |
Presenter(s):Laura Capoccia, MD, PhD | |
View Slides in PDF | |
8:02 AM - 8:07 AM Power Point Presentation with Synched Audio |
7-Year Experience With Micromesh Stents For CAS: Are There Downsides (Thrombosis Or ISR): Technical Tips To Optimize Their Results |
Presenter(s):Stefan Mueller-Huelsbeck, MD | |
View Slides in PDF | |
8:08 AM - 8:13 AM | New Multicenter Data Showing The Long-Term Value Of The C-Guard Micronet Mesh Covered Stent For CAS In High Risk Carotid Lesions (Thrombotic, Calcified And Symptomatic) From The Flow-Guard And Other Trials |
Presenter(s):Piotr Musialek, MD, DPhil / D. Christopher Metzger, MD | |
View Slides in PDF | |
TCAR RELATED TOPICS | |
8:14 AM - 8:19 AM | TCAR Versus CEA (Carotid Endarterectomy): A Propensity Matched SVS VQI Study: 1-Year Results Show Equal Stroke/Death Rates And Decreased Cranial Nerve Injuries With TCAR: Findings Also Confirmed By A Meta-Analysis |
Presenter(s):Mahmoud B. Malas, MD, MHS / Marc L. Schermerhorn, MD | |
View Slides in PDF | |
8:20 AM - 8:25 AM | TCAR Versus Transfemoral CAS (TFCAS): A Propensity Matched SVS VQI Study Shows That TCAR Has Lower Stroke And Death Rates Than TFCAS |
Presenter(s):Marc L. Schermerhorn, MD / Mahmoud B. Malas, MD, MHS / Vikram S. Kashyap, MD | |
View Slides in PDF | |
8:26 AM - 8:31 AM | Why I Am Uncertain That TCAR Will Have Better Outcomes Than TFCAS: What Does The CREST 2 Registry Show |
Presenter(s):Thomas G. Brott, MD / William A. Gray, MD / | |
View Slides in PDF | |
8:32 AM - 8:37 AM | DEBATE: For TFCAS Reversal Or Cessation Of Flow With The Gore Or MoMA Device Cerebral Embolic Protection Is No Better Than Filter Protection: Why Is This So |
Presenter(s):Marc L. Schermerhorn, MD | |
View Slides in PDF | |
8:38 AM - 8:43 AM | DEBATE: Not So: In Some Specific Circumstances Reversal Or Cessation Of Flow Protection During TFCAS Is Better And Safer Than Filter Protection |
Presenter(s):William A. Gray, MD / | |
View Slides in PDF | |
8:44 AM - 8:49 AM | Based On Data To Date When Should TCAR Replace CEA And When Should It Not: A Balanced View |
Presenter(s):Vikram S. Kashyap, MD | |
View Slides in PDF | |
8:50 AM - 8:55 AM | TCAR Seems Better Than TFCAS And Equal To CEA: It Has A Bright Future: What Are Its Drawbacks |
Presenter(s):Wesley S. Moore, MD | |
View Slides in PDF | |
8:56 AM - 9:04 AM | Panel Discussion |
9:04 AM - 9:17 AM | Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 74 | |
SESSION 75 SCHEDULE | |
Friday
SESSION 75:
MORE CAROTID HOT TOPICS RELATED TO TCAR, MINI-INCISION CEA, SIGNIFICANCE OF DW MRI DEFECTS AND COGNITIVE FUNCTION
|
|
x | |
9:17 AM - 9:22 AM | TCAR Is Safe In Recently Symptomatic Patients And Those With Contralateral Carotid Occlusions: Why It Should Be The Procedure Of Choice In Those Conditions |
Presenter(s):Peter A. Schneider, MD | |
View Slides in PDF | |
9:23 AM - 9:28 AM | DEBATE: TCAR Is Not Hard To Learn: Results Are Unrelated To Operator Experience In ROADSTER 2 Trial |
Presenter(s):Vikram S. Kashyap, MD | |
View Slides in PDF | |
9:29 AM - 9:34 AM | DEBATE: Not So: TCAR Has A Steeper Learning Curve Than Commonly Thought: Some Precautions To Prevent Adverse Events |
Presenter(s):Michael B. Silva, Jr., MD / Charles Thang, MD | |
View Slides in PDF | |
9:35 AM - 9:40 AM | Learning And Optimizing The TCAR Procedure |
Presenter(s):Edward Y. Woo, MD / Steven D. Abramowitz, MD | |
View Slides in PDF | |
9:41 AM - 9:46 AM | Complications Of TCAR: How To Avoid Them And Fix Those That Occur |
Presenter(s):Thomas S. Maldonado, MD | |
View Slides in PDF | |
9:47 AM - 9:52 AM | Adjunctive EEG Can Help With TCAR And Decrease The Stroke Rate: When And How |
Presenter(s):Todd R. Vogel, MD, MPH | |
View Slides in PDF | |
9:53 AM - 9:58 AM | Mini-Incision CEA Is Better And Less Costly Than TCAR |
Presenter(s):Enrico Ascher, MD | |
View Slides in PDF | |
9:59 AM - 10:04 AM | TCAR Can Be Performed Under Local Anesthesia With Outcomes Equal To TCAR Under General Anesthesia: From A VQI Study: How To Do It Safely |
Presenter(s):Dipankar Mukherjee, MD | |
View Slides in PDF | |
SIGNIFICANCE OF SMALL DW MRI DEFECTS AFTER CEA/CAS | |
10:05 AM - 10:10 AM | DEBATE: How Size And Number Of Silent Brain Infarcts (DW MRI Defects) After CEA/CAS Affect Cognitive Changes: They Really Do Matter |
Presenter(s):Wei Zhou, MD | |
View Slides in PDF | |
10:11 AM - 10:16 AM | DEBATE: Silent DWI MRI Brain Lesions (Small Infarcts) After CEA/CAS Don’t Matter |
Presenter(s):Thomas G. Brott, MD | |
View Slides in PDF | |
10:17 AM - 10:22 AM Power Point Presentation with Synched Audio |
Why Asymptomatic Carotid Stenosis (ACS) Is Associated With Impaired Cognitive Function And Silent Infarcts: However, CEA And CAS For ACS Cause More Cognitive Impairment Than They Prevent |
Presenter(s):J. David Spence, MD | |
View Slides in PDF | |
10:23 AM - 10:30 AM | Panel Discussion |
END OF SESSION 75 | |
SESSION 76 SCHEDULE | |
Friday
SESSION 76:
MORE CAROTID RELATED NEW DEVELOPMENT TOPICS RELATED TO TCAR, MESH COVERED STENTS, MINI-INCISION CEA, TIMING OF TREATMENT, MEDICAL TREATMENT AND DEALING WITH DISTAL (HIGH) CAROTID LESIONS
|
|
x | |
10:30 AM - 10:35 AM | Comparative Cost Effectiveness: TCAR Versus CEA Versus TFCAS |
Presenter(s):Mohammad H. Eslami, MD, MPH | |
View Slides in PDF | |
10:36 AM - 10:41 AM Power Point Presentation with Synched Audio |
Value Of Lithotripsy (Shockwave) For CAS In Heavily Calcified Lesions: How To Do It Safely And Technical Tips: Limitations And Precautions |
Presenter(s):Max Amor, MD | |
10:42 AM - 10:47 AM Power Point Presentation with Synched Audio |
Results From A Multicenter Italian Study Of The C-Guard Micromesh Stent For CAS: Advantages And Complications |
Presenter(s):Gianmarco de Donato, MD / Carlo Setacci, MD / Francesco Speziale, MD / Wassim Mansour, MD / Pasqualino Sirignano, MD | |
View Slides in PDF | |
10:48 AM - 10:53 AM | OCT Proves CAS Is Rendered Safer Because Emboli Are Decreased By Mesh Covered Stents: The Evidence |
Presenter(s):Francesco Setacci, MD / Carlo Setacci, MD | |
View Slides in PDF | |
10:54 AM - 10:59 AM | Transcranial Doppler (TCD) Hits During TCAR: When Do They Occur And What Is Their Significance |
Presenter(s):Cynthia K. Shortell, MD | |
View Slides in PDF | |
11:00 AM - 11:05 AM | TCAR Versus Minimal Incision CEA: Cost Effectiveness, Advantages And Limitations Of Both |
Presenter(s):Robert M. Proczka, MD, PhD | |
View Slides in PDF | |
11:06 AM - 11:12 AM | Panel Discussion |
TIMING OF CAROTID INTERVENTIONS AFTER SYMPTOM ONSET | |
11:12 AM - 11:17 AM | Optimal Timing Of Carotid Revascularization (CEA, TFCAS, TCAR) After Symptom Onset: Within 48 Hours Risk Is Increased For All Procedures; After 48 Hours Risk Is Less With CEA And TCAR Than With TFCAS: Based On Large National Database Study |
Presenter(s):Mahmoud B. Malas, MD, MHS | |
View Slides in PDF | |
11:18 AM - 11:23 AM | DEBATE: It’s Reasonable To Perform CEA Within 48 Hours After A Stroke’s Symptoms Start: Under What Conditions And What Precautions Should Be Taken |
Presenter(s):R. Clement Darling III, MD | |
View Slides in PDF | |
11:24 AM - 11:29 AM | DEBATE: Patients With Moderate To Severe Strokes Do Poorly With Both CEA And CAS Done Within 48 Hours Of Symptom Onset: Both Procedures Should Be Avoided During This Period: How Long Should One Wait |
Presenter(s):Hernan A. Bazan, MD, DFSVS, FACS | |
View Slides in PDF | |
11:30 AM - 11:35 AM Power Point Presentation with Synched Audio |
What Is The Best Medical Treatment For Patients With Carotid Stenosis (Asymptomatic And Asymptomatic): Can High Risk Plaques Be Made Low Risk And Can They Be Made Smaller: Are Some Plaques Resistant To Medical Treatment And Why |
Presenter(s):J. David Spence, MD | |
View Slides in PDF | |
11:36 AM - 11:41 AM | Technical Tips And Maneuvers To Make Treatment Of High Carotid Lesions Safe And Relatively Simple |
Presenter(s):Richard J. Powell, MD | |
View Slides in PDF | |
11:42 AM - 11:47 AM Power Point Presentation with Synched Audio |
Getting Non-Compliant Carotid Patients To Comply With Best Medical Treatment By Showing Them Their Duplex Scans And Pictures Of Hemorrhagic And Ulcerated Plaques |
Presenter(s):J. David Spence, MD | |
View Slides in PDF | |
11:48 AM - 0:00 AM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 76 | |
SESSION 77 SCHEDULE | |
Friday
SESSION 77:
MORE HOT CAROTID TOPICS: UPDATES ON KEY CAROTID RCTs; NEW INFORMATION ON TREATMENT OF TANDEM LESIONS, CAROTID ANEURYSMS AND STROKES DURING INTERVENTION
Moderators:Samuel R. Money, MD, MBA / Christopher J. Kwolek, MD, MBA
|
|
x | |
1:00 PM - 1:05 PM | Optimal Management Of Extracranial Carotid Aneurysms In 2021: When Open; When Endo: Technical Tips And Results |
Presenter(s):Samuel R. Money, MD, MBA | |
View Slides in PDF | |
UPDATE ON CAROTID RCTs | |
1:06 PM - 1:11 PM | Update On ACST 2: CEA Versus CAS For ACS: What Is It Telling Us And When Will We Have All The Answers |
Presenter(s):Richard Bulbulia, MA, MD, FRCS / Alison Halliday, MS, FRCS | |
View Slides in PDF | |
1:12 PM - 1:17 PM Power Point Presentation with Synched Audio |
Initial Results Of ACST 2 Trial |
Presenter(s):Alison Halliday, MS, FRCS / Richard Bulbulia, MA, MD, FRCS | |
View Slides in PDF | |
1:18 PM - 1:23 PM Power Point Presentation with Synched Audio |
Not So Fast! ACST 2 Has Flaws That Invalidate Its Conclusions: What Are They |
Presenter(s):J. David Spence, MD | |
View Slides in PDF | |
1:24 PM - 1:29 PM Power Point Presentation with Synched Audio |
Update On SPACE 2: CEA Versus Best Medical Treatment (BMT); CAS Versus BMT For ACS: Updated And Interesting Findings From A Stopped RCT |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
View Slides in PDF | |
1:30 PM - 1:35 PM | Update On CREST 2: CEA Versus BMT And CAS Versus BMT For ACS: Findings To Date And When Will We Have Final Results |
Presenter(s):Brajesh K. Lal, MD / Thomas G. Brott, MD | |
View Slides in PDF | |
1:36 PM - 1:41 PM | Why Is BMT With Clopidogrel Different In The Arms Of CREST and CREST 2 And Why This Difference Could Invalidate The RCTs Results |
Presenter(s):Timothy M. Sullivan, MD | |
View Slides in PDF | |
TANDEM CAROTID LESIONS | |
1:42 PM - 1:47 PM | Tandem Lesions At The Carotid Bifurcation Plus The Common Carotid Or Innominate Arteries: Stroke And Mortality Risks Are Higher Than For Simple Bifurcation Lesions: How Best To Treat: Endo, Open, Staged, Hybrid |
Presenter(s):W. Darrin Clouse, MD | |
View Slides in PDF | |
1:48 PM - 1:53 PM | CEA And Retrograde Stenting Of A Tandem Proximal Lesion: Technical Tips To Make It Safe And Effective |
Presenter(s):Christopher J. Smolock, MD | |
View Slides in PDF | |
1:53 PM - 2:02 PM | Panel Discussion |
END OF SESSION 77 | |
SESSION 78 SCHEDULE | |
Friday
SESSION 78:
MORE HOT CAROTID TOPICS: TREATMENT IN 2021 OF BIG CAROTID BODY TUMORS, OPTIMAL PLATELET AND PROTAMINE STRATEGIES; BENIGNANCY OF ACS
Moderators:Cynthia K. Shortell, MD / Ali F. AbuRahma, MD
|
|
x | |
2:02 PM - 2:07 PM | Technical Tips For Treating Large Shamblin III Carotid Body Tumors Safely; From An Ecuadorian Team Which Treats Many |
Presenter(s):Oscar L. Ojeda, MD, FACS | |
View Slides in PDF | |
2:08 PM - 2:13 PM Power Point Presentation with Synched Audio |
Value Of Protamine Use During CEA: How Should It Be Used And With What Precautions |
Presenter(s):David H. Stone, MD | |
View Slides in PDF | |
2:14 PM - 2:19 PM | CEA Can Be Performed Safely And Optimally Under General Anesthesia And Without Completion Duplex Or Angio Control: What Is Required To Do So And Are There Downsides To Duplex Or Angio Controls |
Presenter(s):Ali F. AbuRahma, MD | |
View Slides in PDF | |
2:20 PM - 2:25 PM | Are Symptomatic And Asymptomatic Carotid Stenosis Really 2 Different Diseases As Some Suggest |
Presenter(s):Thomas G. Brott, MD | |
View Slides in PDF | |
2:26 PM - 2:31 PM | Risks And Causes Of Non-Ipsilateral Stroke Complicating CEA |
Presenter(s):W. Darrin Clouse, MD / Mark Conrad, MD, MMSc | |
View Slides in PDF | |
2:32 PM - 2:37 PM | Unnecessary Redundant Testing/Imaging Prior To CEA: What Is The Reason For This Needless Addition To Health Care Costs |
Presenter(s):Reese A. Wain, MD | |
View Slides in PDF | |
2:38 PM - 2:43 PM | DEBATE: CAS Is The Best Treatment For Young Patients With A High Grade Asymptomatic Carotid Stenosis (ACS) |
Presenter(s):William A. Gray, MD / | |
View Slides in PDF | |
2:44 PM - 2:49 PM Power Point Presentation with Synched Audio |
DEBATE: Not So: Young Patients With A High Grade ACS Should Not Be Treated By CAS Or CEA |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
View Slides in PDF | |
2:50 PM - 3:12 PM | Panel Discussion |
3:12 PM - 3:22 PM | Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 78 | |
SESSION 79 SCHEDULE | |
Friday
SESSION 79:
NEW OR UPDATED CONCEPTS FOR ENDOVASCULAR TREATMENTS
Moderators:Sean P. Lyden, MD / Jacob Cynamon, MD, FACR, FSIR
|
|
x | |
3:22 PM - 3:27 PM Power Point Presentation with Synched Audio |
Clinical Judgment Is Required In The Application Of Evidence Based Medicine: RCTs Can Have Flaws Leading To Misleading Conclusions |
Presenter(s):J. David Spence, MD | |
View Slides in PDF | |
3:28 PM - 3:33 PM | How Should Left Subclavian Artery Stenosis Be Treated In Patients Before Coronary Artery Bypass: Stent Versus Carotid Subclavian Bypass Versus Ignore But Don’t Use The Left Internal Mammary Artery |
Presenter(s):Jennifer L. Perri, MD, MBA | |
View Slides in PDF | |
3:34 PM - 3:39 PM | Progress In Open And Endovascular Treatment For Erectile Dysfunction: Diagnosis And Treatment Of Cavernous Leak And Other Pathology: A New Horizon |
Presenter(s):Eric Allaire, MD, PhD | |
View Slides in PDF | |
3:40 PM - 3:45 PM | Embolic Treatment Of Hemorrhoids: How To Do It And How Well Does It Work |
Presenter(s):Gloria Salazar, MD | |
View Slides in PDF | |
3:46 PM - 3:51 PM | Using Machine Learning To Improve Stroke Prediction In Carotid Stenosis Patients |
Presenter(s):Mathew D. Wooster, MD, MBA / Ravi K. Veeraswamy, MD | |
View Slides in PDF | |
3:52 PM - 3:57 PM | Transfemoral Transcaval Liver Biopsy: A Better Way To Do It |
Presenter(s):Jacob Cynamon, MD, FACR, FSIR | |
View Slides in PDF | |
3:58 PM - 4:04 PM | Panel Discussion |
END OF SESSION 79 | |
SESSION 80 SCHEDULE | |
Friday
SESSION 80:
NEW DEVELOPMENTS IN PERCUTANEOUS ACCESS CLOSURE, ENDOVASCULAR SUTURING AND WOUND CARE
Moderators:Kenneth Ouriel, MD, MBA / Mark A. Adelman, MD
|
|
x | |
4:04 PM - 4:09 PM Power Point Presentation with Synched Audio |
Update On Large Bore Percutaneous Access Closure Devices: Key New Devices And Developments: How To Prevent Failure And Complications |
Presenter(s):Zvonimir Krajcer, MD, FACC | |
View Slides in PDF | |
4:10 PM - 4:15 PM Power Point Presentation with Synched Audio |
Endovascular Suturing Devices At The Tip Of An 8-9 French Catheter To Close Large Bore Sheath Access From Inside: The NovelRad Device: How Does It Work And Present Status |
Presenter(s):Elchanan Bruckheimer, MBBS | |
View Slides in PDF | |
PROGRESS IN WOUND CARE | |
4:16 PM - 4:21 PM | Optimal Treatment For Groin Infection After Prosthetic Bypasses From The Common Femoral Artery: How To Save The Graft And The Leg |
Presenter(s):Hosam F. El Sayed, MD | |
View Slides in PDF | |
4:22 PM - 4:27 PM | New Developments In The Treatment Of Mixed Arterial And Venous Wounds And Ulcers |
Presenter(s):Katherine A. Gallagher, MD | |
View Slides in PDF | |
4:28 PM - 4:33 PM | Value Of A Wound Care Center To A Vascular Practice: Who Should Staff It And How To Make It Revenue Positive |
Presenter(s):Venita Chandra, MD | |
View Slides in PDF | |
4:34 PM - 4:39 PM Power Point Presentation with Synched Audio |
Best Treatment Strategies For Complex Infected Groin Wounds After Vascular Surgery: When To Do What: Wide Debridement, Antibiotics, Muscle Flap Reconstruction Or Graft Removal |
Presenter(s):Jan-Willem Elshof, MD | |
View Slides in PDF | |
4:40 PM - 4:50 PM | Panel Discussion |
4:50 PM - 4:50 PM | End of Program I |
END OF SESSION 80 | |
SESSION 81 SCHEDULE | |
Friday
SESSION 81:
POPLITEAL DISEASE TOPICS RELATED TO NEW GUIDELINES, ANEURYSM TREATMENT (PRIMARY AND REDO), ENTRAPMENTS AND ATHERECTOMY FOR OCCLUSIVE LESIONS
Moderators:Enrico Ascher, MD / Keith D. Calligaro, MD
|
|
x | |
POPLITEAL ANEURYSMS AND THEIR BEST CURRENT TREATMENTS | |
7:20 AM - 7:00 AM | High Points Of New SVS Guidelines For The Treatment Of Popliteal Aneurysms: Roles Of Endo And Open Repairs |
Presenter(s):Patrick J. Geraghty, MD / Alik Farber, MD, MBA | |
View Slides in PDF | |
7:26 AM - 7:31 AM Power Point Presentation with Synched Audio |
DEBATE: Endovascular Repair Is The Best Option For Most Popliteal Aneurysms Requiring Repair: Recent Progress In The Procedure: When Is Open Repair Indicated |
Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS | |
View Slides in PDF | |
7:32 AM - 7:37 AM | DEBATE: Open Repair With Prosthetic Bypass Graft Is Better Than Endovascular Treatment For Popliteal Aneurysms Requiring Repair |
Presenter(s):Laurent Chiche, MD, FEBVS | |
View Slides in PDF | |
7:38 AM - 7:43 AM | Update On Optimal Treatment For Popliteal Aneurysms: When Observation; When Endo Repair; When Open Repair And How |
Presenter(s):Fred A. Weaver, MD, MMM | |
View Slides in PDF | |
7:44 AM - 7:49 AM | What Are Complex Popliteal Aneurysms And How Should They Be Fixed: When Endo; When Open |
Presenter(s):Jacques Busquet, MD | |
View Slides in PDF | |
7:50 AM - 7:56 AM | Panel Discussion |
POPLITEAL ENTRAPMENTS | |
7:56 AM - 8:01 AM | What’s New In The Treatment Of Popliteal Entrapments |
Presenter(s):Niten Singh, MD | |
View Slides in PDF | |
POPLITEAL ARTERY INJURY | |
8:02 AM - 8:07 AM | Surgical Approach And Graft Usage For Popliteal Artery Injury From Posterior Knee Dislocation |
Presenter(s):Charles J. Fox, MD, FACS | |
View Slides in PDF | |
POPLITEAL ARTERY ATHERECTOMY | |
8:08 AM - 8:13 AM Power Point Presentation with Synched Audio |
Value Of Orbital Atherectomy For Popliteal Artery Occlusive Lesions: Indications, Results, Precaution |
Presenter(s):Konstantinos P. Donas, MD | |
View Slides in PDF | |
8:14 AM - 8:20 AM | Panel Discussion |
END OF SESSION 81 | |
SESSION 82 SCHEDULE | |
Friday
SESSION 82:
NEW DEVELOPMENTS IN TREATING ARTERIAL (INCLUDING AORTIC) INFECTIONS
Moderators:Keith D. Calligaro, MD / Peter F. Lawrence, MD
|
|
x | |
8:20 AM - 8:25 AM | Update On Deep Vein Use For Arterial Procedures: The NAIS Operation For Infections: Recent Technical Improvements |
Presenter(s):Patrick A. Stone, MD | |
View Slides in PDF | |
TREATMENT OF MYCOTIC ANEURYSMS | |
8:26 AM - 8:31 AM | Optimal Treatment Of Mycotic AAAs In 2021: Value Of And Precautions With EVAR: Is It Ever A Stand-Alone Treatment |
Presenter(s):Timur P. Sarac, MD | |
View Slides in PDF | |
8:32 AM - 8:37 AM | Rifampin Soaked Endografts To Treat Mycotic AAAs: How To Prepare Them And When To Use Them: Are They Stand-Alone Treatment Or Do They Need Adjunctive Techniques |
Presenter(s):Guillermo A. Escobar, MD | |
View Slides in PDF | |
8:38 AM - 8:43 AM | Why Open Repair Is The Best Treatment For Mycotic AAAs: Is EVAR Ever Of Value |
Presenter(s):Yamume Tshomba, MD | |
View Slides in PDF | |
8:44 AM - 8:49 AM | Best Treatment For Mycotic Aortic Aneurysms In The Thorax And Abdomen Based On Long-Term Results |
Presenter(s):Samy S. Nitecki, MD | |
View Slides in PDF | |
TREATMENT OF AORTIC AND ARTERIAL GRAFT AND ENDOGRAFT INFECTIONS | |
8:50 AM - 8:55 AM | Infected Endografts After EVAR: Etiological Factors, Diagnosis, Treatment, Outcomes |
Presenter(s):Mohammad H. Eslami, MD, MPH | |
View Slides in PDF | |
8:56 AM - 9:01 AM | Optimal Techniques For Treating Aorto-Iliac Graft And Endograft Infections In 2021 |
Presenter(s):Anders Wanhainen, MD, PhD | |
View Slides in PDF | |
9:02 AM - 9:07 AM Power Point Presentation with Synched Audio |
Semi-Conservative Therapy May Be Best For Some Aortic Graft Infections: What Is It And When Will Saving All Or Part Of An Infected Graft Work |
Presenter(s):Zoran Rancic, MD, PhD, EMBA HSG | |
View Slides in PDF | |
9:08 AM - 9:13 AM | Open Repair Of Suprarenal Aortic Graft Infections: Technical Tips And Long-Term Results |
Presenter(s):Thomas C. Bower, MD / Manju Kalra, MBBS | |
View Slides in PDF | |
9:14 AM - 9:24 AM | Panel Discussion |
9:24 AM - 9:52 AM | Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 82 | |
SESSION 83 SCHEDULE | |
Friday
SESSION 83:
PROGRESS IN VASCULAR IMAGING AND GUIDANCE FOR ENDOVASCULAR TREATMENTS WITH LESS RADIATION EXPOSURE OR CONTRAST TOXICITY
Moderators:Matthew J. Eagleton, MD / Carlos H. Timaran, MD
|
|
x | |
VASCULAR HOLOGRAPHY | |
9:52 AM - 9:57 AM | How Will The Microsoft Hololens Look Through Patients’ Bodies And Facilitate Endovascular Interventions: The ARCUS System Of Augmented Reality And Its Value In Vascular Surgery |
Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS | |
View Slides in PDF | |
9:58 AM - 10:03 AM Power Point Presentation with Synched Audio |
Real View Holographic Imaging: How Will It Help In Endovascular Treatments: Is It Available In The US |
Presenter(s):Elchanan Bruckheimer, MBBS | |
View Slides in PDF | |
10:04 AM - 10:09 AM Power Point Presentation with Synched Audio |
Holographic Guidance Of Endovascular Procedures: What Is Possible And What Is Not |
Presenter(s):Claude Mialhe, MD | |
View Slides in PDF | |
DUPLEX AND INTRAVASCULAR ULTRASOUND | |
10:10 AM - 10:15 AM | Duplex Ultrasound Guidance: How, Where And When Can It Replace Fluoroscopy For Endovascular Procedures: Advantages, Limitations, And Why Its Use Is Increasing |
Presenter(s):Enrico Ascher, MD / Natalie A. Marks, MD, RPVI, RVT, FSVM | |
View Slides in PDF | |
IMPROVED IMAGING | |
10:16 AM - 10:21 AM | Dual Fluoroscopy With Live Image Digital Zooming: How Does It Work And Why Does It Decrease Radiation During Complex AAA Repairs: What Is Its Cost |
Presenter(s):Carlos H. Timaran, MD | |
View Slides in PDF | |
10:22 AM - 10:27 AM | Cydar Medical System’s Evolution To Facilitate Fusion With All Digital Fluoroscopes: How The System Uses AI To Improve EVAR Planning, Guidance And Deployment |
Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS | |
View Slides in PDF | |
10:28 AM - 10:33 AM | The Cydar System Deformation Tool For Improving Image Fusion Accuracy: How Does It Work And Why Does It Help |
Presenter(s):Cynthia K. Shortell, MD | |
View Slides in PDF | |
10:34 AM - 10:39 AM | The Cydar System’s Value In Standard And Complex EVAR |
Presenter(s):Venkatesh G. Ramaiah, MD | |
View Slides in PDF | |
10:40 AM - 10:50 AM | Panel Discussion |
END OF SESSION 83 | |
SESSION 84 SCHEDULE | |
Friday
SESSION 84:
CHALLENGING RECORDED LIVE CASES FROM THE MAYO CLINIC AND THE UNIVERSITY OF TEXAS, HOUSTON
|
|
x | |
10:50 AM - 11:00 AM | Case 1: 45 Female With Loeys-Dietz Syndrome And Multiple Aortic Repairs |
Presenter(s):Guilherme B. Lima, MD | |
View Slides in PDF | |
11:00 AM - 11:04 AM | Panel Discussion |
11:04 AM - 11:14 AM | Case 2: 83-Year-Old Man With Ascending Aortic Pseudoaneurysm |
Presenter(s):Bernardo C. Mendes, MD | |
View Slides in PDF | |
11:14 AM - 11:18 AM | Panel Discussion |
11:18 AM - 11:28 AM | Case 3: 79 Female With Large Visceral Patch Aneurysm Following Open TAAA Repair |
Presenter(s):Naveed U. Saqib, MD, FACS | |
View Slides in PDF | |
11:28 AM - 11:32 AM | Panel Discussion |
11:32 AM - 11:42 AM | Case 4: 72-Year-Old Woman With Chronic Mesenteric Ischemia And Extent III TAAA |
Presenter(s):Bernardo C. Mendes, MD | |
View Slides in PDF | |
11:42 AM - 11:46 AM | Panel Discussion |
11:46 AM - 11:56 AM | Case 5: 71 Male With Aortic Arch Graft Pseudoaneurysm |
Presenter(s):Guilherme B. Lima, MD | |
View Slides in PDF | |
11:56 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:15 PM | Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 84 | |
SESSION 85 SCHEDULE | |
Friday
SESSION 85:
ONE PRESENTATION FROM MÜNSTER, GERMANY ON LOWER EXTREMITY STENTS
Moderators:Mark A. Adelman, MD / Giovanni B. Torsello, MD
|
|
x | |
1:15 PM - 1:21 PM | One Year Results Of The EMINENT RCT Comparing The Eluvia DES Versus Bare Metal Stents |
Presenter(s):Giovanni B. Torsello, MD | |
View Slides in PDF | |
1:22 PM - 1:25 PM | Discussion |
END OF SESSION 85 | |
SESSION 86 SCHEDULE | |
Friday
SESSION 86:
NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC OUTLET SYNDROMES (TOSs)
Moderators:Robert W. Thompson, MD / Mark A. Adelman, MD
|
|
x | |
1:26 PM - 1:31 PM | New Developments In The Treatment Of Neurogenic TOSs: What Preop Factors Correlate With Good Outcomes; With Bad Outcomes |
Presenter(s):Karl A. Illig, MD | |
View Slides in PDF | |
1:32 PM - 1:37 PM Power Point Presentation with Synched Audio |
Supraclavicular Approach To Arterial And Neurogenic TOSs (Video Presentation) |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Slides in PDF | |
VENOUS TOSs | |
1:38 PM - 1:43 PM | Venous TOSs: Lessons Learned After Treating >1000 Cases |
Presenter(s):Robert W. Thompson, MD | |
View Slides in PDF | |
1:44 PM - 1:49 PM | Spectrum Of Treatment Options For Venous TOS: What Are The Outcomes And How Do They Differ |
Presenter(s):Jason T. Lee, MD | |
View Slides in PDF | |
1:50 PM - 1:55 PM | Venography And Balloon Angioplasty For Neurogenic Thoracic Outlet Syndrome: A New Diagnostic And Therapeutic Approach |
Presenter(s):Sam S. Ahn, MD, FACS, MBA | |
View Slides in PDF | |
1:56 PM - 2:03 PM | Technical Tips For Optimal Surgical Treatment For Venous TOS |
Presenter(s):Robert W. Thompson, MD | |
View Slides in PDF | |
2:04 PM - 2:14 PM | Panel Discussion |
2:14 PM - 2:30 PM | Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
END OF SESSION 86 | |
SESSION 87 SCHEDULE | |
Friday
SESSION 87:
NEW DEVELOPMENTS IN MEDICAL AND DRUG TREATMENTS: BEST ANTIPLATELET REGIMENS; UPDATE ON RARE VASCULAR DISEASES
Moderators:Caron B. Rockman, MD / James H. Black, III, MD
|
|
x | |
ANTIPLATELET REGIMENS | |
2:30 PM - 2:35 PM Power Point Presentation with Synched Audio |
Optimal Antiplatelet Management With CEAs, Lower Extremity Bypasses And Open AAA Repairs |
Presenter(s):David H. Stone, MD | |
View Slides in PDF | |
2:36 PM - 2:41 PM | Optimal Anticoagulation And Antiplatelet Treatment For High Risk Lower Extremity Bypasses – Vein And PTFE |
Presenter(s):Peter Henke, MD | |
View Slides in PDF | |
2:42 PM - 2:47 PM | Most Effective Antiplatelet After Lower Extremity Interventional Treatments For CLTI – POBA, DCBs, Stents, Etc. |
Presenter(s):Maciej L. Dryjski , MD, PhD | |
View Slides in PDF | |
2:48 PM - 2:53 PM | Why Clopidogrel Is Effective In <50% Of Patients At Standard Doses: How To Identify And Fix This Problem |
Presenter(s):Karthik Kasirajan, MD | |
View Slides in PDF | |
NEW DEVELOPMENTS IN LIPID MANAGEMENT – STATINS | |
2:54 PM - 2:59 PM | Safety And Benefit Of Statins And Medical Treatment In Vascular Patients: Shockingly These Treatments Are Underutilized – Especially In Women: Why Is This So |
Presenter(s):Christian A. Behrendt, MD | |
View Slides in PDF | |
3:00 PM - 3:05 PM | Value Of Statins In AAA Patients After Repair: Long-Term Impact On Mortality |
Presenter(s):Adam Beck, MD | |
View Slides in PDF | |
3:06 PM - 3:11 PM | The Importance Of Lipoprotein Little a [Lp(a)] Levels In Determining Atherosclerotic Risk: When Should It Be Measured And If High, How Treated: Do PCSK-9 Inhibitors Help |
Presenter(s):Caron B. Rockman, MD / Jeffrey S. Berger, MD, MS, FAHA, FACC | |
View Slides in PDF | |
3:12 PM - 3:18 PM | Panel Discussion |
3:18 PM - 3:23 PM | Elevated Neutrophil To Lymphocyte Ratio Predicts Poor Outcomes And Mortality After Elective EVAR And CEA: What Is The Mechanism |
Presenter(s):Jae S. Cho, MD | |
View Slides in PDF | |
3:24 PM - 3:29 PM | The Justification For Carotid Screening Is To Promote Medical Treatment To Decrease Stroke And MI Risks, Not To Push Patients To Have Unnecessary Invasive Procedures |
Presenter(s):Kosmas I. Paraskevas, MD | |
View Slides in PDF | |
3:30 PM - 3:35 PM | Lowering LDL-C And Controlling Elevated Blood Pressure Can Lower Cardiovascular Risk 80%: Doing These Things Should Be A Lifetime Goal |
Presenter(s):Richard Bulbulia, MA, MD, FRCS | |
View Slides in PDF | |
3:36 PM - 3:41 PM | How To Make Operations For Complications Of Vascular Ehlers Danlos Syndrome Go Well |
Presenter(s):James H. Black, III, MD | |
View Slides in PDF | |
3:42 PM - 3:48 PM | Panel Discussion |
END OF SESSION 87 | |
SESSION 88 SCHEDULE | |
Friday
SESSION 88:
ADVANCES IN THE ENDO AND OPEN TREATMENT OF VASCULAR TRAUMA
Moderators:Timur P. Sarac, MD / Todd E. Rasmussen, MD, FACS
|
|
x | |
3:48 PM - 3:53 PM | Resuscitative Endovascular Balloon Occlusion Of The Aorta (REBOA): When Is It A Valuable Procedure And When Is It Not: Limitations And Precautions |
Presenter(s):Gilbert R. Upchurch, MD | |
View Slides in PDF | |
3:54 PM - 3:59 PM | Value Of REBOA For Pending And Actual Cardiac Arrest: What Is Partial And Intermittent REBOA And How Is It Helpful |
Presenter(s):Tal M. Hoerer, MD, PhD | |
View Slides in PDF | |
4:00 PM - 4:05 PM | Transexamic Acid – An Antifibrinolytic Drug: Does It Reduce Mortality With Mild To Moderate Traumatic Brain Injuries: Based On A RCT |
Presenter(s):Todd E. Rasmussen, MD, FACS | |
View Slides in PDF | |
4:06 PM - 4:11 PM | Why One Should Have A Stock On Hand Of Balloon-Expandable And Self- Expandable Covered Stents To Deal With Emergencies From Iatrogenic And Other Traumatic Vascular Injuries: What Should Be In The Stock |
Presenter(s):Maria A. Ruffino, MD, EBIR | |
View Slides in PDF | |
4:12 PM - 4:17 PM | Radial Access Techniques And Technology For Embolotherapy To Treat Vascular Trauma: Indications And Results |
Presenter(s):Jonathan J. Morrison, PhD, FRCS | |
View Slides in PDF | |
4:18 PM - 4:23 PM | For Major Venous Injuries: Repair Versus Ligation – Which Is Currently Best When |
Presenter(s):Samy S. Nitecki, MD | |
View Slides in PDF | |
4:24 PM - 4:29 PM | Update On Best Current Management Of Pediatric Vascular Injuries: When Conservative; When Open; When Endo And Precautions |
Presenter(s):Michael C. Dalsing, MD | |
View Slides in PDF | |
4:30 PM - 4:38 PM | Panel Discussion |
BLUNT THORACIC AORTIC INJURY (BTAI) | |
4:38 PM - 4:43 PM | Endovascular Repairs Of Traumatic Aortic Injuries – Civilian And Military: Technology, Technical Tips And Results |
Presenter(s):James W. Dennis, MD | |
View Slides in PDF | |
4:44 PM - 4:49 PM | When Can Minor BTAI Be Treated By Observation Without TEVAR: What Precautions Are Necessary |
Presenter(s):Elina Quiroga, MD, MPH | |
View Slides in PDF | |
4:50 PM - 4:55 PM | DEBATE: Are We Overtreating BTAI – Especially Lesser Injuries |
Presenter(s):Joseph J. DuBose, MD | |
View Slides in PDF | |
4:56 PM - 5:01 PM | DEBATE: Why Many Patients With Lesser Degrees Of BTAI Require TEVAR |
Presenter(s):Ali Azizzadeh, MD | |
View Slides in PDF | |
5:02 PM - 5:07 PM | Why Rapid And Complete Aortic Healing After TEVAR For BTAI Should Influence The Length And Diameter Of The Endograft Used: Oversizing And Length Of Seal Zone Can Be Minimized: Technical Tips |
Presenter(s):Shang Loh, MD | |
View Slides in PDF | |
5:08 PM - 5:13 PM | How To Manage Heparin In TEVAR For BTAI When Head Or Other Injuries Are Also Present: Some, None Or Just Sheath Flushing |
Presenter(s):Charles J. Fox, MD, FACS | |
View Slides in PDF | |
5:14 PM - 5:19 PM | With BTAI Requiring TEVAR, When Can The Left Subclavian Artery Be Covered And When Not: Tips On Endograft Sizing |
Presenter(s):Elina Quiroga, MD, MPH | |
View Slides in PDF | |
5:20 PM - 5:30 PM | Panel Discussion |
END OF SESSION 88 | |
SESSION 89 SCHEDULE | |
Friday
SESSION 89:
PELVIC VENOUS DISORDERS, FEMORO-ILIOCAVAL INTERVENTIONAL STRATEGIES TO REDUCE VENOUS HYPERTENSION
|
|
x | |
7:30 AM - 7:35 AM | Venographic Techniques To Identify Pelvic Anatomy And Escape Points |
Presenter(s):Mark H. Meissner, MD | |
View Slides in PDF | |
7:36 AM - 7:41 AM | Iliocaval Duplex Ultrasound With Image Optimization |
Presenter(s):Jan M. Sloves, RVT | |
View Slides in PDF | |
7:42 AM - 7:47 AM | We Need Dedicated Venous Stents For Nutcracker Syndrome And We NeedThem Now |
Presenter(s):Peter Gloviczki, MD | |
View Slides in PDF | |
7:48 AM - 7:53 AM | Open Surgery For Nutcracker: Techniques And Results |
Presenter(s):Cynthia K. Shortell, MD | |
View Slides in PDF | |
7:54 AM - 7:59 AM | Ovarian Vein Embolization: Which Patient Benefits And Reimbursement |
Presenter(s):Kathleen D. Gibson, MD | |
View Slides in PDF | |
8:00 AM - 8:05 AM | Panel Discussion |
END OF SESSION 89 | |
SESSION 90 SCHEDULE | |
Friday
SESSION 90:
CHRONIC VENOUS OBSTRUCTION
|
|
x | |
8:06 AM - 8:11 AM | CAVA Trial Lessons Learned About Post Thrombotic Syndrome |
Presenter(s):Cees H.A. Wittens, MD, PhD | |
View Slides in PDF | |
8:12 AM - 8:17 AM | Utilizing The Radiofrequency Power Wire To Vaporize A Channel Through Chronic Iliocaval Venous Obstructions (CICVO) |
Presenter(s):Patrick E. Muck, MD, FACS | |
View Slides in PDF | |
8:18 AM - 8:23 AM | Recanalizing Occluded Venous Stents |
Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
View Slides in PDF | |
8:24 AM - 8:29 AM | Contralateral Limb Improvement After Unilateral Iliac Vein Stenting: Argument Against Simultaneous Bilateral Stenting |
Presenter(s):Seshadri Raju, MD | |
View Slides in PDF | |
8:30 AM - 8:35 AM | Panel Discussion |
END OF SESSION 90 | |
SESSION 91 SCHEDULE | |
Friday
SESSION 91:
FEMORO-ILIOCAVAL INTERVENTIONAL STRATEGIES TO REDUCE VENOUS HYPERTENSION
Moderators:Ellen D. Dillavou, MD / Rabih A. Chaer, MD
|
|
x | |
8:36 AM - 8:41 AM | Does Vein Stenting Reduce Great And Small Saphenous Venous Reflux |
Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM | |
View Slides in PDF | |
8:42 AM - 8:47 AM | Best Anticoagulation After Deep Venous Stenting |
Presenter(s):Ellen D. Dillavou, MD | |
View Slides in PDF | |
8:48 AM - 8:53 AM | Reinterventions Following Vein Stent Placements – Lessons Learned From 166 Cases |
Presenter(s):Windsor Ting, MD | |
View Slides in PDF | |
8:54 AM - 8:59 AM | Outcomes And Predictors Of Failure Of Iliac Vein Stenting |
Presenter(s):Rabih A. Chaer, MD | |
View Slides in PDF | |
9:00 AM - 9:05 AM | Panel Discussion |
END OF SESSION 91 | |
SESSION 92 SCHEDULE | |
Friday
SESSION 92:
HYBRID TECHNIQUES, STENT PROBLEMS, POST-IMPLANTATION
Moderators:Erin H. Murphy, MD / Cees H.A. Wittens, MD, PhD
|
|
x | |
9:06 AM - 9:11 AM | Techniques For Endovenectomy And Concomitant Ilio Stenting With And Without Adjuvant Arteriovenous Fistula Creation |
Presenter(s):Steven D. Abramowitz, MD | |
View Slides in PDF | |
9:12 AM - 9:17 AM | Endovascular Remote Endovenectomy For Chronic Venous Disease Using The Inari CloTriever |
Presenter(s):Steven D. Abramowitz, MD | |
View Slides in PDF | |
9:18 AM - 9:23 AM | Technical Properties Of Nitinol |
Presenter(s):Erin H. Murphy, MD | |
View Slides in PDF | |
9:24 AM - 9:29 AM | Biopsy Of Venous In-Stent Stenosis: Histopathology And Treatment |
Presenter(s):David M. Williams, MD | |
View Slides in PDF | |
9:30 AM - 9:35 AM | Utilizing Indigo System To Extract Thrombus Prior To ISR Ballooning And Stenting: Our Institution’s Experience |
Presenter(s):Frank R. Arko, MD | |
View Slides in PDF | |
9:36 AM - 9:41 AM | CAVA Trial: Long-Term Follow Up |
Presenter(s):Cees H.A. Wittens, MD, PhD | |
View Slides in PDF | |
9:42 AM - 9:47 AM | Panel Discussion |
9:48 AM - 10:28 AM | Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers |
END OF SESSION 92 | |
SESSION 93 SCHEDULE | |
Friday
SESSION 93:
STRATEGIES FOR CORRECTING SEVERE DEEP VENOUS REFLUX AND/OR OBSTRUCTION, WOUNDS, MEDICINES, AND NEW HORIZONS FOR VENOUS DISEASE MANAGEMENT
Moderators:Peter F. Lawrence, MD / William A. Marston, MD
|
|
x | |
10:29 AM - 10:34 AM | Management Options Of Infrainguinal Disease: Indications And Options |
Presenter(s):Steve Elias, MD | |
View Slides in PDF | |
10:35 AM - 10:40 AM | A Look At ABRE Stent Occlusions From The IDE Trial: Key Takeaways |
Presenter(s):Erin H. Murphy, MD | |
View Slides in PDF | |
10:41 AM - 10:46 AM | The Economic Impact Of Infections In Venous Leg Ulcer Patients |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
View Slides in PDF | |
10:47 AM - 10:52 AM | What Is The Standard Of Care For Venous Wounds |
Presenter(s):William A. Marston, MD | |
View Slides in PDF | |
10:53 AM - 10:58 AM | Treatment Of Superficial And Perforator Reflux And Deep Venous Stenosis Improves Healing Of Chronic Venous Leg Ulcers |
Presenter(s):Peter F. Lawrence, MD | |
View Slides in PDF | |
10:59 AM - 11:04 AM | Panel Discussion |
END OF SESSION 93 | |
SESSION 94 SCHEDULE | |
Friday
SESSION 94:
VENOUS STENT TRIALS AND CONCEPTS
|
|
x | |
11:05 AM - 11:10 AM | Aspect Ratio Of Iliac Stenosis: Does It Matter |
Presenter(s):Seshadri Raju, MD | |
View Slides in PDF | |
11:11 AM - 11:16 AM | What Is Aspect Ratio And What Does The Clinical Data Reveal |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FAVLS | |
View Slides in PDF | |
11:17 AM - 11:22 AM | Virtus Trial - 3-Year Update |
Presenter(s):William A. Marston, MD | |
View Slides in PDF | |
11:23 AM - 11:28 AM | What Can The Arnsberg Registry Tell Us |
Presenter(s):Michael K.W. Lichtenberg, MD | |
View Slides in PDF | |
11:29 AM - 11:34 AM | ABRE 24-Month Study Data |
Presenter(s):Erin H. Murphy, MD | |
View Slides in PDF | |
11:35 AM - 11:40 AM | Zilver Vena Stent Trial |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Slides in PDF | |
11:41 AM - 11:46 AM | Vernacular 36-Month Study Data |
Presenter(s):Michael K.W. Lichtenberg, MD | |
View Slides in PDF | |
11:47 AM - 11:52 PM | Deep Venous Imaging Strategies To Minimize Stenting Complications |
Presenter(s):Steve Elias, MD | |
View Slides in PDF | |
11:52 AM - 12:00 PM | Panel Discussion |
12:00 PM - 12:45 PM | Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers |
END OF SESSION 94 | |
SESSION 95 SCHEDULE | |
Friday
SESSION 95:
MORE ILIOFEMORAL FLOW AND PELVIC ISSUES
Moderators:Paul J. Gagne, MD / Peter J. Pappas, MD
|
|
x | |
12:46 PM - 12:51 PM | Deep Venous Reconstruction: Is It Safe And Profitable In An OBL |
Presenter(s):Paul J. Gagne, MD | |
View Slides in PDF | |
12:52 PM - 12:57 PM | Which Is More Important: Pelvic Venous Insufficiency Or Iliac Vein Obstruction |
Presenter(s):Peter J. Pappas, MD | |
View Slides in PDF | |
12:58 PM - 1:03 PM | Male Pelvic Congestion And Varicose Veins: How Much Of A Problem |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
View Slides in PDF | |
1:04 PM - 1:09 PM | A Novel Technique And Outcomes For Iliocaval Extravascular Reconstruction (TIER) For Iliocaval Agenesis |
Presenter(s):Steven D. Abramowitz, MD | |
View Slides in PDF | |
1:10 PM - 1:15 PM | Panel Discussion |
END OF SESSION 95 | |
SESSION 96 SCHEDULE | |
Friday
SESSION 96:
STRATEGIES FOR THROMBOEMBOLIC EVENTS IN THE VENOUS SYSTEM
Moderators:Michael K.W. Lichtenberg, MD / Brian G. DeRubertis, MD
|
|
x | |
VTE INTERVENTIONAL | |
1:16 PM - 1:21 PM | Thrombolysis For Acute DVT: Utilization And Guidance From Current Clinical Trials |
Presenter(s):Brian G. DeRubertis, MD | |
View Slides in PDF | |
1:22 PM - 1:27 PM | Venous Aneurysms: Should They Be Treated |
Presenter(s):Peter F. Lawrence, MD | |
View Slides in PDF | |
1:28 PM - 1:33 PM | DVT Removal Without Thrombolytics – Mechanical Thrombectomy Is Now The Standard Of Care For Both Upper And Lower Extremity DVT |
Presenter(s):Patrick E. Muck, MD, FACS | |
View Slides in PDF | |
1:34 PM - 1:39 PM | P-Max Study: Mechanical Thrombectomy For Iliofemoral DVT With Aspirex |
Presenter(s):Michael K.W. Lichtenberg, MD | |
View Slides in PDF | |
1:40 PM - 1:45 PM | Panel Discussion |
1:46 PM - 2:21 PM | Break - Visit Exhibits And Pavilions (North, West, Center and South Foyers) |
CENTRAL VENOUS THROMBOSIS; COVID-19; VTE MEDICAL | |
Moderator(s): Steve Elias, MD / Mikel Sadek, MD | |
2:22 PM - 2:27 PM | COVID-19 Treatment Of Venous Thrombosis In Hospitalized Patients |
Presenter(s):Mikel Sadek, MD | |
View Slides in PDF | |
2:28 PM - 2:33 PM | COVID-19 Outpatient Experience With Anticoagulation |
Presenter(s):Steve Elias, MD | |
View Slides in PDF | |
2:34 PM - 2:39 PM | Closed Plication Is A Safe And Effective Method For Treating Popliteal Venous Aneurysm |
Presenter(s):Thomas W. Wakefield, MD | |
View Slides in PDF | |
2:40 PM - 2:45 PM | Mesenteric Vein Thrombosis: What Is The Best Strategy |
Presenter(s):Mark G. Davies, MD | |
View Slides in PDF | |
2:46 PM - 2:51 PM | DOAC Revolution – Which Drug For What Disease: Review Of Ongoing Trials |
Presenter(s):Andrea T. Obi, MD | |
View Slides in PDF | |
2:52 PM - 2:57 PM | Update In Experimental DVT Pathogenesis And Resolution |
Presenter(s):Peter Henke, MD | |
View Slides in PDF | |
2:58 PM - 3:03 PM | Inflammation And Venous Thrombosis: An Evidence Summary |
Presenter(s):Thomas W. Wakefield, MD | |
View Slides in PDF | |
3:04 PM - 3:09 PM | Pediatric DVT: An Evidence Summary |
Presenter(s):Dawn M. Coleman, MD | |
View Slides in PDF | |
3:10 PM - 3:15 PM | Using The Femoral Vein As A Tunneling Conduit For An Arterial Bypass: Venous Outcomes In PQ Bypass |
Presenter(s):Mark A. Adelman, MD | |
View Slides in PDF | |
3:16 PM - 3:21 PM | Duration Of Anticoagulation |
Presenter(s):Rachel Rosovsky, MD, MPH | |
View Slides in PDF | |
3:22 PM - 3:27 PM | Should All Patients With Acute VTE Be Treated With A Statin: When And Dose |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Slides in PDF | |
3:28 PM - 3:33 PM | Update On Reversal Agents For The DOACs |
Presenter(s):Timothy K. Liem, MD, MBA | |
View Slides in PDF | |
3:34 PM - 3:39 PM | Role Of Thrombophilia Testing |
Presenter(s):Rachel Rosovsky, MD, MPH | |
View Slides in PDF | |
3:40 PM - 3:45 PM | Panel Discussion |
END OF SESSION 96 | |
SESSION 97 SCHEDULE | |
Friday
SESSION 97:
DEEP VEIN VALVE TECHNOLOGIES, CAVAL INTERRUPTION
Moderators:Mikel Sadek, MD / Jorge H. Ulloa, MD, FACS
|
|
x | |
DEEP VALVE PROGRESS | |
3:46 PM - 3:51 PM | US Experience Of The BlueLeaf®Endovenous Valve Formation: Update |
Presenter(s):William A. Marston, MD | |
View Slides in PDF | |
3:52 PM - 3:57 PM | Safety And Efficacy Report On The Venovalve (First In Man) IDE Feasibility Study |
Presenter(s):Jorge H. Ulloa, MD, FACS | |
View Slides in PDF | |
3:58 PM - 4:03 PM | The Need For A Deep Venous Valve For Severe CVI Patients With DVT |
Presenter(s):Mikel Sadek, MD | |
View Slides in PDF | |
4:04 PM - 4:09 PM | Implantable Bicuspid Valve: Early Preclinical Results |
Presenter(s):Paul J. Gagne, MD | |
View Slides in PDF | |
4:10 PM - 4:15 PM | Panel Discussion |
CAVAL INTERRUPTION | |
Moderator(s): Timothy K. Liem, MD, MBA / Jose I. Almeida, MD, FACS, RPVI, RVT | |
4:16 PM - 4:21 PM | Thrombosed IVC Filter: How To Recanalize The Cava And Manage The Filter |
Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
View Slides in PDF | |
4:22 PM - 4:27 PM | IVC Management In Pregnant Patients |
Presenter(s):Joann Lohr, MD | |
View Slides in PDF | |
4:28 PM - 4:33 PM | Surgical Removal Of IVC Filters: Perforation Or Infiltration |
Presenter(s):Timothy K. Liem, MD, MBA | |
View Slides in PDF | |
4:34 PM - 4:39 PM | Why Temporary Filters Are Not Removed: Clinical Predictors In 1,000 Consecutive Cases |
Presenter(s):Heron E. Rodriguez, MD | |
View Slides in PDF | |
4:40 PM - 4:45 PM | Panel Discussion |
END OF SESSION 97 | |
Saturday, November 20, 2021
Print Entire 2021 Program:
|
|
SESSION 98 SCHEDULE | |
Saturday
SESSION 98:
LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS (4 ¾-MINUTE TALKS)
|
|
x | |
7:00 AM - 7:05 AM | Optimal Vessel Prep Is Key To Successful BTK And Tibial Angioplasty (PTA): How To Do It |
Presenter(s):Peter A. Schneider, MD | |
View Slides in PDF | |
7:05 AM - 7:10 AM | Why Endovascular Treatments Should Be The First Choice For Common Femoral Artery (CFA) Occlusive Lesions |
Presenter(s):Niten Singh, MD | |
View Slides in PDF | |
7:10 AM - 7:15 AM | What Is The Real Complication Rate With Retrograde Tibial And Pedal Access: How To Minimize These Complications |
Presenter(s):Michael H. Wholey, MD, MBA | |
View Slides in PDF | |
7:15 AM - 7:20 AM | DEBATE: An Endo First Approach Is Best For Treating CLTI In All Patients: Is There Any Role For Open Bypasses |
Presenter(s):Christopher J. Abularrage, MD | |
View Slides in PDF | |
7:20 AM - 7:25 AM | DEBATE: Not So: Open Bypass Should Be The First Treatment For Some CLTI Patients: When Is This So And In What Percentage Of CLTI Patients |
Presenter(s):Karan Garg, MD | |
View Slides in PDF | |
7:25 AM - 7:30 AM | Panel Discussion |
7:30 AM - 7:35 AM | Value Of Atherectomy And Other Technologies In Heavily Calcified Infrapopliteal Lesions For CLTI: Which Lesions To Treat And What Do We Know About Their Impact |
Presenter(s):Venita Chandra, MD | |
View Slides in PDF | |
7:35 AM - 7:40 AM | Are Isolated Pedal Interventions For CLTI Worthwhile |
Presenter(s):Mark G. Davies, MD | |
View Slides in PDF | |
7:40 AM - 7:45 AM | DEBATE: Multivessel Tibial Revascularization Does Not Improve Limb Salvage In CLTI Patients: From A VQI Study |
Presenter(s):Venita Chandra, MD | |
View Slides in PDF | |
7:45 AM - 7:50 AM Power Point Presentation with Synched Audio |
DEBATE: Not So: In Some Circumstances Multivessel Tibial Revascularization Does Improve Outcomes In CLTI Patients: Which Circumstances |
Presenter(s):Brian G. DeRubertis, MD | |
View Slides in PDF | |
7:50 AM - 7:55 AM | Technical Tips For Open Tibial And Pedal Artery Exposures In Virginal And Redo Situations |
Presenter(s):William P. Robinson, MD | |
View Slides in PDF | |
7:55 AM - 8:00 AM | When Are Oral Antibiotics Without Excision Of Infected Bone Adequate Treatment For Osteomyelitis In The Foot |
Presenter(s):Wayne J. Caputo, DPM | |
View Slides in PDF | |
8:00 AM - 8:10 AM | Panel Discussion |
END OF SESSION 98 | |
SESSION 99 SCHEDULE | |
Saturday
SESSION 99:
MORE LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS (5-MINUTE TALKS)
Moderators:Ali F. AbuRahma, MD / Enrico Ascher, MD
|
|
x | |
8:10 AM - 8:15 AM | Dangers And Pitfalls Of Retrograde Lower Extremity Access Distal To The Common Femoral Artery |
Presenter(s):Venita Chandra, MD | |
View Slides in PDF | |
8:16 AM - 8:21 AM | Impact Of A Dedicated Limb Preservation/Limb Salvage Service On Amputation Rates: Must It Include An Open Bypass Surgery Component |
Presenter(s):Niten Singh, MD | |
View Slides in PDF | |
8:22 AM - 8:27 AM | Importance Of Functional And Ambulatory Status In Decision Making In CLTI Patients: Why Limbs Should Be Saved In Patients Who Are Not Ambulatory |
Presenter(s):Vincent L. Rowe, MD | |
View Slides in PDF | |
8:28 AM - 8:33 AM | Open Versus Endo Revascularizations In Dialysis Patients With CLTI: What Is The Role Of Each |
Presenter(s):Rabih A. Chaer, MD | |
View Slides in PDF | |
8:34 AM - 8:39 AM | What Is The Best Vessel Prep For Endo Treatments Of Heavily Calcified Lesions: Technical Tips And Precautions |
Presenter(s):Theodosios Bisdas, MD | |
8:40 AM - 8:45 AM | Real World Outcomes With Zilver PTX DESs For Complex Fempop Disease: Why Do They Differ From Trial Results |
Presenter(s):Ali F. AbuRahma, MD | |
View Slides in PDF | |
8:46 AM - 8:54 AM | Panel Discussion |
8:55 AM - 9:00 AM | Value Of Duplex Gray Scale In Predicting Successful SFA CTO Crossing, Re-Entry And The Need For Distal Access |
Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM | |
View Slides in PDF | |
9:01 AM - 9:06 AM Power Point Presentation with Synched Audio |
Effect Of Short-Term Complications Of Lower Extremity Revascularizations On Long-Term Outcomes And Patient Survival |
Presenter(s):Joseph L. Mills, MD | |
View Slides in PDF | |
9:07 AM - 9:12 AM Power Point Presentation with Synched Audio |
Endovascular Diagnosis And Control Of Hemorrhage After Fempop Open Operations: It Is A Better Way And How To Do It |
Presenter(s):Francesco Setacci, MD / Carlo Setacci, MD | |
View Slides in PDF | |
9:13 AM - 9:18 AM | Longer Procedure Times Are Predictive Of Worse Outcomes With Endovascular Treatments Of Lower Extremity Occlusive Lesions |
Presenter(s):Alan M. Dietzek, MD, RPVI, FACS | |
View Slides in PDF | |
9:19 AM - 9:24 AM Power Point Presentation with Synched Audio |
Lower Extremity Interventions (PTA, Stents, Atherectomy) Under IVUS Guidance: its Costs, Value And Limitations |
Presenter(s):Ignacio Escotto, MD | |
9:25 AM - 9:30 AM | Panel Discussion |
9:30 AM - 9:35 AM | Break – Visit Exhibits And Pavilions (North and West Foyers) |
END OF SESSION 99 | |
SESSION 100 SCHEDULE | |
Saturday
SESSION 100:
NEW DEVELOPMENTS IN COVID-19 TREATMENTS AND THE EFFECTS OF COVID-19 ON THE VASCULAR SYSTEM (5-MINUTE TALKS)
Moderators:Mark A. Adelman, MD / Ronald L. Dalman, MD
|
|
x | |
9:35 AM - 9:40 AM | Patients With AAAs Who Had COVID-19 May Need More Frequent Surveillance |
Presenter(s):Ronald L. Dalman, MD | |
View Slides in PDF | |
9:41 AM - 9:46 AM | What Will Be The Post-Pandemic Steady State Of Novel Infection And Acquired Immunity: Is “Herd Immunity” A Realistic Concept |
Presenter(s):Clayton J. Brinster, MD | |
View Slides in PDF | |
9:47 AM - 9:52 AM | Impact Of COVID-19 On The Extra- And Intracranial Circulation: How Effective Are Endovascular Treatments |
Presenter(s):Allan L. Brook, MD | |
View Slides in PDF | |
9:53 AM - 9:58 AM | Current Treatment Paradigms For Symptomatic COVID-19 Infection: What Works, What Doesn’t, What’s Available And What’s In The Pipeline |
Presenter(s):Clayton J. Brinster, MD | |
View Slides in PDF | |
9:59 AM - 10:04 AM | Endovascular Management Of COVID-19 Induced Acute Limb Ischemia: When Is It Effective And When Not |
Presenter(s):Karthik Kasirajan, MD | |
View Slides in PDF | |
10:05 AM - 10:10 AM | Do Current Vaccines Or Previous Infection Protect Against New Variants Of COVID-19: Will Vaccine Boosters Be Required – For Whom And How Often |
Presenter(s):Clayton J. Brinster, MD | |
View Slides in PDF | |
10:11 AM - 10:20 AM | Panel Discussion |
END OF SESSION 100 | |
SESSION 101 SCHEDULE | |
Saturday
SESSION 101:
AORTIC TOPICS TOO IMPORTANT TO MISS (5-MINUTE TALKS)
Moderators:James F. McKinsey, MD / Kenneth Ouriel, MD, MBA
|
|
x | |
10:20 AM - 10:25 AM | Improved System For Evaluating Aortic Neck Anatomy And Suitability For EVAR And F/EVAR |
Presenter(s):David J. Minion, MD | |
View Slides in PDF | |
10:26 AM - 10:31 AM | Top 10 Clinical Trials That Are Needed In AAA Disease |
Presenter(s):Ronald L. Dalman, MD | |
View Slides in PDF | |
SPINE EXPOSURE SURGERY | |
10:32 AM - 10:39 AM | Technical Tips And Tools For The Vascular Surgeon To Provide Anterior Exposure For Spine Procedures (7-Minute Presentation) |
Presenter(s):Jeffrey Jim, MD, MPHS | |
View Slides in PDF | |
10:40 AM - 10:47 AM | Vascular Complications Of Anterior Spine Exposures; How To Avoid Them And How To Treat Them If They Occur (7-Minute Presentation) |
Presenter(s):William P. Robinson, MD | |
View Slides in PDF | |
10:48 AM - 10:53 AM | EVAR Outside The IFUs Of Commercial Devices Is Sometimes Justified And Does Not Negatively Impact On Midterm Outcomes: When Is This So |
Presenter(s):George A. Antoniou, MD, PhD, MSc, FEBVS | |
View Slides in PDF | |
10:54 AM - 11:00 AM | Panel Discussion |
11:00 AM - 11:05 AM | How To Avoid Axillary Artery Complications After Large Sheath Use In Complex AAA Repairs |
Presenter(s):Michael C. Stoner, MD | |
View Slides in PDF | |
11:06 AM - 11:11 AM | Late Complications Of F/B/EVAR In An Experience Of >1000 Cases |
Presenter(s):Eric L.G. Verhoeven, MD, PhD / Athanasios Katsargyris, MD | |
View Slides in PDF | |
11:12 AM - 11:17 AM | With F/EVAR Intraoperative Endoleaks Do Not Predict Midterm Failure |
Presenter(s):Michael J. Singh, MD | |
View Slides in PDF | |
11:18 AM - 11:23 AM | Left Subclavian Revascularization With TEVAR: Technical Tips And Tools To Make In Situ Fenestration Easy |
Presenter(s):Wayne W. Zhang, MD | |
View Slides in PDF | |
11:24 AM - 11:29 AM | Variable Curve Directional Sheaths Will Eliminate The Need For Upper Extremity Access With F/B/EVAR: Which Sheath Is Best And Pitfalls |
Presenter(s):James F. McKinsey, MD | |
View Slides in PDF | |
11:30 AM - 11:35 AM | How Can Computer Modeling Help To Improve The Treatment Of TBADs |
Presenter(s):Ross Milner, MD | |
View Slides in PDF | |
11:36 AM - 11:42 AM | Panel Discussion |
END OF SESSION 101 | |
SESSION 102 SCHEDULE | |
Saturday
SESSION 102:
AORTIC AND CAROTID TOPICS TOO IMPORTANT TO MISS 5-MINUTE TALKS)
|
|
x | |
AORTIC TOPICS | |
11:42 AM - 11:47 AM | Options For Managing The Left Subclavian Artery When Performing Endovascular Treatment Of Zone 2 Lesions |
Presenter(s):Edward Y. Woo, MD / Steven D. Abramowitz, MD | |
View Slides in PDF | |
11:48 AM - 11:53 AM | Carotid-To-Axillary Bypass Is Better Than Carotid-Subclavian Bypass For Revascularizing Subclavian Arteries With TEVAR: Why And How To Do It |
Presenter(s):Frank J. Criado, MD | |
View Slides in PDF | |
11:54 AM - 11:59 AM | When Is A Left Subclavian Chimney Graft Better Than A Carotid-Subclavian Bypass For Preserving Subclavian Artery Flow |
Presenter(s):R. Clement Darling III, MD | |
View Slides in PDF | |
12:00 PM - 12:05 PM | Upper Extremity Access For Complex Endo AAA Repairs Is Associated With A High Rate Of Stroke: From A VQI Study |
Presenter(s):Marc L. Schermerhorn, MD | |
View Slides in PDF | |
12:06 PM - 12:11 PM | DEBATE: The Vast Majority Of Failed EVARs Can Be Treated Endovascularly |
Presenter(s):Jean-Pierre Becquemin, MD, FRCS | |
View Slides in PDF | |
12:12 PM - 12:17 PM | DEBATE: Not So: Many Failed EVARs Are Best Repaired By Open Conversion |
Presenter(s):Michel Makaroun, MD | |
View Slides in PDF | |
12:18 PM - 12:23 PM | AAAs With Large Diameter Necks (>34 mm) Do Poorly With EVAR: How Should Such Patients Be Treated |
Presenter(s):Matt M. Thompson, MD | |
View Slides in PDF | |
12:24 PM - 12:29 PM | Value Of 3D Flow Models To Analyze The Cause Of Failure After F/EVAR And TEVAR |
Presenter(s):Maciej L. Dryjski , MD, PhD | |
View Slides in PDF | |
12:30 PM - 12:35 PM | Panel Discussion |
CAROTID TOPICS | |
12:35 PM - 12:40 PM | How To Use The Silk Road TCAR Device In The Treatment Of Tandem Carotid Lesions: Technical Tips And Results |
Presenter(s):Michael C. Stoner, MD | |
View Slides in PDF | |
12:41 PM - 12:46 PM | Radiation And Carotid Stenosis: What Is The Relationship And How Is Radiation Stenosis Best Treated When Asymptomatic And When Symptomatic |
Presenter(s):Cynthia K. Shortell, MD | |
View Slides in PDF | |
12:47 PM - 12:52 PM | Mini-Incision CEA With Standard Or Eversion Techniques: How To Do It Safely: It’s Better Than Transfemoral CAS Or TCAR |
Presenter(s):Alan M. Dietzek, MD, RPVI, FACS | |
View Slides in PDF | |
12:53 PM - 12:58 PM Power Point Presentation with Synched Audio |
TCAR With Flow Reversal Versus Transcervical CAS With Distal Protection: TCAR’s Benefit Is Not Just Due To Its Avoidance Of Having To Traverse The Aortic Arch |
Presenter(s):Mahmoud B. Malas, MD, MHS | |
View Slides in PDF | |
12:59 PM - 1:05 PM | Panel Discussion Lunch Available |
END OF SESSION 102 | |
SESSION 103 SCHEDULE | |
Saturday
SESSION 103:
IMPORTANT ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
Moderators:Larry A. Scher, MD / Anton N. Sidawy, MD, MPH
|
|
x | |
8:06 AM - 8:13 AM | What Vascular Access Issues Are Important To Patients |
Presenter(s):Dori R. Schatell, MS | |
View Slides in PDF | |
8:14 AM - 8:21 AM | Where Should Patients And Physicians Get Information About Hemodialysis Access |
Presenter(s):Ellen D. Dillavou, MD | |
View Slides in PDF | |
8:22 AM - 8:29 AM | AmplifiTMVein Dilation System: First In Human Study |
Presenter(s):Surendra Shenoy, MD, PhD | |
View Slides in PDF | |
8:30 AM - 8:37 AM | Update On The Use Of Fist Assist To Maximize Creation And Maturation Of Autogenous AV Fistula |
Presenter(s):Tej M. Singh, MD, MBA | |
View Slides in PDF | |
8:38 AM - 8:45 AM | Surgical Management Of The Mega Fistula |
Presenter(s):John R. Ross, Sr., MD | |
View Slides in PDF | |
8:46 AM - 8:53 AM | Cardiovascular Implantable Electronic Devices In Hemodialysis Patients: Prevalence And Strategies For Management |
Presenter(s):Theodore F. Saad, MD | |
View Slides in PDF | |
8:54 AM - 9:04 AM | Panel Discussion |
9:05 AM - 9:12 AM | Body Image, Sexuality And Hemodialysis Access |
Presenter(s):Dori R. Schatell, MS | |
View Slides in PDF | |
9:13 AM - 9:20 AM | Options For Management Of Deep AV Fistulas |
Presenter(s):William Jennings, MD | |
View Slides in PDF | |
9:21 AM - 9:28 AM | Managing The Pulsatile AV Access: How To Prolong Access Life |
Presenter(s):Surendra Shenoy, MD, PhD | |
View Slides in PDF | |
9:29 AM - 9:36 AM | Use Of Drug Eluting Balloons And Stents: What Does The Data Tell Us |
Presenter(s):Theodore F. Saad, MD | |
View Slides in PDF | |
9:37 AM - 9:44 AM Power Point Presentation with Synched Audio |
LIMA Steal Syndrome After Ipsilateral AV Fistula: Is It Real |
Presenter(s):Jeffrey E. Indes, MD | |
View Slides in PDF | |
9:45 AM - 9:52 AM | Early Banding For High Flow AV Fistulas |
Presenter(s):Moro Salifu, MD | |
View Slides in PDF | |
9:53 AM - 10:03 AM | Panel Discussion |
10:04 AM - 10:25 AM | Break – Visit Exhibits And Pavilions (North, West and Center Foyers) |
END OF SESSION 103 | |
SESSION 104 SCHEDULE | |
Saturday
SESSION 104:
MORE IMPORTANT ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
|
|
x | |
10:26 AM - 10:33 AM | Performance Of Vascular Access Procedures During A Global Pandemic |
Presenter(s):Haimanot (Monnie) Wasse, MD, MPH, FASN | |
View Slides in PDF | |
10:34 AM - 10:41 AM | Surgeon’s Perspective On Management Of Acute Kidney Injury During The COVID-19 Pandemic |
Presenter(s):Clifford M. Sales, MD, MBA, FACS | |
View Slides in PDF | |
10:42 AM - 10:49 AM | How Has COVID-19 Impacted Medicare Reimbursement |
Presenter(s):Evan C. Lipsitz, MD, MBA | |
View Slides in PDF | |
10:50 AM - 10:57 AM | Does A High Bifurcation Brachial Artery Affect Outcomes For AV Fistulas And Grafts |
Presenter(s):John S. Futchko, MD | |
View Slides in PDF | |
10:58 AM - 11:05 AM Power Point Presentation with Synched Audio |
Accelerating Technology Development During A Pandemic To Bring More People With Kidney Failure Home |
Presenter(s):Prabir Roy-Chaudhury, MD, PhD | |
View Slides in PDF | |
11:06 AM - 11:16 AM | Panel Discussion |
THE USE OF ULTRASOUND IN CONTEMPORARY DIALYSIS ACCESS PRACTICE | |
Moderator(s): John E. Aruny, MD / Clifford M. Sales, MD, MBA, FACS | |
11:17 AM - 11:24 AM | Preoperative Vessel Mapping: Did KDOQI Really Make This Optional |
Presenter(s):Surendra Shenoy, MD, PhD | |
View Slides in PDF | |
11:25 AM - 11:32 AM | Economic And Clinical Impact Of Changes In Reimbursement For Predialysis Duplex Planning |
Presenter(s):Jason K. Wagner, MD | |
View Slides in PDF | |
11:33 AM - 11:40 AM | Incorporating Point Of Care Ultrasound Into The Practice Of Nephrology |
Presenter(s):Vandana D. Niyyar, MD | |
View Slides in PDF | |
11:41 AM - 11:48 AM | Use Of IVUS For Evaluation And Sizing Of Central Vein Stenosis |
Presenter(s):John E. Aruny, MD | |
View Slides in PDF | |
11:49 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (North, West and Center Foyers) |
END OF SESSION 104 | |
SESSION 105 SCHEDULE | |
Saturday
SESSION 105:
POLITICAL, ECONOMIC AND LEGAL ISSUES IN HEMODIALYSIS ACCESS (7- 10-MINUTE TALKS)
Moderators:Larry A. Scher, MD / Anton N. Sidawy, MD, MPH
|
|
x | |
1:00 PM - 1:07 PM | Creating AV Fistulas For Children In Guatemala |
Presenter(s):William Jennings, MD | |
View Slides in PDF | |
1:08 PM - 1:15 PM Power Point Presentation with Synched Audio |
How Will Government Initiatives Move Patients From Dialysis Centers To Home Dialysis |
Presenter(s):Sean D. Kalloo, MD | |
View Slides in PDF | |
1:16 PM - 1:23 PM | Implementing The Results Of A Randomized Trial Comparing Early Cannulation Grafts To Catheters Into Practice |
Presenter(s):David Kingsmore, MD, FRCS (Ed), MBChB, BMedBiol | |
View Slides in PDF | |
1:24 PM - 1:31 PM | How Artificial Kidneys And Miniaturized Dialysis Could Save Millions Of Lives |
Presenter(s):Buddy D. Ratner, PhD | |
View Slides in PDF | |
1:32 PM - 1:36 PM | Panel Discussion |
END OF SESSION 105 | |
SESSION 106 SCHEDULE | |
Saturday
SESSION 106:
NEW TECHNOLOGIES AND OTHER IMPORTANT CLINICAL ISSUES IN AV ACCESS (7-MINUTE TALKS)
|
|
x | |
1:47 PM - 1:54 PM | Use Of External Support Devices To Improve AV Fistula Maturation |
Presenter(s):Ellen D. Dillavou, MD | |
View Slides in PDF | |
1:55 PM - 2:02 PM | Use Of Pharmacologic Adjuncts To Improve AV Fistula Maturation |
Presenter(s):Alan Dardik, MD, PhD | |
View Slides in PDF | |
2:03 PM - 2:10 PM | DEBATE: Will EndoAV Fistulas Ever Become The Gold Standard: EndoAV Fistula Is Better Than Surgery |
Presenter(s):Neghae Mawla, MD, FASDIN | |
View Slides in PDF | |
2:11 PM - 2:18 PM | DEBATE: Will EndoAV Fistulas Ever Become The Gold Standard: Surgery Is Still The Gold Standard |
Presenter(s):John R. Ross, Sr., MD | |
View Slides in PDF | |
2:19 PM - 2:26 PM | Cannulation Issues With Endovascular Fistulas |
Presenter(s):Deborah Brouwer-Maier, RN, CNN | |
View Slides in PDF | |
2:27 PM - 2:34 PM | A Non-Biologic Vascular Prosthesis That Heals And Integrates: Application For Dialysis Blood Access And Small Diameter Sites |
Presenter(s):Buddy D. Ratner, PhD | |
View Slides in PDF | |
2:35 PM - 2:42 PM | What Is The Best Option For Cephalic Arch Stenosis |
Presenter(s):Mark G. Davies, MD | |
View Slides in PDF | |
2:43 PM - 2:50 PM | Management Of The Abandoned HeRO Device |
Presenter(s):Stephen E. Hohmann, MD | |
View Slides in PDF | |
2:51 PM - 2:58 PM | HeRO Graft With ARtegraft Attachment For Hemodialysis Access: What Are The Outcomes |
Presenter(s):Jesse Garcia, MD | |
View Slides in PDF | |
2:59 PM - 3:06 PM | WRHAPSODY™ Endovascular Stent Graft (Merit Medical) For Treatment Of Hemodialysis Access Outflow Stenosis |
Presenter(s):James A. Gilbert, MD | |
View Slides in PDF | |
3:07 PM - 3:25 PM | Panel Discussion |
END OF SESSION 106 | |